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5. De consumptie van doorbakken vlees zou zeker aan personen met een verhoogde 
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Cancer Research 2001, 61, 2381-2385 
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6. Als modelorganisme voor de selectie van verbindingen met antischimmel en antitu-
mor activiteit is Saccharomyces cerevisiae geen goede keuze vanwege het beperkte 
detoxificeringsvermogen van deze gist. 
Clinical Microbiology Reviews 1999, 12, 583-611 
7. Indien men een biokatalytisch kinetisch resolutie proces als 'Green Chemistry' wil 
typeren zou men er ook naar kunnen streven om de gei'ntegreerde synthese van sub-
straten volgens overeenkomstige richtlijnen uit te voeren. 
Tetrahedron 2001, 57, 695-701 
Green Chemistry: designing chemistry for the environment, ACS Symposium Series 
626, 1998, pp 1-17 
8. DNA Copyright zou een effectief voorbehoedsmiddel zijn. 
BBC News, August 15, 2001 
9. Wachtlijsten in de zorgsector zijn het gevolg van de toegenomen vraag naar een 
betere 'kwaliteit van leven' voor het personeel. 
10. Het laten opgroeien van kinderen op een 'Vinexlocatie' kan gezien worden als een 
hedendaagse vorm van Spartaanse opvoeding. 
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resolution. Caret A. CM. Weijers. 
Wageningen, 21 november 2001. 
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Introduction 
1.1 Enantiopure epoxides as building blocks 
1.1.1 Molecular chirality 
Objects that cannot be superimposed on their mirror image are called chiral, derived 
from the Greek word chiros meaning 'handed'. The term chirality is therefore based on 
the familiar analogy of the morphological mirror-image relation between the left and 
right hand. The concepts of chirality can be extended from macroscopic objects like 
hands, screws and spiral staircases to molecules. A molecule is chiral if it contains a chi-
rality center, which is usually a tetrahedral carbon atom attached to four different atoms 
or groups of atoms. The four atoms or groups can be arranged in different ways corre-
sponding to different stereoisomers. The precise arrangement of substituents at a chiral-
ity center is termed absolute configuration. 
Stereoisomers that are related as nonsuperimposable mirror images are called enan-
tiomers. The nomenclature of enantiomers is based on their absolute configurations and 
generally assigned by the Sequence Rule notation of the 'Cahn-Ingold-Prelog system'1. 
In this way, molecules are assigned the (.^-configuration (descending priority of sub-
stituents in clockwise direction) or (^-configuration (anticlockwise direction). Mixtures 
containing equal quantities of enantiomers are called racemic mixtures or racemates. 
Abiotically produced chemical compounds are generally racemic. In sharp contrast to 
this, the chemistry of living organisms is homochiral, being based almost exclusively on 
L-amino acids (or (5)) and D-polysaccharide monomers (or (/?)). The current biosphere 
is thus commonly characterized as being composed of building blocks with biomolecu-
lar homochirality. The term 'homochirality' is synonym with 'enantiopurity' but the lat-
ter is more commonly used to describe a certain compound in particular. 
Many physical properties like density, melting point and boiling point are identical for 
enantiomers. There is one difference in physical properties: enantiomers can be distin-
guished because they rotate plane-polarized light (PPL) in opposite directions. 
Enantiomers that rotate PPL to the right are indicated by a (+) before the name; those that 
rotate PPL to the left are indicated by a (-). The direction and amount of rotation of an 
enantiopure compound, determined under standard conditions, is termed specific rotation 
([a]) and is a typical physical property of that compound. The chemical properties of 
enantiomers are identical in a symmetric environment, but they are distinct in a chiral 
environment. This difference is of crucial importance in many reactions in living cells. 
The importance of 'handedness' in Nature is such that scientists have long been won-
dered about its origin. Theories for the origin of homochirality were at first distinguished 
in two main categories, biotic and abiotic23. The biotic or selection theories suggest that 
life arose in a racemic environment and that homochirality as such developed later. 
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Nowadays it is generally accepted that homochirality did not have a biogenic origin46. 
Homochirality is now assumed to be a prerequisite for the enantiopure monomers to 
form the folded structures of a protein (for example the a-helix) essential for the catalyt-
ic function of enzymes, and the double helix of DNA, essential for replication. In view 
of this, abiotic theories suggest that primitive biomolecules required an initial enan-
tiomeric excess. Such an enantiomeric imbalance could have occurred by chance or in a 
determinate way. Abiotic theories have been discussed recently in literature49. Chance or 
random mechanisms include competing autocatalysis, asymmetric adsorption and spon-
taneous crystallization of conglomerates. Alternatively, determinate mechanisms suggest 
that some chiral physical interaction acting on racemates would have caused an initial 
very small enantiomeric excess that subsequently could be amplified. Examples of this 
are photochemistry with circularly polarized light and magnetochiral photochemistry. 
Despite the many theories, the mystery of the origin of the homochirality of life still has 
not been solved. 
At a molecular level, biological systems are homochiral environments composed of 
biopolymers from chiral precursors as amino acids and carbohydrates. Many biochemi-
cal processes involve an interaction with these homochiral biomolecules. Examples are 
interactions with enzymes and receptor systems for hormones, sensory recognition and 
drug metabolism. It can thus be understood that biological receptors almost always show 
a stereochemical preference for one of a pair of enantiomers. In order to rationalize these 
observed differences in biological activity, a 3-point fit model has been proposed1011. 
Such a model is schematically depicted in Scheme 1. 
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Scheme 1. Enantiomeric interactions of a chiral ligand with protein sites A, B, C and D of a biologi-
cal receptor molecule. 
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In interactions between chiral ligands and receptor molecules, the geometry of the active 
site on the biological receptor is the determinant, rather than the geometry of the ligand. 
In Scheme 1, the receptor is considered as a fixed conformation and thus showing max-
imal interaction with the (7?)-enantiomer of the chiral ligand (combination 
Aa+Bb+Cc+Dd). For the (S)-enantiomer only two interactions are possible. Due to the 
difference in interaction and subsequent biological activity, the (7?)-enantiomer is termed 
in this case as the eutomer and the (S)-enantiomer as distomer10. The terminology of 
eutomer and distomer is only related to a higher or lower activity, respectively, regard-
less of the absolute configuration of the ligand enantiomers. 
Very recently, a more general model for enantiomeric receptor interactions has been 
reported12. This new model is called a 'four-point location' model in which a protein 
might provide two sites (D' and D") in either of two locations for interaction with site D: 
D' would bind one enantiomer and D" the other one. In this model, it is not necessary 
for there to be four binding sites, but, for example, three interaction sites and a fourth 
direction also makes discrimination of enantiomers possible. 
1.1.2 Enantiopure bioactive compounds 
In biological systems, the transfer of information is largely controlled by interaction of 
specific substrates with particular sites on enzymes, receptors and carrier molecules13. On 
the molecular level, selective interaction with specific substrates is based upon comple-
mentary chemistry with a high degree of homochirality as described before. Endogenous 
and exogenous substrates that activate biological activity by their interaction are called 
bioactive compounds. Since the late 1980s, it has been understood and generally accept-
ed that exogenous bioactive compounds like agrochemicals and pharmaceuticals can be 
more effectively exploited by using their single eutomer rather than the racemate. Apart 
from low or high activity, also the presence or absence of adverse side effects, and 
desired or antagonistic effects has been observed additionally1316. In view of their differ-
ential molecular configuration and consequent biological activity, stereoisomers have to 
be regarded as essentially different compounds13. Bioactive compounds are therefore 
now preferably produced as single isomers. 
In the case of racemic synthetic agrochemicals, differential biological activity of 
stereoisomers can be expressed by different degrees of intrinsic activity and by different 
selectivity between the target and all other species with which the product comes into 
contact1718. For these compounds most concern has been directed towards the environ-
mental consequences of application of the less active distomer which poses an addition-
al loading on the environment. Differing biological activities, synthesis and analysis of 
isomers of various synthetic agrochemicals have been reported1920. 
The structure-activity relationship of stereoisomers from pharmaceuticals has been 
similarly well recognized to have a major influence on their pharmacological response16. 
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Nowadays, pharmaceutical companies are aware that, where appropriate, new pharma-
ceuticals should be enantiopure to avoid the possibility of adverse side effects due to an 
undesirable stereoisomer. During the last decade, the portion of synthetic pharmaceuti-
cals introduced as single isomers has grown very rapidly. This growth was made possi-
ble by (z) a strategic conversion to the development of single isomers as initiated by the 
publication of the 'Stereoisomer Drug Policy' of the US Food and Drug Administration 
(FDA)21-22 in 1992 and (ii) recent advances in the synthesis of enantiopure compounds23. 
For the production of enantiopure agrochemical and pharmaceutical intermediates, an 
increasingly prominent position has been occupied by biocatalytic processes, using 
enzymes and microbial cells as catalysts2429. 
1.1.3 Enantiopure epoxides 
A great number of bioactive compounds can be effectively synthesized from enantiopure 
epoxides used as chiral building blocks. Epoxides, or oxiranes, are three-membered 
cyclic ethers that are highly reactive due to their considerable bond angle strain. Products 
of ring-opening reactions have normal tetrahedral bond angles and are not strained 
(Scheme 2). 
In organic synthesis, ring-opening reactions by addition of nucleophilic reagents to 
epoxides has been widely used to form 1,2-disubstituted products30. In this way, nucle-
ophiles containing oxygen, nitrogen, sulfur and halides can be added to the target mole-
cule. As a consequence of their high reactivity, epoxides must be handled carefully and 
regarded as hazardous genotoxic compounds which are able to alkylate nucleophilic cen-
ters of DNA3i.32. 
Nucleophilic ring-opening can occur at either neutral, basic, or acid conditions, but 
acids generally accelerate ring-opening. Unsymmetrical epoxides give different products 
under acid-catalyzed and base-catalyzed or neutral conditions, as shown in Scheme 2. 
Normally, backside attack of the nucleophile on an epoxide carbon occurs, resulting in 
inversion of configuration at this center. Under base-catalyzed and neutral conditions, 
attack predominantly takes place at the sterically less hindered Cp carbon atom in a typi-
cal SN2-type reaction. The mechanism under acid-catalyzed conditions is dictated by the 
stability of the protonated transition state, which favors nucleophilic attack at the more 
substituted Ca carbon. Although these are typical SN1 conditions, the actual acid-catalyzed 
mechanism is somewhere between SN1 and SN2. The influence of SN2 is contributed by the 
stereochemistry of the reaction: the nucleophile approaches from the side opposite of the 
leaving oxygen. Because such reactions have features of both the SN1 mechanism (regio-
chemistry) and the SN2 mechanism (stereochemistry), they are termed 'borderline SN2' 
reactions. 
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Scheme 2. Ring-opening of epoxides under acid-catalyzed (a, b, c; attack at Ca) and base-catalyzed 
conditions (d, e; attack at CB). Under acid-catalyzed conditions, epoxides are protonated and opened 
to a carbocation-like intermediate. The positively charged intermediate can be converted to (a) a 1,2-
disubstituted product by addition of a nucleophile following a 'borderline SN2' mechanism, to (b) a 
ketone by an internal hydride-shift, or to (c) an aldehyde by an internal carbon-shift. Most important 
base-catalyzed reactions are (d) nucleophilic ring-opening by a pure SN2 reaction and (e) hydrogen 
abstraction from Cp adjacent R3 and subsequent epoxide opening to form allylic alcohols. 
Attack on Ca or Cp is not strictly defined by the reaction conditions but depends as well 
on the balance of steric and electronic factors arising from both substituent and nucle-
ophile. For example, alkyl substituents favor attack at Cp whereas conjugating sub-
stituents tend to stabilize carbocations and thus favor attack at C„. The chemistry and 
chemocatalytical ring-opening of epoxides has been reviewed in literature30-35. 
Enantiopure epoxides can be used to introduce one or two adjacent chirality centers in 
a target molecule or, in some specific cases, directly as compound with intrinsic bio-
logical activity. Biologically important enantiopure natural epoxides are for example 
Juvenile insect hormones36 and the antitumor agent Epothilone A37. Table 1 shows 
'classical' examples of enantiopure synthetic epoxides used as key intermediates in the 
synthesis of specific pharmaceuticals. 
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Table 1. Synthetic epoxides prepared by kinetic resolution and used as enantiopure pharmaceutical 
intermediates. 
Epoxide product pharmacological 
activity 
02N 
(*)-l 
sAK 
(2R,3S)-2 
(lS,2R)-3 
(J-adrenergic 
blocker38 
Ca2+ channel 
blocker39 
HIV protease 
inhibitor40 
The desired biological activity of the pharmaceutical products given in Table 1 is present 
only in the eutomers having the configuration as shown. Preparation of the enantiopure 
epoxides 1, 2, and 3 has been demonstrated by biocatalytic kinetic resolution processes 
(see paragraph 1.2). For this, optimized methods using bacterial lipases for the large-
scale preparation of epoxide-2 and fungal epoxide hydrolases for preparation of epoxide-
1 and 3 respectively, were applied successfully4143. 
1.2 Kinetic resolution of epoxides 
1.2.1 Principles of kinetic resolution 
The process for separation of enantiomers forming a racemic compound is defined as res-
olution. In fact, two types of resolution can be distinguished, depending on the composi-
tion of the racemic starting material. 
13 
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Spontaneous resolution is defined as a process in which the two enantiomers of a con-
glomerate are equally separated44. A conglomerate is a 1:1 mechanical mixture of crys-
tals, each crystal consisting of pure enantiomers. It is estimated that about 10% of the chi-
ral organic solids form conglomerates45. In conglomerate systems, the racemate is more 
soluble that the constituent enantiomers. During crystallization of conglomerates, sepa-
ration of the crystals, consisting of the single enantiomers, occurs spontaneously. 
Kinetic resolution is an enantioselective reaction in which one of the enantiomer con-
stituents of a racemic mixture is more readily transformed into a product, or adsorbed to 
a matrix, than the other46. 
R 
h 
— P 
Kinetic resolution by substrate transformation occurs if k^ ^ k5 and the reaction is termi-
nated between 0% and 100% conversion of the racemate (R,S). Kinetic resolution essen-
tially requires the partial transformation of a racemic mixture. This is in contrast with 
spontaneous resolution, which usually involves complete transformation of a racemic 
mixture. 
Kinetic resolution is basically linked to kinetics and can be applied to both chemocat-
alytic as well as biocatalytic reactions. In the case of kinetic resolution of racemic epox-
ides, the reaction can be described as an irreversible conversion of a single substrate (R 
or S) into a single product (P or Q). Therefore, the quantitative analysis of biocatalytic 
kinetic resolutions as developed by Chen et al.41 can be applied to enzymatic epoxide 
ring-opening reactions. 
The (biochemical) stereoselectivity factor E, or enantiomeric ratio E, is by definition 
an intrinsic property of the biocatalyst. The value of E depends on the ratio of the enzyme 
specificity constants V (Vmax, maximal velocity) and K (Km, Michaelis-Menten constant) 
of the (R)- and (^-enantiomers, as shown in equation [1]: 
E = 
VRKR 
VSKS 
[1] 
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The enantiomeric composition of a racemate during the course of resolution is repre-
sented by its e.e. value (enantiomeric excess). In case of preferential conversion of a (S)-
enantiomer, the enrichment in (7?)-enantiomer is determined by equation [2]: 
([R] - [S]) 
e.e. = [2] 
([R] + [S]) 
For the determination of E, several different methods are available, dependent on the 
combination of monitored parameters48. In irreversible enantioselective ring-opening 
reactions of epoxides, equations [3], [4] and [5] are appropriate methods for the determi-
nation of E. Equation [3] represents the e.e. of substrate versus extent of conversion C, 
and equation [4] the e.e. of product versus extent of conversion C. 
ln[(l-0(l-e.e. s)] 
E= [3] 
ln[(l-C)(l+e.e.s)] 
ln[(l-0(l+e.e.p)] 
E= P— [4] 
ln[(l-0(l-e.e.p)] 
In equation [5], R0 and S0 are the initial concentrations of the individual enantiomers at 
t=0. The slope of the plotted curve, obtained by data from equation [5], represents the E 
value. 
In ([/?(,] / [R]) 
E= [5] 
In ([S0] / [S]) 
In Figure 1, the evolution of e.e. (substrate) as a function of conversion, for various val-
ues of E, is visualized. These graphic representations are very helpful to estimate the 
amount of enantiopure remaining substrate that can be obtained. The curves represented 
in Figure 1 show that the maximal feasible yield is 50%, in kinetic resolutions. It is also 
obvious that reactions with £=100 are almost as effective as those are with E - °°. In gen-
eral, reactions with significant enantioselectivities show values of £>20. 
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100 
conversion (%) 
Figure 1. Effect of the e.e. of remaining substrate as function of the conversion, for various enan-
tiomeric ratios E46. 
1.2.2 Chemocatalytic and biocatalytic kinetic resolution of epoxides 
The synthesis of enantiopure epoxides by chemocatalytic and biocatalytic methods has 
been studied extensively during the last decade. Well developed are chemocatalytic epox-
idation reactions for the preparation of enantiopure epoxides from allylic alcohols and 
from conjugated alkenes49. However, due to the absence of methods for preparation of 
simple alkyl epoxides also alternative procedure have been explored. From these inves-
tigations, a most promising method has appeared to be chemocatalytic hydrolytic kinet-
ic resolution. The method has shown to be successful in the preparation of several enan-
tiopure aliphatic 1,2-epoxides and 1,2-diols (Scheme 3)50. For this, synthetic chiral cata-
lysts have been prepared with their structure mimicking the enzyme active-site geome-
try. By use of the synthetic Jacobsen's (R,R)- and (1S',5)-salen(Co)III(OAc) catalysts, both 
enantiopure (5)- and respectively (/?)- 1,2-epoxides were prepared from C3 and from C10 
to C20 racemic epoxides51. Recently, the range of substrates has been extended by epox-
ides bearing substituents with varying steric demand and composition. The method how-
ever is still restricted to the resolution of monosubstituted epoxides35. 
16 
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(5,5)-salen(Co)III(OAc) 
O 
R 
+ H70 
(/?,/?)-salen(Co)III(OAc) 
(R) '" (S) 
Scheme 3. Chemocatalytic hydrolytic kinetic resolution of various aliphatic 1,2-epoxides. 
Alternatively, biocatalytic production methods for enantiopure epoxides have been 
developed simultaneously. Biocatalytic production methods have been reviewed in liter-
ature5256. However, mainly due to the high toxicity of epoxides towards the biocatalysts, 
several biocatalytic methods were hampered by product inhibition and therefore are dif-
ficult to scale-up. 
Most effectively were the methods based on the use of enzymes that were able to enan-
tioselectively degrade epoxides. Known epoxide-converting enzymes are epoxide hydro-
lases and epoxide carboxylases. And, also lipases have been used for the kinetic resolu-
tion of glycidyl esters. In Scheme 4, general reactions of biocatalytic epoxide resolutions 
are shown. 
lipase 
H7o R 
O 
OH 
O 
Ri* 
O 
O 
A. 
R, 
O epoxide carboxylase 
NAD, NADPH R 
O 
+ 
epoxide hydrolase O 
R,' H2U R, 
Scheme 4. Biocatalytical kinetic resolution of epoxides 
+ 
HO 
l OH 
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Lipase-catalyzed resolutions are generally easy to scale-up because the enzyme is not 
deactivated by reaction with the epoxide moiety. The reaction was successful in the 
preparation of enantiopure epoxy alcohols57 and enantiopure glycidyl esters5859. But 
lipase-catalyzed resolutions, being based on hydrolysis of the ester side-chain, are how-
ever limited by the scope of suitable epoxide substrates. 
Resolution of epoxides by direct asymmetric ring-opening are catalyzed by epoxide 
carboxylase and epoxide hydrolase enzymes (Scheme 4). All epoxide-bearing com-
pounds can thus be regarded as potential substrates for these enzymes. Consequently, 
these two enzymes can be regarded as attractive tools in biocatalysis. 
1.2.3 Asymmetric ring-opening o/meso epoxides 
Compounds that have two or more equivalent chirality centers, but are nevertheless achi-
ral, are called meso compounds. Meso compounds can be converted to enantiopure prod-
ucts in a theoretical 100% chemical yield60. The possible high yield makes this process 
of desymmetrization in certain cases even more advantageous than kinetic resolution. 
Unfortunately, desymmetrization of meso epoxides is limited to some specific exam-
ples of symmetric ds-disubstituted and tetrasubstituted molecules. Asymmetric ring-
opening of meso epoxides is possible by use of synthetic catalysts356162 and epoxide 
hydrolase enzymes63. In Scheme 5, asymmetric nucleophilic ring-opening reactions of 
meso 1,2-epoxycyclohexane are shown. 
o PhCO,H 
(S,S)-salen(Co)III 
catalyst 
/ \ .OH 77% e.e. 
98% yield 
O SiCL 
aryl phosphonic amide 
catalyst a OH CI 82% e.e. 84% yield 
O H20 
epoxide hydrolase 
yeast a OH 90% e.e. 95% yield 
Scheme 5. Formation of enantiopure (17?,2./?)-disubstituted cyclohexanes by asymmetric ring-opening 
of meso 1,2-epoxycyclohexane. 
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1.3 Bacterial epoxide carboxylase 
1.3.1 Biological function 
Biologically produced epoxides can either occur as end products of biosynthetic routes 
or as intermediates in the metabolism of alkenes and aromatic compounds. In most meta-
bolic routes, epoxides are converted by ring-opening to less reactive and consequently 
less harmful compounds by detoxifying enzymes like epoxide hydrolases and glutathione 
S- transferases. 
However, in microbial metabolism, some aliphatic epoxides play a completely differ-
ent role. In alkene-utilizing bacteria, epoxides are generated by mono-oxygenases and 
subsequently further metabolized by known biochemical pathways. The bacteria 
involved play an important role in the global carbon cycle by using various short-chain 
alkenes (C2 to C7) as sole source of carbon and energy6465. Their contribution to the 
reduction of gaseous alkenes in the atmosphere is of importance because the global emis-
sion of these compounds has grown to more than 200 million tons produced annually 
from biogenic and anthropogenic sources6566. 
Bacterial metabolism of 1,2-epoxypropane has been studied in detail for two propene-
utilizing bacteria, Xanthobacter strain Py2 and Rhodococcus rhodochrous strain B276 
(formerly referred to as Nocardia corallina B276). The interest in epoxide metabolism in 
Xanthobacter Py2 has been initiated by the study on the highly enantioselective conver-
sion of aliphatic 2,3-epoxides by this organism6768. Kinetic resolution of short-chain 2,3-
epoxides was successful with cells of Xanthobacter Py2 since disubstituted epoxides 
were no intermediates in 1-alkene metabolism and therefore only partially degraded. In 
a subsequent study69, the in vitro isomerization of epoxides to ketones has been described 
for various aliphatic 1,2- and (25)-epoxides by cell extracts of Xanthobacter Py2. Under 
physiological conditions, however, ketones were not further metabolized by propene-
grown Xanthobacter cells. The enzymes required for ketone metabolism are repressed 
during growth on propene and are expressed only upon addition of acetone or 2-propanol 
to the growth medium™. Follow-up studies by other research groups concentrated on 
epoxide metabolism under physiological conditions. Eventually, these studies showed 
that intermediate epoxides in alkene metabolism were carboxylated with C02 as a cosub-
strate to produce p-keto acids71. The key enzyme in this route is an epoxide carboxylase 
which catalyzes the formation of f}-keto acids or ketones by addition of C02 or H+ to the 
ring-opening product of 1,2-epoxypropane, respectively. In the absence of C02 , epoxides 
were found to be stoichiometrically converted to ketones, confirming preceding investi-
gations72. The summarized pathway of propene metabolism in Xanthobacter Py2 is 
shown in Scheme 6. 
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O, + NADH 
H,0 + NAD+ 
O 
epoxide 
carboxylase \ ^ 
s- NADPH + NAD+ 
NADP+ + NADH 
presence of 
C 0 2 
absence of 
C 0 2 
O 0 
OH 
HSCoA 
T 
O O 
SCoA 
HSCoA 
O O general 
»• metabolic 
^SCoA ^ ^SCoA pathways 
Scheme 6. Role of the epoxide carboxylase system71 in propene metabolism by Xanthobacter Py2. 
1.3.2 Enzyme characteristics 
Enzymatic isomerization of epoxides to ketones initially was shown to be dependent on 
both NAD+ and a reducing dithiol compound and was sensitive to inhibition by TV-ethyl-
maleimide (NEM)69. These findings strongly indicated that oxidation and reduction of 
reaction intermediates would play a central role in this reaction. And, in addition, from 
the sensitivity of the enzyme to inhibition by Af-ethylmaleimide (NEM) involvement of 
enzyme thiol groups were concluded69. 
The first progress in refinement of this puzzling reaction was made by Chion and 
Leak73. They found that synthetic dithiol compounds could be replaced by the physio-
logical reductant NADPH, and also that in the reaction at least two proteins should be 
involved. NADPH-dependency and further fractionation of the enzyme system has been 
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described by Swaving et al.14. The NADPH-dependent enzyme was subsequently puri-
fied and characterized as a member of the NADPH-dependent FAD-containing disulfide 
oxidoreductases as reported by Westphal et al.15. Very recently, the catalytic activities of 
this enzyme have been studied in detail by Clark et al.16. The authors reported that this 
enzyme is involved in the third step of the epoxide metabolism, catalyzing the NADPH-
dependent reductive cleavage and carboxylation of a (3-ketothioether to form a (3-keto 
acid and coenzyme M (see next paragraph). In the absence of C02 , a proton can serve as 
an alternative electrophile for ketone production. Therefore, the enzyme is renamed as 
NADPH: 2-ketopropyl-CoM oxidoreductase/carboxylase. The mini-metabolic pathway 
of epoxide to (3-keto acid or ketone, respectively, is called the epoxide carboxylase sys-
tem. 
Ring-opening of the epoxide was initially proposed by nucleophilic attack of an enzyme 
thiol on the less substituted carbon to form a covalently bound (3-hydroxythioether inter-
mediate69. Recently, Allen et al. have shown in their investigations that the physiological 
nucleophile for this reaction is CoM (coenzyme M, 2-mercaptoethanesulfonic acid)77. 
The ring-opening by conjugation of the deprotonated nucleophile CoM-S- has thus been 
described as an epoxyalkane: CoM transferase reaction. CoM biosynthesis is coordinate-
ly regulated with the expression of the alkene mono-oxygenase and enzymes of the epox-
ide carboxylase system. The lack of CoM in glucose-, propane-, 2-propanol- and acetone-
grown cells shows the highly specialized role for CoM in metabolism of alkenes and 
epoxides. The latter observations recently have been found in cells of Xanthobacter Py2 
and of Rhodococcus rhodochrous B27678. 
The NAD-dependent oxidation in epoxide metabolism was proposed to be a hydride 
abstraction of the p-hydroxythioether intermediate to form a (3-ketothioether69. It is now 
more precisely described that the P-hydroxythioether is not covalently bound to an 
enzyme-thiol but coupled to CoM. The NAD-dependent enzyme is therefore named 2-
hydroxypropyl-CoM dehydrogenase76. Very interestingly, there are two specific dehy-
drogenases involved: one for each hydroxyalkyl enantiomer formed by ring-opening of 
the respective epoxide enantiomer79. The enzymes of the epoxide carboxylase system of 
Xanthobacter Py2 are summarized in Table 2. 
Table 2. Enzymes of the epoxide carboxylase system of Xanthobacter Py2 
Enzyme cofactor / coenzyme 
Epoxyalkane: CoM transferase HS-CoM, Zn 
(27?)-hydroxypropyl-CoM dehydrogenase NAD+ 
(25')-hydroxypropyl-CoM dehydrogenase NAD+ 
NADPH: 2-ketopropyl-CoM oxidoreductase/carboxylase FAD, NADPH+ H+, C02 
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Scheme 7. Proposed mechanism76 of carboxylation/isomerization of (R)- and (5)-l,2-epoxypropane 
by the epoxide carboxylase system of Xanthobacter Py2. 
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1.3.3 Catalytic mechanism 
The results obtained by the various research groups suggested that the epoxide carboxy-
lase system should be regarded as a multiprotein enzyme complex. Actually, recent 
insights in the reaction mechanism75-76 justifies the term mini-metabolic pathway with 
distinct intermediates as shown in Scheme 7. 
The proposed pathway of carboxylation/isomerization of 1,2-epoxypropane starts with 
the conjugation of CoM as catalyzed by an epoxyalkane: CoM transferase. Actually, this 
is a base-catalyzed SN2 ring-opening with the deprotonated CoM-S- acting as the nucle-
ophile. In this way, (/?)- and (5)-2-hydroxypropyl-CoM are formed from the correspon-
ding epoxide enantiomers. In the second step, the individual 2-hydroxypropyl enantiomers 
are oxidized by specific NAD-dependent dehydrogenases to form the common achiral 
intermediate 2-ketopropyl-CoM. The terminal enzyme is an NADPH: 2-ketopropyl-CoM 
oxidoreductase/carboxylase which catalyzes the reductive cleavage of 2-ketopropyl-CoM 
to form the enol of acetone. As shown in Scheme 7, this reaction proceeds by binding of 
NADPH to the oxidized enzyme. Subsequently, NADPH reduces FAD, which reduces 
the redox-active disulfide. The protonated thiol opens the 2-ketopropyl thioether by 
nucleophilic attack, thereby forming a CoM/interchange mixed disulfide and the enol of 
acetone. The final step is completed by base-catalyzed deprotonation of the enol and elec-
trophilic addition of either a proton or C0 2 to generate acetone or acetoacetate, respec-
tively. Concomitantly, the redox-active thiol of the terminal enzyme is reoxidized, the 
CoM/interchange mixed disulfide is reduced and CoM and NADP+ are released. 
The puzzling epoxide degradation pathway in Xantobacter Py2 has been studied 
thoroughly in the case of 1,2-epoxypropane. The question still remains to what extend 
these highly specialized enzymes are also involved in the enantioselective isomerization 
of 2,3-epoxides, being substrates which are no intermediates in 1-alkene metabolism. 
1.4 Yeast epoxide hydrolase 
1.4.1 Biological function 
Epoxides with intrinsic biological activity in many cases are toxic to living cells34. This 
toxicity can be displayed by both acute cytotoxicity and by long-term mutagenic effects. 
In many eukaryotic organisms, the first line of biochemical defense against these exoge-
nous epoxides is the detoxifying enzyme epoxide hydrolase. Epoxide hydrolases have 
been found in all types of living organisms, including mammals, insects, plants and microor-
ganisms, and are thus ubiquitous in Nature. In mammals, these enzymes are also involved 
in the detoxification of endogenous produced arene oxides, which are formed in vivo by oxi-
dation of aromatic hydrocarbons. A main role for biochemical detoxification of epoxides 
has been assigned to the mammalian microsomal epoxide hydrolase (MmEH)80-82. 
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Epoxide hydrolases (EC 3.3.2.3) catalyze the addition of water to epoxides resulting in the 
formation of vicinal diols. Because this reaction in many cases proceeds with a high 
degree of enantioselectivity are these enzymes of interest as biocatalysts for kinetic reso-
lution. The biocatalytical potential of epoxide hydrolases from various microbial sources 
has been reviewed recently638385. 
Among the sources of microbial epoxide hydrolases, yeasts are particularly of interest 
as catalysts since these unicellular organisms are (/) easy to cultivate, especially on a 
large scale and (ii) are relatively insensitive to mechanical shear damage which facili-
tates whole-cell biotransformations on a large scale. Yeast epoxide hydrolase activity 
with moderate to high enantioselectivity was found to be restricted to specific strains of 
basidiomycetes genera, which include Xanthophyllomyces, Trichosporon, 
Rhodosporidium and RhodotorulaS6&s. The substrate scope and catalytic activity of the 
epoxide hydrolase of Rhodotorula glutinis has been reviewed in comparison with other 
epoxide hydrolases63. 
The biological function of epoxide hydrolases in yeasts, and almost all other microbial 
sources, is still unknown. As an exception, the very specific bacterial limonene-1,2-epox-
ide hydrolase from Rhodococcus erythropolis DCL 14 was found to be involved in the 
limonene metabolism of this microorganism89. Nevertheless, it is likely to consider that 
yeast epoxide hydrolases (YEHs) play a role in the defense mechanisms against cytotox-
ic compounds. The key characteristic of detoxifying enzymes is their loose restriction in 
substrate recognition in order to be able to react with xenobiotics of variable structure90. 
YEH shares this common feature as it can accept structurally diverse molecules as sub-
strates thus being actually only functional group specific63. Final proof for the biological 
role of YEH will be given by the identification of the physiological substrate(s). 
Possibly, natural YEH substrates belong to the epoxide-bearing mycotoxins, the tri-
chothecenes. These fungal metabolites are a large group of tricyclic sesquiterpenes pro-
duced by strains of Fusarium, Trichoderma, Trichothecium and Myrothecium, showing 
potent antifungal and cytostatic activity91. About more than 45 compounds have been 
classified in this group. The toxic effects of these compounds appear to result from their 
ability to inhibit protein synthesis. For the biological activity of trichothecenes, the 
12,13-epoxide moiety is generally assumed to be essential and derivatives lacking this 
structural feature are inactive91. The structure of the trichothecene skeleton is represent-
ed by compound 5 in Scheme 8. 
R. 4 
4 5 
Scheme 8. Structures of l-oxaspiro[2.5]octane 4 and the trichothecene skeleton 5. 
24 
Introduction 
The inhibitory effect of trichothecenes on yeast growth and metabolism has been inves-
tigated9294. These studies showed an interspecies differential trichothecene-sensitivity, 
which indicates the existence of a biochemical detoxification mechanism in yeasts. As a 
possible detoxification mechanism, enzymatic reduction of the 12,13-epoxide group has 
been suggested94. Similarly, epoxide reduction to a diene has been proposed for some 
gastrointestinal bacteria to be the explanation of their trichothecene-resistance95. 
However, there is not much support for this hypothesis in literature. Epoxide reductases 
have not been observed in any other type of microorganism and a related enzyme pres-
ent in mammalian cells, was assigned no role in epoxide detoxification as it accepts no 
trichothecene T-2 toxin or other structurally divers xenobiotic epoxide96. Hence it will be 
more likely, due to their characteristics and distribution, that epoxide hydrolases will be 
involved in such a detoxification mechanism. 
A preliminary study has been set up recently to test whether substrates containing the 
spiro attachment of an epoxide group, like the epoxypyran ring B of trichothecenes 
(Scheme 8), are accessible substrates for the YEH of Rhodotorula glutinis91. 
Interestingly, the YEH showed a very high activity for the tested carbocyclic tri-
chothecene analogue l-oxaspiro[2.5]octane (epoxide 4). Oxaspiro epoxycompounds, and 
the structurally related trichothecenes, may thus be regarded as potentially accessible 
substrates for YEH. 
The cytotoxic activity of synthetic oxaspiro trichothecene analogues has been investi-
gated. Independent studies, using cells of Salmonella and mice, respectively, showed that 
epoxide 4 was more biologically active than synthetic oxaspirooctanes containing the 
pyran structure9899. A lower general cytotoxicity was, however, to be expected from the 
less polar epoxide 4. The differential biological activity therefore indicated that the pyran 
oxygen was not essential for maximal activity. Other results from the study of Fullerton 
et al." were (/) an observed complete inactivation of the biological activity after hydrol-
ysis of the trichothecene 12,13-epoxide followed by a molecular rearrangement to the 
apotrichothecene structure, and (ii) a significant influence of the oxaspiro stereochem-
istry in biological activity. The influence of stereochemistry is in accordance with the 
generally observed phenomenon of chiral recognition in the action of many other bioac-
tive compounds. 
All these findings clearly support a possible role for enzymatic epoxide hydrolysis in 
microbial mycotoxin detoxification. For elucidation of the biological role of YEH and 
other microbial epoxide hydrolases, more detailed investigations will be necessary for the 
identification of the natural epoxide substrates. 
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1.4.2 Enzyme characteristics 
Epoxide hydrolases comprise a group of functionally related enzymes that catalyze the 
cofactor-independent hydrolysis of epoxides to their corresponding diols. In spite of their 
broad range of accepted substrates, epoxide hydrolases show a narrow specificity to their 
cosubstrate: only water can be used as a cosubstrate. 
Epoxide hydrolases have been divided into two classes based on homology and prop-
erties: soluble epoxide hydrolases (sEH) and membrane-associated microsomal epoxide 
hydrolases (mEH). Most epoxide hydrolases belong to the a/fi hydrolase fold family of 
enzymes100. This family is an evolutionary divergent group of enzymes that function with 
a catalytic triad consisting of (/) a nucleophile (Ser, Cys or Asp) for formation of an alkyl-
enzyme intermediate, (ii) a general base (always His) that initiates hydrolysis of the inter-
mediate, and (Hi) a charge relay residue (Asp or Glu) to activate and assist His by hydrol-
ysis of the intermediate. The catalytic triads of all members are arranged in the same 
manner by the sequence: nucleophile, charge relay acid, general base. The 'canonical' 
oc/(3 hydrolase fold consists of a mostly parallel eight-stranded polypeptide (3-sheet sur-
rounded on both sides by polypeptide a-helices (Scheme 9). The parallel P-strands 3 to 
8 are connected by a-helices, which pack on either side of the central p-sheet. The nucle-
ophile is located at the 'nucleophile elbow' (between strand P5 and the connecting a-
helix), which positions the nucleophile such that it is easily accessible for the substrate 
on one side and for the hydrolytic water molecule on the other side. Characteristic enan-
tio- and regioselectivities for the different enzymes can be explained by the specific 
shape and composition of the respective active sites. 
NH2 
Scheme 9. Schematic diagram of the 'canonical' a/p hydrolase fold100. 
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In all epoxide hydrolases, a common role of acidic tyrosine residues in the active site is 
proposed. Support by Tyr is suggested for substrate activation by protonation and sub-
strate binding by hydrogen bond donation. Sequence alignments have shown that a cat-
alytic Tyr residue is present in all sequenced microbial and eukaryotic epoxide hydro-
lases, and a second Tyr is at least partly conserved101104. Recent studies indicate that 
epoxide hydrolases in general need two Tyr residues for catalytic activity and high sub-
strate affinity102104. 
The yeast epoxide hydrolase (YEH) of Rhodotorula glutinis has been characterized 
very recently by Visser et al. to be a member of the cc/(3 hydrolase fold family105. For this, 
the epoxide hydrolase-encoding gene was isolated and the encoded polypeptide charac-
terized. A molecular mass of 46 kDa was calculated for the YEH. The catalytic triad 
(nucleophile, charge relay acid, base) was proposed to consist of Asp 190, Glu359 and 
His385. Corresponding Tyr residues for substrate binding and activation are highly con-
served as well in YEH106. Highest amino acid sequence similarities were found for two 
mammalian microsomal epoxide hydrolases: human MmEH and rat MmEH. Particularly 
the Glu residue as charge relay function in contrast to Asp residues, is unique for YEH 
and MmEH when compared to other well-characterized enzymes including bacterial 
sEH, mammalian MsEH and fungal AnEH102104. These results are in accordance with 
previously reported common features of YEH and MmEH, like similar localization in the 
cell membrane107 and corresponding substrate specificities63. The recent findings indicate 
that both the eukaryotic MmEH and YEH share a common ancestry and proposed role in 
biochemical detoxification. 
1.4.3 Catalytic mechanism 
Most epoxide hydrolases are members of the oc/(3 hydrolase fold enzymes which implies 
that their catalytic mechanism proceeds in two steps via an alkyl-enzyme intermediate. 
The commonly accepted two-step mechanism has been first elucidated for the mam-
malian enzyme MmEH108 and independently confirmed for the mammalian MsEH109. 
The first step in this mechanism, epoxide ring-opening, is assumed to be a base-catalyzed 
SN2 reaction110. Exceptional acid-catalyzed ring-opening has however been reported for 
the non-oc/(3 hydrolase fold limonene-1,2-epoxide hydrolase from Rhodococcus erythro-
polis DCL14, indicating the existence of alternative mechanisms111. 
Common features of the mechanism112 of a/(3 hydrolase fold epoxide hydrolases are: (i) 
backside nucleophilic attack with inversion of configuration at the attacked epoxide car-
bon, (ii) distinction of two different transition states, one formed by epoxide ring-open-
ing and the second during hydrolysis of the alkyl-enzyme intermediate, and (Hi) substrate 
binding and subsequent activation by two tyrosine residues. Based on the generally 
accepted mechanism and the recent characterization of the epoxide hydrolase from 
Rhodotorula glutinis™5, a catalytic mechanism for YEH is proposed (Scheme 10). 
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Scheme 10. Proposed catalytic mechanism for epoxide hydrolysis by a/(3 hydrolase fold epoxide 
hydrolases. A catalytic triad of Aspl90, Glu359 and His385 is proposed for the yeast epoxide hydro-
lase of Rhodotorula glutinis. The two-step mechanism proceeds via nucleophilic ring-opening of the 
epoxide (step 1) and subsequent hydrolysis of the alkyl-enzyme intermediate (step 2a and 2b). 
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In the YEH reaction mechanism, epoxide hydrolysis is initiated by positioning of the sub-
strate in the active site by hydrogen bonding of two tyrosine residues. Subsequent sub-
strate protonation by one of the tyrosine residues promotes the ring-opening in concert 
by attack of the nucleophile Asp 190 (step 1). The so formed alkyl-enzyme (ester) inter-
mediate is subsequently hydrolyzed by a water molecule, activated by the general base 
His385. The basicity of His is enhanced by the negatively charged carboxylate side-chain 
of Glu359. Nucleophilic attack by the deprotonated water molecule to the carbonyl of the 
alkyl-enzyme intermediate results in the formation of a tetrahedral oxyanion intermedi-
ate (step 2a). The carbonyl oxygen of this second intermediate is negatively charged 
('oxyanion') and stabilized by at least two hydrogen bonds from amide nitrogens of 
residues forming the 'oxyanion hole' (not shown in Scheme 10). The tetrahedral inter-
mediate collapses upon protonation of the aspartate oxygen by His, resulting in release 
of the diol from the broken ester bond (step 2b). Proton transfer from the resultant Asp 
carboxylic acid to one of the Tyr phenolate anions completes the reaction. Eventually, the 
diol is released from the active site and the enzyme is ready for another catalytic cycle. 
Final evidence for the detailed information on the residues involved the YEH catalytic 
mechanism eventually will be obtained from subsequent high-resolution crystal struc-
tures of this epoxide hydrolase. 
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1.5 Outline of this thesis 
This thesis describes the biocatalytic kinetic resolution of epoxides by enantioselective 
ring-opening. For this study, the catalytic activity of two different enzymes has been 
explored: the bacterial epoxide carboxylase of Xanthobacter Py2 and the yeast epoxide 
hydrolase of Rhodotorula glutinis. 
In Chapter 2, the first example of kinetic resolution of epoxides by enzymatic ring-
opening is presented. (2i?)-Enantiomers of short-chain aliphatic disubstituted epoxides 
were obtained by selective conversion of the respective (2S)-enantiomers using cells of 
Xanthobacter Py2. 
Epoxide conversion by Xanthobacter Py2 is described in more detail in Chapter 3. 
Ketones were identified as reaction products of epoxides. The reaction was found to be 
dependent on NAD+ and an unknown reducing cofactor, which could be replaced by syn-
thetic dithiol compounds. Involvement of catalytic thiol residues was indicated by sensi-
tivity for the thiol blocking reagent ./V-ethylmaleimide. Based on these findings, a puta-
tive catalytic mechanism is proposed. 
In Chapter 4, the biocatalytical potential of yeast epoxide hydrolases (YEHs) is 
explored. Epoxide hydrolysis by cells of Rhodotorula glutinis was examined and the 
scope of substrates presented. Enantioselective hydrolysis of trans-l-phenyl-1,2-
epoxypropane is described in more detail. 
In Chapter 5, YEH-catalyzed hydrolysis of a homologous range of monosubstituted 
aliphatic epoxides is described. Reaction rates as well as enantioselectivities were found 
to be strongly influenced by the substrate chain length. Resolution of 1,2-epoxyhexane 
showed the best combination of enantioselectivity and activity. 
In Chapter 6, two methods for YEH-catalyzed preparative-scale kinetic resolution of 
1,2-epoxyhexane are presented. Critical parameters in scaling-up were determined to be 
the limited water-solubility of the epoxide substrate, and toxicity of both the epoxide and 
formed diol. An efficient process to overcome these problems was developed using a 
two-phase hollow fiber membrane bioreactor. The process configuration was operated in 
a batch-wise mode and subsequently modified for continuous extractive kinetic resolu-
tion. 
A discussion on the work presented in this thesis is given in Chapter 7, followed by a 
Summary in English and in Dutch. 
35 
2 
Chiral resolution of 2,3-epoxyalkanes by Xanthobacter Py2 
Abstract 
With propene-grown cells of Xanthobacter Py2 it was possible to resolve racemic mixtures of 2,3-
expoxyalkanes. Only 2S-forms were metabolized bij this organism, resulting in pure 2R-2,3-
expoxylkanes. Chiral resolution was obtained with trms-2,3-epoxybutane, trans-2,3-epoxypen-
tane and c\s-2,3-epoxypentane. Xanthobacter Py2 was however not able to discriminate between 
the enantiomeric forms of 1,2-epoxyalkanes, resulting in the complete degradation of both enan-
tiomers of 1,2-epoxyalkanes. 
C.A.G.M. Weijers, A. de Haan, and J.A.M. de Bont 
Applied Microbiology and Biotechnology 1988, 27, 337-340 
Chapter 2 
Introduction 
Epoxides are valuable starting materials in organic synthesis and they are used on a large 
scale in chemical industry as precursors of many different compounds. Epoxides are of 
even greater interest when available in enantiopure form because they then can serve as 
synthons in the preparation of other more valuable optically active compounds. Synthesis 
of chiral epoxides by chemical methods has been studied extensively1, but apart from the 
asymmetric epoxidation of allylic alcohols2 and apart from the formation of some other 
chiral epoxides as for instance 1,2-epoxypropane3 no general procedure is available for 
the selective formation of the respective enantiomeric forms of epoxides. Consequently, 
many attempts have been made in recent years to produce chiral epoxides from alkenes 
by biological methods. Bacteria have been described that are able to produce chiral 
epoxyalkanes from gaseous alkenes45, from higher alkenes6 and from more complex 
alkenes as for instance arylallyl ethers7. Prospects and limitations of such systems that all 
depend on the action of mono-oxygenases are presently studied by several research 
groups89. 
However, another biological method to obtain enantiopure epoxides may be available 
by using enzymes that degrade epoxides stereoselectively. Such method would involve 
the complete degradation of one enantiomer while the other would not be affected. 
Although resolution of epoxides in this manner involves the destruction of half of the 
amount of epoxide, it nevertheless may be an economically feasible method in view of 
the difference in price between the racemic and optically pure epoxides. Enantioselective 
hydrolysis has previously been observed for microsomal epoxide hydrolase10, and the 
conversion of epoxides into trans-diols by this enzyme has recently been reviewed by 
Berti11 from the point of view of the relations between substrate structure and the regio-
and stereoselectivity of the enzyme. 
Recently we have screened several epoxide-degrading bacteria for their ability to 
degrade epoxyalkanes enantioselectively and the effect of these strains on racemic mix-
tures of both 1,2-epoxyalkanes and 2,3-epoxyalkanes has been investigated. In the pres-
ent paper we report on the results obtained with Xanthobacter Py2 for the selective degra-
dation of epoxyalkanes. The organism was originally isolated on propene12 and it also 
grows on other 1-alkenes (ethene, 1-butene) as well as on 1,2-epoxyalkanes (1,2-
epoxypropane, 1,2-epoxybutane)13. It contains an alkene mono-oxygenase that oxidizes 
1-alkenes to (/?)-1,2-epoxyalkanes5. It is now shown that the organism contains an 
enzyme involved in the further metabolism if epoxyalkanes that is able to discriminate 
between the enantiomeric forms of 2,3-epoxyalkanes. 
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Table 1. Degradation of epoxyalkanes by propene-grown Xanthobacter Py2 
Substrate Degradation rate* 
1,2-Epoxypropane 35 
1,2-Epoxybutane 32 
Q'.s-2,3-epoxybutane 10 
7Varc.5-2,3-epoxybutane 6 
C/s-2,3-epoxypentane 9 
7ra«.j-2,3-epoxypentane 4 
1,2-Epoxyhexane 15 
* Rates are expressed in nmol per minute per mg protein 
Results and discussion 
Epoxyalkane utilization by Xanthobacter Py2 
Xanthobacter Py2, when growing on an alkene, in an at present unknown type of reac-
tion further degrades epoxyalkanes to eventually cell biomass and carbon dioxide14. 
Washed cell suspensions of propene-grown cells metabolize several epoxyalkanes and 
the initial rates of degradation of various racemic epoxyalkane mixtures are given in 
Table 1. From these results it appears that an epoxide-degrading enzyme with a broad 
substrate specificity is present in propene-grown Xanthobacter Py2 cells, although it can 
not be excluded that more than one enzyme system is involved in the metabolism of the 
various epoxyalkanes. 
Stereoselectivity of epoxyalkane degradation 
The enantioselectivity of the epoxide-degrading enzyme in Xanthobacter Py2 was tested 
by incubating washed propene-grown cells with racemic mixtures of 1,2-epoxypropane 
and ?rans-2,3-epoxybutane respectively. Enantiomeric resolution of the epoxyalkanes 
was followed by taking samples from head space and analysis by complexation gas chro-
matography15. No clear preferential utilization of one of the configurations of 1,2-
epoxypropane was observed; both isomers were fully degraded (Figure la). Interestingly, 
a complete different situation was met with Jrans-2,3-epoxybutane. In this case only the 
(25,35J-isomer was degraded while the (2/?,3/?)-isomer was not metabolized at all 
(Figure lb). 
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Figure 1.Degradation of epoxyalkanes by propene-grown Xanthobacter Py2. (a) Simultaneous degra-
dation of (/?)-l,2-epoxypropane (O) and (,S)-l,2-epoxypropane (•); (b) degradation of trans-(2S,3S)-
epoxybutane (•), /ra«.r-(27?,3/?)-epoxybutane (O) was not degraded. 
Furthermore, no effect of the (2R,3R)-isomer on the degradation of the (2S,3S)-isomer 
was observed since an extra addition of racemic ?rani,-2,3-epoxybutane, after resolution 
of the initial mixture, did not affect the rate of degradation of the (2S,3S)-isomer (Figure 
2). In another experiment was the initial concentration of the racemic trans-2,3-epoxybu-
tane raised to 100 mM and under that condition was also a complete resolution of the 
mixture obtained. In this way it was possible to obtain in a very simple way the pure 
trans-(2R,3R)-epoxybutane whereas the chemical method for the preparation of this chi-
ral compound from (25,35J-tartaric acid involves eight different steps16. 
C«-2,3-epoxybutane is not a chiral compound and it was degraded to completion by 
washed-cell suspensions of propene-grown Xanthobacter Py2. 
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Figure 2. Effect of fra/M-(2/?,3fl)-epoxybutane (O) on the degradation of rrarcs-(2.S',35')-epoxybutane 
(•) by Xanthobacter Py2. 
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Figure 3. Chromatograms of 2,3-epoxypentanes as obtained by complexation gas chromatography. 
7rans-(2/?,3/?)-epoxypentane (1), fra«s-(25,,3-S')-epoxypentane (2), c«-(25',3/f)-epoxypntane (3) and 
m-(2/?,3S)-epoxypentane (4); (a) initial mixture, (b) mixture remaining after treatment with 
Xanthobacter Py2. 
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Investigations were further extended by preparing racemic 2,3-epoxypentanes from both 
cw-2-pentene and from trans-2-pentcne and the effect of Xanthobacter Py2 cells on the 
resulting four epoxyalkanes was recorded. The racemic mixtures of both the trans and 
the cis form were given in separate experiments to the washed cells. Both mixtures were 
resolved and the remaining enantiomers were /rans-(2.ft,3/?)-epoxypentane and cis-
(2/?,35')-epoxypentane respectively. In another experiment were both racemic mixtures 
given simultaneously to the cells again resulting in the degradation of the (2S)-forms and 
in an accumulation of the (2i?)-forms (Figure 3). 
a) b) 
o -. o 
(2R,3R) (25,35) 
O
 v 
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O reaction 
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Scheme 1. Racemic mixtures of (a) ?rani'-2,3-epoxypentane, (b) cw-2,3-epoxypentane and the 
remaining enantiomers after resolution by Xanthobacter Py2. 
Conclusions 
From the results presented it is concluded that Xanthobacter Py2 cells are able to dis-
criminate between the enantiometric forms of 2,3-epoxyalkanes (Scheme 1) whereas 
both enantiomers of 1,2-epoxyalkanes are fully degraded. At present it remains uncertain 
whether only one enzyme is involved in these epoxide-degrading reactions, but it never-
theless is obvious that raising Xanthobacter Py2 it is possible to resolve racemic mixtures 
of 2,3-epoxyalkanes. This stereoselective degradation of epoxyalkanes appears to be a 
very elegant way to obtain an epoxyalkane in an enantiomerically pure form and we 
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therefore at present are studying the epoxide-degrading enzyme of Xanthobacter Py2 
involved in the resolution of 2,3-epoxyalkanes and we also are testing other organisms 
for the resolution of 1,2-epoxyalkanes. 
Experimental section 
Organism and culture conditions 
Xanthobacter Py2 has been described previously by van Ginkel and de Bont14. The 
organism was cultivated continuousley in mineral medium in a 3-litre fermentor (with 2 
litre working volume) at 30°C, with a dilution rate of 0.02 h1 . The pH of the culture was 
maintained at 7.0. As carbon source propene was supplied as a 100 ml/min 4% in air mix-
ture. The cells were harvested by centrifugation at 16,000g, washed twice with 50mM 
potassium phosphate buffer pH 7.0 and stored at -20°C. 
Chemicals 
Gaseous alkenes were obtained from Hoek Loos, Schiedam (NL). Other alkenes, 1,2-
epoxyalkanes, ?ran5-2,3-epoxybutane and cz's-2,3-epoxybutane and cw-2,3-epoxybutane 
were from Aldrich Chemie N.V., Brussels. rra«5'-2,3-epoxypentane and cw-2,3-epoxy-
pentane were synthesized by oxidation of the corresponding 2-pentenes with m-chloro-
peroxybenzoie acid17. 
Analysis of epoxyalkanes 
The characterization of the synthesized epoxypentanes was carried out by NMR spec-
troscopy and mass spectroscopy. iH-NMR spectra were recorded on a Varian EM-390 90 
Mhz spectrometer and mass spectra on a Vacuum Generators Ltd. Micromass 7070F 
Mass-spectrometer. 
A complexation GLC method15 was used to determine the enantiomeric composition of 
the various epoxyalkanes. Analyses were carried out on a Packard model 438 gas chro-
matograph. As carrier gas N2 was used and the oven temperature was 50°C. A glass cap-
illary column was used: Length 25 m, diameter 0.25 mm, coated with 'Chirametal-27-/?-
3-1-13'. This column was obtained from CC & CC, P.O. Box 14, D-7402 
Kirchentellinsfurt, FRG. Peak areas were determined with a Shimadzu model 
Chromatopac C-R3A integrator. 
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Degradation of epoxyalkanes by Xanthobacter Py2 
Epoxyalkane degradation by Xanthobacter Py2 was tested in 27 cm3 screw-cap bottles 
sealed with rubber septa. Bottles contained 4ml 50mM potassium phosphate buffer with 
the appropiate epoxyalkanes and 0.05 ml methane serving as internal standard. The bot-
tles were placed into an shaking waterbath (30°C, 3 Hz) and the reaction was started by 
injecting 1 ml washed cell-suspension (25 mg protein). Periodically lOOul samples of the 
gas phase were taken and analyzed by complexation GLC. Concentrations of epoxyalka-
nes were derived from calibration curves using heat killed cells. Epoxyalkane concentra-
tions are expressed in mM in the water-phase assuming the quantity of epoxyalkane in 
the gas-phase is negligible in comparison with the quantity epoxyalkane in the water-
phase. 
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Dithiol- and NAD-dependent degradation of 
epoxyalkanes by Xanthobacter Py2 
Abstract 
A broad range of epoxyalkanes was converted into the corresponding ketones by cell extracts of 
Xanthobacter Py2. Both 1,2-and 2,3'-epoxyalkanes were degraded and in addition, the degrada-
tion of 2,3-epoxyalkanes in all cases was highly enantioselective. 
Conversion of a deuterium-labelled substrate indicated that the ketone product was probably 
formed indirectly via a hydroxy intermediate. 
Degradation of epoxyalkanes by Xanthobacter Py2 was dependent on both NAD and another, 
not yet identified cofactor which was present in the low molecular weight fraction (LMF) of 
propene-grown cells. It is proposed that the LMF was involved in a reductive reaction step since 
it could be replaced by dithiothreitol (DTT) and various other dithiol compounds. Epoxyalkane-
degrading activity was inhibited by the sulfhydryl blocking reagent N-ethylmaleimide (NEM). 
Inhibition by NEM and stimulation by LMF, DTT and other dithiols was only effective in the 
simultaneous presence of NAD. 
C.A.G.M. Weijers, H. Jongejan, M.C.R. Franssen, Ae. de Groot and J.A.M. de Bont 
Applied Microbiology and Biotechnology 1995, 42, 775-781 
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Introduction 
Studies on epoxide metabolism have focused on the biotransformation of arene oxides by 
mammalian systems and fungi and only limited information is available on the bacterial 
metabolism of epoxides. In bacterial metabolism, epoxides are not frequently observed 
as intermediates, but nevertheless, different types of reactions involved in microbial 
epoxide degradation are known1. Metabolism of epoxides in microorganisms has been 
studied mainly because these compounds are very useful starting materials in organic 
synthesis. Epoxides may be obtained in enantiopure form from racemic mixtures if they 
are metabolized enantioselectively. Such epoxides can be used in subsequent chemical 
synthesis of valuable bioactive compounds. Enantioselective degradation and various 
other biological methods for production of enantiopure epoxides have recently been 
reviewed23. 
Examples of well-studied enzymes in bacterial epoxide metabolism are a styrene oxide 
isomerase from a Xanthobacter sp. with very narrow substrate specificity4 and epoxide 
hydrolases from different Pseudomonas spp. catalyzing the hydrolysis of several epox-
ides56. These enzymes were not enantioselective. Epoxide hydrolase activity has further 
been observed in the 1,2-epoxypropane-utilizing Nocardia A607 and also in crude 
enzyme preparations of a Rhodococcus sp.. The latter enzyme showed enantioselectivity 
in the hydrolysis of branched methyl-alkyl epoxides but not in the case of straight-chain 
terminal epoxides8. Fungal hydrolysis of an epoxide has been described for Aspergillus 
niger and Beauveria sulfurescens. These two strains show opposite enantioselectivity in 
the degradation of racemic styrene oxide9. Bacterial hydrolytic degradation of cyclic 
epoxides has recently been observed in a Corynebacterium sp.10. 
A specific group of epoxides, epoxyalkanes, are known as intermediates in the bacter-
ial metabolism of aliphatic alkenes. Very little is known, however, about the enzyme sys-
tems that degrade these epoxyalkanes. In a study with ethene-grown Mycobacterium E20 
it was proposed that epoxyethane was converted directly into acetyl-CoA in the presence 
of NAD, CoA and an unknown cofactor11. The alkene-utilizing Xanthobacter Py2 grows 
on short chain 1-alkenes as well as on the corresponding epoxyalkanes12. Propene-grown 
cells of Xanthobacter Py2 degrade both enantiomers of 1,2-epoxyalkanes tested but from 
2,3-epoxyalkanes only the (2S)-forms are degraded, resulting in enantiopure (2R)-
epoxyalkanes13. 
In the present study, the enzymatic degradation of 1,2- and 2,3-epoxyalkanes in 
Xanthobacter Py2 has been investigated in more detail. 
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Results 
Epoxyalkane degradation by crude cell extracts 
Crude cell extracts of propene-grown Xanthobacter Py2 showed the same degradation 
pattern as the corresponding whole cells: degradation of both enantiomers of 1,2-
epoxyalkanes and highly enantioselective degradation of only the (25'J-forms of 2,3-
epoxyalkanes. The degradation rates for 1,2-epoxyalkanes were about ten times higher 
than for (25)-epoxyalkanes. Therefore, most experiments were performed with 1,2-
epoxybutane as substrate while enantioselectivity was verified with ?rans-2,3-epoxybu-
tane as substrate. 
Both the pH and the temperature optimum were determined to optimize assay condi-
tions. Maximum activity in the extract was at pH 8.2 and at a temperature of 38°C. The 
extract was stable for 30 minutes at temperatures of up to 50°C and between pH values 
of 6.5 to 8.5. Stability of the enzyme activity was further enhanced by adding glycerol 
(10% v/v). Purification of the enzyme using various chromatographic techniques was not 
successful. A reason for this was probably the loss of an essential non-protein component 
as will be discussed later in this report. 
Cofactor requirements were studied in crude cell extracts under standard assay condi-
tions. NAD (2 mM) and NADP (2 mM) raised the initial degradation rates of 1,2-
epoxybutane from 4 to 12 and 5 nmoles per minute per milligram protein respectively. 
Identification of the initial products 
Crude cell extracts of Xanthobacter Py2 with additional NAD converted all 1,2- and 2,3-
epoxyalkanes tested into ketone compounds. From 1,2-epoxyalkanes the corresponding 
2-ketones were formed stoichiometrically and (25)-epoxyalkanes were similarly con-
verted into 3-ketones (Table 1). A deuterium labelled substrate was used to elucidate 
whether the ketone was formed via a rearrangement reaction, or whether a mechanism 
with a hydroxy intermediate was involved in the epoxyalkane degradation. Cis-2,3-
dideutero-2,3-epoxypentane was converted into 2-deutero-3-pentanone as determined by 
GC/MS analysis (Figure 1). The two major peaks in the mass spectrum at m/e 57 and m/e 
58 show the mass fragments without and with one deuterium label at the keto-neigh-
bouring C-atom respectively. Obviously one of the two deuterium atoms of the 
epoxyalkane was lost in the reaction. This result indicates that formation of the ketone 
was not accompanied by rearrangement of the deuterium atoms. In additional experi-
ments it has been found that, apart from epoxides, ketones were only formed from the 
corresponding alcohols by cell extracts, and not from other possible intermediates like 
vicinal diols or oc-hydroxy ketones. However, attempts to isolate any intermediate alco-
hol were unsuccessful. Subsequently, 2-methyl-l,2-epoxypropane and 2,3-dimethyl-2,3-
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epoxybutane were synthesized in order to enzymatically accumulate the corresponding 
tertiary alcohols which would not be oxidized to a ketone. Unfortunately, these epoxides 
were not converted at all. 
Table 1. Conversion of various epoxyalkanes by crude cell extract of Xanthobacter Py2. 
Substrate Detected product 
1,2-Epoxypropane 
1,2-Epoxybutane 
7ra«s-2,3-epoxybutane 
C«-2,3-epoxybutane 
1,2-Epoxypentane 
7ran.?-2S',3S'-epoxypentane 
Cw-2S,3/?-epoxypentane 
1,2-Epoxyhexane 
1,2-Epoxyethylbenzene (styrene oxide) 
Acetone 
Butanone 
Butanone 
Butanone 
2-Pentanone 
3-Pentanone 
3-Pentanone 
2-Hexanone 
Acetophenone 
Conversions were performed at pH 8.2 and at a temperature of 38°C with 5 ml crude cell extract (100 
mg protein). The concentrations of the compounds added were glycerol (10% v/v), NAD (2 mM) and 
epoxyalkane (3 mM). The composition of the reaction products was determined by GC/MS analysis. 
relative abundance (%) 
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Figure 1. Relative abundances of mass fragments in the spectrum of 2-deutero-3-pentanone, formed 
by conversion of c«-2,3-dideutero-2,3-epoxypentane by crude cell extract of Xanthobacter Py2. 
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LMF-dependent epoxyalkane degradation 
Dialyzed extracts of Xanthobacter Py2 were completely inactive in degrading epoxyalka-
nes, also in the presence of NAD. The activity was also lost when various chromato-
graphic separation techniques were used for enzyme purification. Epoxyalkane-degrad-
ing activity could be restored by addition of a low molecular weight fraction (LMF), pre-
pared by ultrafiltration from the corresponding crude cell extract. Addition of the LMF 
was only effective in the simultaneous presence of NAD. The relationship between the 
amount of LMF added to dialyzed extract and the specific activity restored is shown in 
Figure 2. The active form of LMF was only present in propene-grown cells, but not in 
glucose-grown cells. Attempts to purify the active compound from the LMF by gel fil-
tration, ion-exchange chromatography or by solvent extraction were not successful. The 
molecular mass of the compound was lower than 3 kDa as indicated by ultrafiltration 
experiments. The compound is not a protein since it was not affected by proteolytic 
enzymes or heat (15 minutes at 110°C) and since it was stable for at least 30 minutes at 
pH-values between 2 and 11. 
125 
50 100 150 200 
relative amount LMF (%) 
Figure 2. Recovery of the epoxyalkane degrading activity in dialyzed extract of Xanthobacter Py2 by 
addition of increasing amounts of the low molecular weight fraction (LMF). The relative amount of 
100% LMF corresponds with the LMF concentration of the original crude cell extract. The specific 
activity of the original crude cell extract, taken as 100%, was 9.4 nmoles epoxyalkane per minute per 
milligram protein. 
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DTT-dependent epoxyalkane degradation 
The finding that NAD is essential for epoxyalkane degradation indicates that an oxida-
tive step is involved in this reaction. On the other hand, the oxidation states of an 
epoxyalkane and a ketone are identical and therefore a reductive counterpart is necessary. 
Possibly, the LMF has a role in this respect and consequently it was tested if some reduc-
ing reagents might replace the LMF. Addition of ascorbate and cysteine resulted in no or 
only in partly restored activity of dialyzed extracts. However, dithiothreitol (DTT) in the 
simultaneous presence of NAD restored activity. The stimulating effect of DTT was 
observed not only with 1,2-epoxybutane but also with fra«5-2,3-epoxybutane as sub-
strate. The degradation of trans-2,3-epoxybx\tane was completely enantioselective 
excluding a non-enzymic conversion of the compound. The effect of different concen-
trations of DTT on enzyme activity was tested in analogy with the concentration-depend-
ent LMF-effect. In Figure 3 it is shown that the stimulating effect of DTT was also con-
centration-dependent. A final concentration of 5 mM was chosen as optimal DTT con-
centration for further experiments. 
o 
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Figure 3. Effect of various concentrations dithiothreitol (DTT) on the epoxyalkane degrading activity 
of dialyzed extract of Xanthobacter Py2. The specific activity with addition of DTT to a final con-
centration of 5 mM, taken as 100%, was 13.8 nmoles epoxyalkane per minute per milligram protein. 
Inhibition experiments with the sulfhydryl blocking reagent iV-ethylmaleimide (NEM) 
were undertaken to investigate the effect of DTT. Inhibition with 1 mM NEM was only 
effective in the presence of NAD and the order of additions of NEM, DTT or NAD was 
important: NEM inhibition was maximal when NEM was added to the dialyzed extract 
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prior to either NAD or DTT. The order of addition of NAD and DTT also had an effect: 
maximal activity required NAD as the first binding component. The effects of DTT, 
NAD and NEM on the activity of dialyzed extract are summarized in Table 2. 
Table 2. Effect of DTT, NAD, and NEM on the rate of degradation of 1,2-epoxybutane by dialyzed 
extract of Xanthobacter Py2 
Compound added Relative activity (%)a 
None 6 
NAD 7 
NADH 10 
DTT 22 
NAD + DTT 100 
DTT + NAD 84 
NEM + DTT 20 
NAD + DTT + NEM 92 
NAD + NEM + DTT 65 
DTT + NAD + NEM 40 
DTT + NEM + NAD 16 
NEM + NAD + DTT 21 
NEM + DTT + NAD 12 
DTT, heat-denaturated extract 3 
aThe maximum specific activity, taken as 100%, was 16.2 nmoles epoxyalkane per minute per mil-
ligram protein. The concentrations of the compounds added were NAD (2 mM), NADH (2 mM), DTT 
(5 mM) and NEM (1 mM). Rates were determined by adding 1,2-epoxybutane (3 mM) to extracts and 
subsequently the compounds were added in the order indicated and at intervals of 10 minutes. 
Other thiol compounds serving as cofactor 
Apart from DTT, various other synthetic and biological monothiol and dithiol com-
pounds were tested for their ability to serve as a cofactor for epoxyalkane degradation. 
For this, these compounds were added to dialyzed extract with additional NAD and the 
initial rates for degradation of 1,2-epoxybutane were determined. In Table 3 these activ-
ities are compared with the activity achieved with DTT as cofactor. In the cases where 
significant activity was observed, enantioselectivity of the reaction was checked using 
?ra«s-2,3-epoxybutane as substrate. In this way nonenzymatic reactions due to thiols was 
excluded. 
In general, it was found that monothiol compounds were inactive as cofactor while 
most dithiols were as active as DTT. 
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Table 3. The effect of various monothiol and dithiol compounds on the rate of degradation of 1,2-
epoxybutane by dialyzed extract of Xanthobacter Py2 
Thiol compound Relative activity (%)a 
None 8 
1-Propanethiol 16 
2-Propanethiol 13 
1-Butanethiol 14 
Glutathione (red) 17 
L-Cysteine 34 
1,2-Ethanedithiol 112 
1,3-Propanedithiol 102 
2,3-Butanedithiol 12 
1,4-Butanedithiol 94 
1,5-Pentanedithiol 38 
Lipoic acid (red) 10 
Dithioerythritol 109 
Dithiothreitol 100 
a
 The specific activity with addition of dithiothreitol, taken as 100%, was 12.4 nmoles epoxyalkane per 
minute per milligram protein. The concentrations of the compounds added were NAD (2 mM) and 
thiol compounds (5 mM). Rates were determined by adding 1,2-epoxybutane (3 mM) to extracts and 
subsequently NAD was added prior to the thiol compounds. 
Discussion 
Cofactor requirement 
In the present study it is shown that epoxyalkane degradation by Xanthobacter Py2 is 
dependent on both NAD and another cofactor which is present in the LMF of propene-
grown cells. The requirement of a LMF as additional cofactor in epoxyalkane metabo-
lism has been observed previously in Mycobacterium E20". The composition of the 
active components of the LMF in either case is still unknown. The synthetic thiol com-
pound dithiothreitol (DTT) restored the activity of dialyzed extracts and showed a simi-
lar concentration-dependent pattern as observed for the LMF (Figures 2,3). The involve-
ment of DTT in the bioconversion of an epoxide has been described previously for the 
extensively studied mammalian enzyme vitamin K epoxide reductase. Whitlon et alJ4 
reported that among various biological reducing agents tested, DTT was the most effec-
tive cofactor in vitro for this specific enzyme. The mammalian enzyme and our 
Xanthobacter enzyme furthermore have similar substrate specificities for thiols since 
they are both stimulated by the dithiol compounds whereas synthetic monothiols exhib-
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ited no cofactor activity15. Vitamin K epoxide reductase, however, differs from the 
enzyme of Xanthobacter Py2 in that it is not NAD-dependent. At this moment the phys-
iological cofactor for vitamin K epoxide reductase is still unknown. 
From the data in Table 3 it can be concluded that the only apparent structural require-
ment for cofactor activity is the presence of two terminal thiol groups. Nevertheless, 2,3-
butanedithiol was inactive which probably is due to the terminal methyl groups present, 
thus preventing the formation of the sterically favorable cyclic disulfide after oxidation16. 
Therefore, reduction reactions with 2,3-butanedithiol and also with monothiol com-
pounds result in much lower steady-state concentrations of reduced forms of the inter-
acting enzyme. Of the natural occuring thiol compounds tested only cysteine showed 
some cofactor activity while glutathione and lipoic acid did not. The data presented for 
the dithiol-dependent activities do not distinguish between direct action of the dithiol as 
a primary reductant or its ability to reduce some other compound which is then acting as 
the in vitro reducing agent. 
Stimulation by dithiol compounds suggests that the reduction of one or more critical 
disulfide bonds is required for enzyme activity. The involvement of sulfhydryl groups in 
the active center of the epoxyalkane degrading enzyme of Xanthobacter Py2 was con-
firmed using the sulfhydryl blocking reagent yV-ethylmaleimide (NEM). Inhibition with 1 
mM NEM was maximal when it was added to the dialyzed extract prior to NAD or DTT 
(Table 2). The effect observed by the order of addition of NAD and NEM, and also of NAD 
and DTT, indicates that sulfhydryl groups might participate in binding of NAD. Alkylation 
of sulfhydryl groups by NEM could not be reversed by the addition of NAD. Protection 
against sulfhydryl group inhibitors by first adding NAD has previously been established 
for several other enzymic reactions17. More recently, this NAD-effect has been observed in 
the reduction of formaldehyde by the NAD-linked factor-dependent formaldehyde dehy-
drogenase from Amycolatopsis methanolica. This enzyme and its unidentified cofactor 
have been described18. The properties of their unknown cofactor are reminiscing of the 
cofactor from Xanthobacter Py2 because it was found to be a heat-stable, low-molecular-
mass compound which inactive form could be reactivated by reduction with DTT. 
Proposed enzyme mechanism 
Formation of ketones in the degradation of epoxyalkanes was studied in detail using cis-
2,3-dideutero-2,3-epoxypentane. Cell extracts of Xanthobacter Py2 converted this com-
pound to 2-deutero-3-pentanone (Figure 1), indicating no rearrangement of the deuteri-
um atoms had taken place. A one step conversion would have been accompanied with an 
internal 1,2-shift, resulting in 2,2-dideutero-3-pentanone. A mechanism consisting of 
more than one reaction step will probably proceed via the intermediate 2,3-dideutero-3-
pentanol which will be oxidized to 2-deutero-3-pentanone. Oxidation of 2,3-dideutero-3-
pentanol by crude cell extract also resulted in the 2-deutero-3-pentanone product, thus 
55 
Chapter 3 
supporting the proposed mechanism. Other possible intermediates can be excluded 
because it has been observed in related experiments that formation of ketones did not 
occur from vicinal diols or from the corresponding oc-hydroxy ketones. Under standard 
assay conditions, ketones were only formed from the corresponding secondary alcohols 
by cell extracts of Xanthobacter Py2. 
Enzymic reduction of an epoxide to an alcohol has only been described for very few 
and very specific reactions. The first example was given by Steckbeck et al.19 who report-
ed that incubation of (24/?)-24,25-oxidolanosterol with standard S10 rat liver homogenate 
had resulted in the formation of (24/?)-hydroxycholesterol. A hydroxy intermediate was 
further observed in the very specific formation of hydroxyvitamin K by warfarin-resist-
ant rat liver microsomes, whereas it was not found in those from normal rats20. This 
hydroxy compound has also been demonstrated as an intermediate in a chemical model 
study for the mechanism of vitamin K epoxide reductase21. However, activity of the lat-
ter enzyme is restricted to the reduction of vitamin K epoxide to the corresponding vita-
min K. Other epoxides of different size, structure and polarity, including styrene oxide, 
were not converted by the mammalian enzyme22. 
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Scheme 1. Proposed enzyme mechanism in the degradation of epoxyalkanes to ketones by 
Xanthobacter Py2. R1= H, CH3; R2= CH3, C2H5, C3H7, C4H9, C6H5. The unknown reducing cofac-
tor is represented by X. 
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Scheme 1 shows a proposed enzyme mechanism in the degradation of epoxyalkanes to 
ketones by Xanthobacter Py2. The degradation of epoxyalkanes in four steps is based on 
the conversion of the deuterium labelled substrate and on the requirement of both the 
reductive and oxidative cofactors. The proposed covalent bond between the enzyme and 
substrate is also based on the inability to isolate any intermediate alcohol in the degrada-
tion reaction. Elucidation of the mechanism may be possible by purifying the epoxyalka-
ne-degrading enzyme. However, many attempts to purify the enzyme while using sever-
al techniques (results not reported) were without success. Consequently, we subsequent-
ly will investigate the genetics of epoxyalkane degradation. Furthermore, it would be 
extremely interesting to identify the cofactor involved in epoxyalkane-degradation in 
Xanthobacter Py2 since a similar and presently unknown factor is involved in a NAD-
linked formaldehyde dehydrogenase18 and in vitamin K epoxide reduction15. 
Experimental section 
Organism and culture conditions 
The isolation and characterization of Xanthobacter Py2 has been described previously by 
van Ginkel and de Bont23. During the present study the organism was continuously cul-
tivated in mineral medium in a 2-litre fermentor (with 1-litre working volume) at 30°C, 
with a dilution rate of 0.025 h1 . The pH of the culture was maintained at 7.0. As carbon 
source propene was supplied as a 100 ml min-' 1.25% in air mixture. The cells were har-
vested by centrifugation at 16,000 g, washed twice with 50 mM potassium phosphate 
buffer pH 7.0, concentrated, and stored at -20°C. 
Preparation of cell extracts 
Crude cell extracts were obtained after ultrasonic disintegration of concentrated 
Xanthobacter Py2 cells followed by removal of cell debris and unbroken cells by cen-
trifugation at 30,000 g for 20 min at 4°C. Subsequently, glycerol was added to the crude 
cell extract to a final concentration of 10% (v/v) in order to stabilize enzyme activity. 
Dialyzed extracts were prepared by dialysing crude cell extracts overnight at 4°C against 
50 mM potassium phosphate buffer pH 8.0 supplemented with 10% (v/v) glycerol. 
Preparation of the low molecular weight fraction (LMF) 
The low molecular weight fraction (LMF) was prepared by ultrafiltration of crude cell 
extracts without additional glycerol. Ultrafiltration was performed in Centriprep-10 con-
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centrators (Amicon Ltd., Rotterdam, The Netherlands) by stepwise centrifugation at 
3,000 g for 20 min each, at room temperature. The collected colorless, clear filtrate was 
designated as the LMF. The LMF could be stored at -20°C for at least six months with-
out any significant loss of activity. 
Chemicals 
2,3-Dimethyl-2,3-epoxybutane and 2-methyl-l,2-epoxypropane were synthesized by 
direct oxidation of the corresponding alkenes with ra-chloroperbenzoic acid (MCPBA)24. 
Other epoxides, alkenes, unnatural thiol compounds and Lindlar-catalyst were purchased 
from Aldrich (Belgium). Glutathione, L-cysteine and lipoic acid were from Sigma 
(Belgium). N-ethylmaleimide (NEM), MCPBA and lithium aluminium hydride (LiAlH4) 
were obtained from Janssen-Chimica (Belgium) and all biochemicals were from 
Boehringer Mannheim (Germany). 
Synthesis of the deuterium labelled compounds 
Cz's-2,3-dideutero-2,3-epoxypentane was obtained by direct oxidation of cis-2,3-
dideutero-2-pentene with MCPBA24. For the synthesis of c«-2,3-dideutero-2-pentene 
680 mg 2-pentyne was dissolved in 10 ml pentane and subsequently 68 mg Lindlar-cat-
alyst and one drop of quinoline were added. Hydrogenation of the reaction mixture was 
performed with 220 ml of deuteriumgas at room temperature25. Eventually, the catalyst 
was filtered off and the filtrate was used for synthesis of c/s-2,3-dideutero-2,3-epoxypen-
tane. For this, 10 ml diethylether and 320 mg of sodium bicarbonate were added to the 
filtrate, cooled to 5°C and the reaction was started by addition of 1,01 eq. of MCPBA. 
The reaction mixture was stirred for 15 min, warmed to room temperature and stirred for 
another three hours. Subsequently, the mixture was washed with sodium thiosulphate and 
sodium bicarbonate solution and dried. The solvent was evaporated via Spaltrohr distil-
lation and the epoxide was further purified by preparative GC. The yield was 350 mg 
(40% from 2-pentyne). 
2,3-Dideutero-3-pentanol was obtained by LiAlH4 reduction of c/s-2,3-dideutero-2,3-
epoxypentane and further purified by preparative HPLC (column: Silica Nucleosil ET 
250, with hexane:t-butylmethylether = 85:15 as eluent) and preparative GC (2 m* 3/8" 
column with 30% superox 0.6 on chromosorb WAW 45/60 Mesh at 45°C). 'H-NMR 
spectra and mass spectra of the synthesized compounds were in accordance with the pro-
posed structures. 
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Analytical methods 
Epoxyalkane- and ketone-concentrations were determined by headspace analysis on a 
Carlo Erba model 4200 gas chromatograph fitted with a capillary Poraplot Q column 
(Chrompack, The Netherlands). As carrier gas N2 was used and the oven temperature was 
170°C. The complexation gas-liquid chromatography (GLC) method of Schurig and 
Biirkle26 was used to determine the enantiomeric composition of the epoxyalkanes, as 
described in one of our previous studies13. The characterization of the synthesized 
methyl-substituted epoxyalkanes and all deuterium labelled compounds was carried out 
by NMR spectroscopy and GC/MS analysis. 'H-NMR spectra were recorded on a Varian 
EM-390 90 MHz spectrometer and mass spectra on a Hewlett-Packard 5970 mass selec-
tive detector coupled to an HP 5890 gas chromatograph. 
The protein content of cell extracts was determined by the method of Bradford27, using 
bovine serum albumin as a standard. 
Degradation of epoxyalkanes by cell extracts 
Epoxyalkane-degradation by crude cell extracts of Xanthobacter Py2 was tested in 40 ml 
screw-cap bottles sealed with rubber septa. In standard assays, the bottles contained 4 ml 
crude cell extract (100 mg protein), 1 ml potassium phosphate buffer pH 8.2 supple-
mented with 10% (v/v) glycerol and NAD in a final concentration of 2 mM. 
Subsequently, the bottles were placed into a shaking waterbath of 38°C and the reaction 
was started by addition of the appropriate epoxyalkane to a final concentration of 3 mM. 
Periodically 100 ul headspace samples were taken and analyzed by gas chromatography 
in order to determine the initial degradation rates. Complexation GLC was performed in 
experiments where enantioselective degradations were studied. Concentrations of 
epoxyalkanes were derived from calibration curves using heat-denaturated cell extracts. 
In experiments with dialyzed extracts, the LMF, dithiothreitol (DTT) and other thiol com-
pounds were added after 10 minutes equilibrium of the complete reaction mixture with 
epoxyalkane. 
Accumulation of reaction products was followed by periodically analyzing headspace 
samples from the reaction mixture in analogy with the analysis of epoxyalkanes. 
Eventually, the composition of the reaction products was determined by GC/MS analy-
sis. 
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Enantioselective hydrolysis of aryl, alicyclic 
and aliphatic epoxides by Rhodotorula glutinis 
Abstract 
Enantioselective epoxide hydrolysis by yeasts has been demonstrated for the hydrolysis of sever-
al aryl, alicyclic and aliphatic epoxides by a strain of Rhodotorula glutinis. High enantioselec-
tivity was obtained in the hydrolysis of disubstituted aryl and aliphatic epoxides whereas selec-
tivity towards terminal epoxides in all cases was lower. Enantiopure vicinal diols were formed 
from several disubstituted epoxides and also from meso epoxides. Kinetic resolution of trans-1-
phenyl-1,2-epoxypropane was studied in more detail. 
C.A.G.M. Weijers 
Tetrahedron: Asymmetry 1997, 8, 639-647 
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Introduction 
Enantiomerically pure epoxides are important chiral building blocks in organic synthesis 
and can be used as key intermediates in the synthesis of more complex enantiopure bioac-
tive compounds. Therefore, a great interest exists in the development of methods for the 
synthesis of enantiopure epoxides. Various chemical and biological production methods 
have been reviewed12. Among biological production routes, enantioselective bioconver-
sion might be a very promising method because epoxides with very high enantiomeric 
purities can be obtained and the enzymes involved seem to react with a homologous 
range of epoxides345. However, only limited information is available on the use of micro-
bial enzymes in enantioselective bioconversion. Nevertheless, different types of reactions 
involved in microbial epoxide conversion are known6. Enantioselectivity in microbial 
epoxide conversion has been detected in the case of conversion of 1,2-epoxyalkanes by 
a Nocardia sp7. This organism and also a Xanthobacter sp contains an NAD-dependent 
enzyme which is able to resolve enantiomerically pure (2/?j-epoxyalkanes from racemic 
2,3-epoxyalkanes8. 
Hydrolytic enzymes9 may be more promising as enantioselective biocatalysts, because 
they are cofactor independent and because the epoxide enantiomer degraded may be 
recovered as enantiomerically pure diol. Enantioselectivity of epoxide hydrolases of 
mammalian origin (MmEH and MsEH) has been studied extensively with special atten-
tion to the microsomal enzyme510. However, biocatalysts from microbial sources might 
be more applicable on an industrial scale and therefore studies on microbial enantiose-
lective epoxide hydrolysis have been set up recently. An enantioselective epoxide hydro-
lase from a bacterial source has been observed in a Rhodococcus sp which showed selec-
tivity in the hydrolysis of 2,2-disubstituted epoxides11. Deracemization of epoxides using 
bacterial epoxide hydrolases has subsequently been reported for the hydrolysis of cis-2,3-
epoxyheptane by a Nocardia sp12 and of 1-methyl-1,2-epoxycyclohexane by a 
Corynebacterium sp13. Fungal epoxide hydrolysis has been described for Aspergillus 
niger and Beauvaria sulfurescens. These two strains showed different enantio- and 
regioselectivities in the hydrolysis of styrene oxide14 and several other substituted styrene 
oxide derivatives1516. Based on hypothetical active site models it was proposed that the 
two fungal enzymes operate with different mechanisms for oxirane ring-opening. Other 
examples of fungal epoxide hydrolase activities have been reported for the enantioselec-
tive hydrolysis of indene oxide by Diplodia gossipina11 and of aliphatic epoxides by 
Ulocladium atrum and Zopfiella karachiensisl&. 
Recently, we have investigated the presence of enantioselective epoxide hydrolases in 
yeasts. These organisms are most promising because they are easy to cultivate which 
would make the production of epoxide hydrolases on a large scale more feasible. 
Enantioselective hydrolysis of various aryl, alicyclic and aliphatic epoxides by a strain of 
the yeast Rhodotorula glutinis has been observed. 
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Results and Discussion 
Scope of epoxide hydrolysis 
Screening for epoxide hydrolase activity in yeasts was performed with styrene oxide and 
trans-l-phenyl-1,2-epoxypropane as potential substrates. These two aryl epoxides are 
known to be typical substrates for the microsomal (MmEH), and soluble (MsEH) mam-
malian epoxide hydrolase respectively1920. We tested both substrates not knowing which 
type of enzyme was to be expected in yeasts. A number of yeast strains was tested for 
epoxide hydrolase activity and Rhodotorula glutinis strain CIMW 147 was eventually 
selected for further studies. Rhodotorula glutinis is able to hydrolyse both aryl epoxides 
tested, with relatively high activity and, in addition, the organism is very easy to culti-
vate. When grown on various simple carbon sources, the yeast possessed in all cases 
epoxide hydrolase activity which facilitates the production of large amounts of this bio-
catalyst. In the present study, Rhodotorula glutinis was routinely grown in a chemostat 
culture on a mineral medium supplemented with glucose as carbon source. 
Substrate specificity and enantioselectivity of the yeast epoxide hydrolase was investi-
gated by incubating epoxide (±)-l to (±)-15 with resting cell suspensions of Rhodotorula 
glutinis (Scheme 1). The reactions were monitored by periodically taking samples and 
subsequent analysis by GLC using enantioselective columns. 
In the hydrolysis of racemic epoxide 1 to 15, the reaction was terminated when the 
residual epoxide reached an e.e. of more than 98%. Then the reaction time, yield and 
configuration of the epoxide and e.e. and configuration of the formed diol were deter-
mined. Reactions with meso epoxides were terminated when more than 98% conver-
sion was reached. Initial hydrolysis rates, absolute configurations and yields of the 
residual epoxides 1 to 15 and e.e. values and absolute configurations of the formed diols 
la to 15a are summarized in Table 1. Absolute configurations of the diols were deter-
mined via prepared, or commercially available, compounds by co-injection on chiral 
GLC and, in specific cases, by comparison of the specific rotation values. 
From the results of Table 1 it is concluded that the epoxide hydrolase from Rhodotorula 
glutinis has a broad substrate specificity because all tested epoxides, with the exception 
of epoxide 10, are accepted by this enzyme. Nevertheless, among the accepted substrates 
there are significant differences in reaction rate and enantioselectivity, resulting in chiral 
epoxides and diols with different yield and e.e. values respectively. Terminal epoxides 
were, as expected, hydrolyzed with relatively low regioselectivity to (R) diols with reten-
tion of configuration at the more hindered carbon atom. 
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Scheme 1. Epoxides used as substrates for epoxide hydrolysis by Rhodotorula glutinis. 
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In the case of disubstituted epoxides the reaction proceeded with inversion of configura-
tion at the more hindered carbon atom. Enantioselectivity in the second case was to such 
an extend that very high values of enantiomeric purity of the formed diol and of the yield 
of the residual epoxide were obtained. 
Table 1. Hydrolysis of various epoxides by Rhodotorula glutinis 
Epoxide (residual substrate) 
1 
2 
3 
4 
5 
(-)-6 
(+)-6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
reaction 
ratea 
6.5 
0.91 
12.7 
0.29 
2.1 
1.2 
0.64 
11.4b 
0.50 
2.0 
— 
1.4 
0.07 
0.52 
0.21 
1.2 
e.e. 
> 9 8 % 
> 9 8 % 
> 9 8 % 
— 
— 
>98% 
>98% 
>98% 
>98% 
>98% 
abs. 
conf. 
(S) 
(1R,2R) 
(R) 
meso 
meso 
(\S,2R,4S) 
(IS,2RAR) 
(IR,2S) 
(S) 
(R) 
no epoxide hydrolysis 
>98% 
>98% 
— 
>98% 
>98% 
(S) 
(2R,3R) 
meso 
(2R,3R) 
(2R,3S) 
yield 
18% 
45% 
14% 
<2% 
<2% 
48% 
28% 
22% 
15% 
10% 
— 
16% 
47% 
<2% 
48% 
48% 
reaction 
time 
0.8 
1.3 
0.2 
11.0 
1.4 
1.2 
3.2 
0.2 
3.0 
1.0 
— 
0.8 
18.3 
13.0 
3.4 
0.6 
Diol 
la 
2a 
3a 
4a 
5a 
(-)-6a 
(+)-6a 
7a 
8a 
9a 
10a 
11a 
12a 
13a 
14a 
15a 
product 
e.e. 
48% 
>98% 
33% 
>98% 
90% 
>98% 
30% 
54% 
30% 
22% 
— 
25% 
C 
90% 
54% 
>98% 
abs. 
conf. 
(R) 
(IR,2S) 
(S) 
(IR,2R) 
(IR,2R) 
(IR,2RAS) 
(IR,2RAR) 
n.d. 
(R) 
(S) 
— 
(R) 
meso 
(2R,3R) 
(2S,3R) 
(2R,3R) 
a) Initial rate of epoxide hydrolysis in nmol/min, mg dw 
b) Under the present reaction conditions there was also significant chemical hydrolysis of epoxide 7 
<=) > 98 % cis diol 
n.d. not determined 
Hydrolysis of 10 mM epoxide in 20 ml reaction mixture with glucose-grown cells of Rhodotorula glu-
tinis (dry weights ranging from 1.0 to 1.5 g). 
Experiments for epoxide hydrolysis were routinely performed under aerobic conditions 
resulting in the data presented in Table 1. Under these conditions, however, it was 
observed that in the hydrolysis of some of the short-chain aliphatic epoxides 8 to 15 small 
amounts of the formed diols were subsequently oxidized to the corresponding a-hydroxy 
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keto compounds. Fortunately, it was found that partial oxidation of vicinal diols by one 
or more oxidoreductases from Rhodotorula glutinis could be minimized under anaerobic 
conditions. No oxidation of the more complex diols la to 7a was detected in either reac-
tion condition. 
The aryl epoxides 1, 2, and 3 appeared to be very good substrates for the epoxide 
hydrolase of Rhodotorula glutinis with maximum activity for benzyl glycidyl ether 3. 
From the reaction rates determined for the various epoxides it can be concluded that the 
epoxide hydrolase has a preference for phenyl group containing substrates. Relatively 
high activity combined with high enantioselectivity was found for the hydrolysis of the 
trans-methyl substituted styrene oxide derivative 2. Furthermore, biocatalytic prepara-
tion of this compound will be of interest because chemical synthesis using recently devel-
oped selective catalysts2122 is still less satisfactory. For these reasons kinetic resolution of 
epoxide 2 was eventually selected to be studied in more detail. 
Alicyclic epoxides 4 to 7 were all hydrolyzed to (IR,2R) diols with relatively high reac-
tion rates. The hydrolyses of the meso epoxides 4 and 5 are of special interest because in 
these cases enantiopure trans diols can be obtained possibly in 100% theoretical yield. In 
this context, our results obtained for diol (lR,2R)-4a ( >98% e.e. and 98% yield) and diol 
(\R,2R)-5a (90% e.e. and 93% yield) are rather encouraging. For the hydrolysis of sub-
stituted alicyclic epoxides, the (45)-(-) and (4R)-(+) isomers of limonene oxide 6 were 
selected. It was observed that the position of the sidechain at the stereogenic C4 carbon 
atom is of great influence on the activity and enantioselectivity. Very high selectivity was 
found when the alkylsubstituent was in the (45) configuration, leading to the single trans-
(\R,2R,4S)-6a diol and 48% yield of epoxide (\S,2R,4S)-6. With the sidechain of epox-
ide 6 in the (4R) configuration a much lower activity and selectivity were obtained, 
resulting in a low yield for the residual epoxide. The diol formed was in this case a mix-
ture of 65% (\R,2RAR)-6a and 35% (\S,2S,4R)-6a. A similar effect of the orientation of 
the sidechain has been observed in the hydrolysis of limonene oxide by rabbit MmEH23. 
The mammalian enzyme, however, showed a preference for the two other enantiomers 
of (-)- and (-i-)-limonene oxide. Indene oxide 7 was chosen as another example of a sub-
stituted alicyclic epoxide. Enantiomericaily pure indene oxide is of commercial interest 
because it is a precursor to a side chain of a specific HIV protease inhibitor. In our 
experiments for biocatalytic resolution of epoxide 7 we observed, however, that the 
reaction was strongly hampered by the chemical instability of this compound. As a 
result, the yield of (\R,2S)-7 as well as the e.e. of diol-7a were unsatisfactory. At the 
moment, experiments for enhancement the stability of indene oxide by use of organic 
solvents are in progress. 
The terminal aliphatic epoxides 8, 9, and 11 were found to be poor substrates for the yeast 
epoxide hydrolase. Activity and enantioselectivity for these compounds was relatively low 
and was slightly increased by increasing length of the side chain. Glycidol 10 was not 
hydrolyzed at all by the yeast epoxide hydrolase, nor at lower concentrations of 5 and 1 mM. 
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Activity for disubstituted 2,3-epoxides, represented by substrates 12 to 15, was low in the 
case of trans substituted side chains and higher when the side chains were cis situated. 
Enantioselectivity was very high for the epoxides 12,14 and 15 resulting in residual (2R) 
epoxides with nearly the maximal feasible yields of 50%. Hydrolysis of the meso epox-
ide 13 was somewhat unsatisfactory concerning the relatively low yield of 78% of diol 
product 13a. This was most probably caused by some subsequent oxidation of the diol 
since significant amounts of 3-hydroxy-2-butanone were detected in the final reaction 
mixture. 
Kinetic resolution of epoxide-2 
A detailed study of the resolution of epoxide {\R,2R)-2 was performed by monitoring the 
course of the e.e. values of {\R,2R)-2 in relation to the proceeding conversion in the 
hydrolysis of (±)-2. In Figure 1 it is shown that a complete kinetic resolution of (IR,2R)-
2 (e.e. >98%) is achieved at a conversion of 55% which is a rather encouraging result for 
a resolution process. During the initial phase of the reaction enantiomerically pure 
(\R,2S)-2a was found to be the product of the hydrolysis of (±)-2 and was even detected 
slightly above 50% conversion, indicating that this diol was also formed in some very 
small amounts from (lR,2R)-2. From Figure 1 it is also obvious that at conversion val-
ues of 60% or more the decrease of e.e.'s seems to be dramatic. However, it must be con-
sidered that resolution of the initial reaction mixture takes place in about one hour where-
as the final part of the reaction is still not completed after more than 40 hours. In this 
period, chemical hydrolysis of epoxides may be significant. Formation of other diol 
enantiomers was investigated by monitoring the chemical hydrolysis in the final part of 
the reaction. For this, the yeast cells were separated from the reaction mixture after com-
plete hydrolysis of (lS,2S)-2 after which the incubation of the reaction mixture was con-
tinued without cells. In Figure 1 it is shown that the loss of enantiomeric purity of 
(li?,25)-2a in the reaction mixture is mainly caused by formation of the other diol enan-
tiomers by chemical hydrolysis of the residual (lR,2R)-2. 
Enantioselective hydrolysis of trans-l-phenyl-l,2-epoxypropane has been studied 
before with epoxide hydrolases from other sources. In a study on the substrate enan-
tioselectivity of the rabbit microsomal epoxide hydrolase (MmEH) only a low selectivity 
in favor of epoxide (lS,2S)-2 has been observed, resulting in epoxide (\R,2R)-2 and diol 
(15,2/?)-2a both with low enantiopurity and low yield20. Better results were obtained with 
an epoxide hydrolase from the fungus Beauvaria sulfurescens. It has been reported that 
with this organism resolution of (±)-2 is possible resulting in epoxide (\R,2R)-2 (e.e. 98%, 
yield 30%) and diol (l/?,25)-2a (e.e. 90%, yield 38%)'*. The results from the present study 
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indicate the yeast Rhodotorula glutinis performs even better than the fungus. 
Epoxide hydrolases, in some cases showing high enantioselectivity, have been report-
ed from mammalian sources4-59, plants24 and from fungal151718 and bacterial111213 micro-
organisms. The pool of sources of these useful biocatalytic enzymes has now been 
extended with the yeast Rhodotorula glutinis. By further research on the yeast enzyme 
and other epoxide hydrolases a better selection for a specific enzyme, based on charac-
teristics of both enzyme as well as of source organism, will be made possible. 
100 
ID 
ID 
100 
conversion (%) 
Figure 1. Resolution of 10 mM trans-\-phenyl- 1,2-epoxypropane by Rhodotorula glutinis (2.3 g 
weight of dry cells in 50 ml). (•) Epoxide {\R,2R)-2; (O) diol (17?,2S)-2a; (V) diol (l/?,2S)-2a by 
chemical hydrolysis of residual (\R,2R)-2 (dotted line). 
Conclusions 
Enantioselective epoxide hydrolysis by yeasts has been first demonstrated for the hydrol-
ysis of several aryl, alicyclic and aliphatic epoxides by cells of Rhodotorula glutinis. By 
use of this biocatalyst enantiomerically pure forms of disubstituted aryl and aliphatic 
epoxides as well as the corresponding diols can be prepared. Diol formation was also 
promising in the hydrolysis of (-)-limonene oxide and of alicyclic meso epoxides. At the 
moment, experiments for enhancement of the hydrolase activity and isolation and char-
acterization of the epoxide hydrolase from Rhodotorula glutinis are in progress. 
70 
Epoxide hydrolysis by Rhodotorula glutinis 
Experimental Section 
General 
Gas chromatography (GLC) was performed on Chrompack CP9000 and Hewlett-Packard 
6890 gaschromatographs equipped with FID detectors and using N2 as carrier gas. 
Determination of the enantiomeric excesses was performed by GLC using fused silica 
cyclodextrin capillary columns (30 m length, 0.25 mm ID and 0.25 jum film thickness). 
For epoxide 1, 2, 6 and 7 an a-DEX 120 column (Supelco Inc.) was used at an oven-
temperature of 85°C, 90°C, 80°C and 110°C respectively. Enantiomer analysis of epox-
ide 3 and 10 was done at a (3-DEX 120 column (Supelco Inc.) at oventemperatures of 
110°C and 60°C. Complexation gas chromatography253 with a Chirametal-27-/?-3-l-13 
column was used at an oven temperature of 55°C to determine the enantiomeric compo-
sition of epoxide 8, 9 and 11 to 15. Chiral GLC analysis for diol 3a and 7a was performed 
on a (3-DEX 120 column at an oven temperature of 145°C after derivatization into their 
acetonides. Enantiomer analysis of the other diol compounds was carried out by direct 
analysis on a [3-DEX 120 column at oven temperatures ranging from 70°C to 145°C. 
Quantification of epoxides and diols was by GLC analysis using the respective capillary 
columns and conditions as for determination of e.e.'s. The concentrations of epoxides and 
diols were derived from calibration curves. Mass spectra of diol compounds were record-
ed on a Hewlett-Packard 5970 mass selective detector coupled to an HP 5890 gas chro-
matograph and were in accordance with the proposed structures. Optical rotation values 
were measured on a Perkin-Elmer 241 polarimeter at 589 nm. 
Epoxides 1 to 15 
The commercially available racemic and meso substrates cyclopentene oxide 4, cyclo-
hexene oxide 5, cis/trans-(4S)-\imonene oxide 6, (±)-1,2-epoxybutane 11, (±)-trans-2,3-
epoxybutane 12 and c/s-2,3-epoxybutane 13 were all obtained from Aldrich Chemie. 
Several of the other epoxides were available in enantiomeric pure form as well: (1R,2R)-
and (lS,2S)-trans-\-Phenyl- 1,2-epoxypropane 2 (Aldrich), (5)- and (i?)-Benzyl glycidyl 
ether 3 (Fluka), (IR,2S,4R)- and (lS,2fi,4fl)-limonene oxide 6 (Fluka), (/?)- and (S)-l,2-
epoxypropane 8 (Fluka), (5)- and (i?)-epichlorohydrin 9 (Fluka) and (R)- and (S)-glyci-
dol 10 (Aldrich). 
(±)-Indene oxide 7 was synthesized by cyclization of the indene bromohydrin26. To 75 
ml 13N KOH solution 12.5 g ?ran5,-2-bromo-l-indanol (Aldrich) was added. After stir-
ring for 1 hour at roomtemperature, the reaction mixture was extracted three times with 
ethyl acetate. The organic extracts were combined, washed with water and dried over 
MgS04. Evaporation under reduced pressure yielded 7.2 g of a white solid of epoxide 7. 
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The structure of epoxide 7 was characterized by GC/MS analysis. 
(±)-/rans-2,3-Epoxypentane 14 and (±)-cw-2,3-epoxypentane 15 were prepared by 
direct epoxidation of the corresponding trans- and cz's-2-pentene using m-chloroperoxy-
benzoic acid (MCPBA) as described in our previous studies38. 
Reference compounds la to 15a 
For identification and determination of the absolute configurations and yields of the 
formed diols from epoxides 1 to 15, the corresponding reference diol compounds were 
purchased or prepared. Commercially available were the enantiomerically pure forms of 
diol l a (Fluka), 3a (Fluka), 4a (Fluka), 5a (Fluka), 8a (Fluka), <7?)-9a (Fluka), 10a 
(Aldrich), 11a (Aldrich), 12a (Aldrich) and 13a (Fluka). 
A reference compound of enantiopure (lR,2S)-2a was prepared according to the 
reported method of microbial asymmetric reduction of 1 -phenyl-1,2-propanedione with 
Saccharomyces cerevisiae21. By using this method with Saccharomyces cerevisiae CBS 
1394 (from Centraalbureau voor Schimmelcultures, Yeast Division, The Netherlands), 38 
mg (li?,2S)-2a was obtained from 70 mg 1-phenyl-1,2-propanedione (Fluka Chemie). 
The structure of the reference compound (\R,2S)-2a was confirmed by GC/MS analysis 
and the enantiomeric excess and specific optical rotation were determined as 90% e.e. 
and [a]24D = - 36.3 (c = 1.9, CHC13) respectively. Chiral GLC analysis with an (3-DEX 
120 column at 145°C resulted in a major peak at Rt = 33.8 min (95%) and a minor peak 
at Rt = 30.8 min (5%). 
?ran^-8-p-Menthene-l,2-diols 6a were prepared by hydrolysis of the corresponding 
epoxides28. For this, a solution of 150 mg epoxide in 10 ml of 0.1 M HC104 in 1:9 (v/v) 
dioxane-water was stirred for 5 minutes at room temperature. After addition of 2 ml 
water, the diols were extracted twice with ethyl acetate. The ethyl acetate extracts were 
combined, washed with 2 ml of water, and dried over MgS04. Removal of the solvent 
yielded about 90% diol compound. In this way, {\R,2R,4R)-6a was prepared from 
\\R,2SAR)-6 and (\S,2S,4R)-6a was the minor hydration product of (lS,2fl,4fl)-6 respec-
tively. Diol (lR,2R,4S)-6a was prepared from (\R,2S,4S)-6. 
(±)-zrans-Indan-l,2-diol 7a was prepared by a reported method29 from indene oxide 7. A 
solution of 1.0 g epoxide 7 in 100 ml 2N KOH was heated to 102°C for 4 hours. 
Subsequently, the reaction mixture was saturated with NaCl, extracted with ethyl acetate, 
dried over MgS04 and evaporated under reduced pressure yielding 0.43 g of compound 7a. 
Acid-catalyzed epoxide hydrolysis was used in the synthesis of erythro (±)-2,3-pen-
tanediol 14a from trans 14 and threo (±)-2,3-pentanediol 15a from cis 15 respectively. 
After derivatization of the diols into their acetonides, determination of the absolute con-
figurations was performed by complexation gas chromatography30 using a Ni(II)-&/s-(3-
heptafluorobutyryl-(l/?,25')-pinan-4-onate column at 75°C. The obtained peak elution 
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orders were used for correlation to those obtained after direct analysis on a (3-DEX 120 
column at 75°C. 
Derivatization ofdiols into their acetonides 
Samples of 1.0 ml of diol-containing reaction mixture or 10 mM reference solution, were 
saturated with NaCl and subsequently extracted with an equal amount of 2,2-
dimethoxypropane. To 0.5 ml of the organic phase, 200 mg Amberlite IR-120 H+ (BDH, 
UK) was added and the mixture was stirred for an hour at room temperature. After neu-
tralization with approximately 200 mg NaHC03, the mixture was extracted with 1.0 ml 
ethyl acetate and dried over MgS04. Analysis of the prepared acetonides was by chiral 
GLC. 
Absolute configuration ofdiol 2a 
Absolute configurations were determined of the diols formed from hydrolysis of 0.50 
mmol of epoxide (±)-2, (\R,2R)-2 and (15,2S)-2 by Rhodotorula glutinis cells. 
Experiments for epoxide hydrolysis were carried out as described in this paper. By 
monitoring the duplicate reaction bottle, the moment for terminating the reaction of each 
epoxide was determined. The reactions were stopped by removal the yeast cells by cen-
trifugation (20,000 g, 10 minutes). The supernatants were saturated with NaCl and sub-
sequently extracted twice with an equal volume of ethyl acetate containing decane as an 
internal standard. GLC analysis was performed for determination the yields and e.e. val-
ues of the formed diols. 
The combined organic layers from the respective reaction mixtures were dried over 
MgS04 and evaporated under reduced pressure to give each an oily residu. For measure-
ment of the specific optical rotation values the diols were redissolved in CHC13. Data of 
chiral GLC analysis (Rt's on 8-DEX 120 column at 145°C) and specific optical rotation 
values are: 
diol 2a from (±)-2: Rt = 33.8 min; [ a p D = - 31.6 (c = 1.2, CHC13) 
diol 2a from (l/?,2/?)-2: Rt = 30.8 and 32.7 min; [a]2*D = + 8.8 (c = 0.16, CHC13) 
diol 2a from (15,25)-2: Rt = 33.8 min; [ a p D = - 32.8 (c = 0.6, CHC13). 
Determination of the absolute configurations was by comparison of the results with data 
from literature2731 and from the prepared reference compound of (\R,2S)-2a. 
Growth conditions Rhodotorula glutinis 
The yeast Rhodotorula glutinis strain CIMW 147 was obtained from our own laboratory 
culture collection. A mineral medium supplemented with 0.2% (w/v) yeast extract and 
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1% (w/v) glucose was used for cultivation. In the present study, R. glutinis was routine-
ly grown in a chemostat culture under aerobic conditions in a 2-1 fermentor (with 1-1 
working volume) at 30°C, with a dilution rate of 0.15 h1. The pH of the culture was 
maintained at 6.0. The cells were harvested by centrifugation at 16,000 g, washed twice 
with 50 mM potassium phosphate buffer pH 7.5, concentrated, and stored at -20°C. 
Epoxide hydrolysis by Rhodotorula glutinis 
Hydrolysis of epoxides was performed in 100 ml screw-capped bottles sealed with rub-
ber septa. The bottles contained 10 ml concentrated washed cell suspension of 
Rhodotorula glutinis (1.0 to 1.5 g dry weight) and 50 mM potassium phosphate buffer 
pH 7.5 to a total volume of 20 ml. The bottles were placed into a shaking waterbath at 
35°C and the reaction was started by addition of 0.20 mmol epoxide. The course of the 
epoxide hydrolysis was followed by periodically taking samples from the reaction mix-
ture, centrifuging for 4 minutes at 15.000 g, extracting 0.5 ml supernatants with 1.0 ml 
ethyl acetate and analysis by chiral GLC. Diols were analyzed similarly, however, extrac-
tion with ethyl acetate was after saturation of the supernatants with NaCl. Chiral GLC of 
epoxide 8, 9, 11 and 12 to 15 was performed by analysis of headspace samples taken 
from the reaction mixture3. Initial reaction rates were determined from the epoxide dis-
appearance and correlated to the dry weight of the used yeast suspension. In general, 
reactions were terminated when the residual epoxides reached e.e.'s of more than 98%. 
The detailed kinetic resolution of (±)-2 was performed in 250 ml screw-capped bottles 
with 25 ml concentrated washed cells, 0.50 mmol epoxide and phosphate buffer to a total 
volume of 50 ml. Chemical hydrolysis of residual epoxide from (±)-2 was tested by 
removal of the yeast cells by centrifugation (20,000 g, 10 minutes) from the reaction mix-
ture after complete hydrolysis of (15,25)-2. Subsequently, the obtained clear supernatant 
was further incubated at 35°C. Chemical hydrolysis was determined by monitoring the 
diol formation and epoxide conversion in the supernatant without cells. Eventually, four 
enantiomers of diol 2a were detected in the final part of the reaction. There was no sig-
nificant difference in the relative ratio of the four enantiomers in the final reaction mix-
tures with and without cells (4:9:21:66, ratio of peaks with ascending elution order by 
chiral GLC). A detailed course of the kinetic resolution of (±)-2 is shown in Figure 1. 
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Enantioselective hydrolysis of unbranched 
aliphatic 1,2-epoxides by Rhodotorula glutinis 
Abstract 
Epoxide hydrolase catalysed resolution of aliphatic terminal epoxides has been demonstrated for 
the hydrolysis of a homologous range of unbranched 1,2-epoxyalkanes by the yeast Rhodotorula 
glutinis. Both enantioselectivity and reaction rate were strongly influenced by the chain length 
of the epoxide used. Enantioselectivity showed an optimum in the hydrolysis of 1,2-epoxyhexane 
(E = 84). Resolution of (±)-l,2-epoxyhexane resulted in (S)-l,2-epoxyhexane (e.e. > 98%, yield 
= 48%) and (R)-l,2-hexanediol (e.e. = 83%, yield = 47%). 
C.A.G.M. Weijers, A.L. Botes, M.S. van Dyk and J.A.M. de Bont 
Tetrahedron: Asymmetry 1998, 9, 467-473 
Chapter 5 
Introduction 
A great interest exists in the development of methods for the synthesis of enantiomeri-
cally pure epoxides, because they are important chiral building blocks in the preparation 
of more complex enantiopure bioactive compounds. Various chemical and biological 
production methods have been reviewed12. In biological production methods, special 
attention has been given to terminal aliphatic epoxides because of their relatively high 
chemical stability in water-containing reaction mixtures. Furthermore, the absence of 
reactive side groups other than the oxirane ring, in most cases excludes undesired side-
reactions while using crude enzyme preparations or whole cell biocatalysts. 
Most studies on the biological production of enantiopure aliphatic epoxides involved 
direct epoxidation of alkenes by mono-oxygenase containing bacterial cells345. In all 
cases, aliphatic 1,2-epoxides were produced either as a racemic mixture or with the (R) 
configuration in excess. The method, however, was problematic due to product toxicity6. 
Resolution of several aliphatic 1,2-epoxides has been observed in a previous study for 
non-hydrolytic epoxide conversions by Nocardia H87. However, because of insufficient 
enantioselectivities, the yields of the obtained enantiopure (S) epoxides were low. 
Epoxide hydrolase catalyzed hydrolysis of aliphatic 1,2-epoxides has been studied with 
biocatalysts from different sources. Mammalian microsomal epoxide hydrolase (MmEH) 
was used for the hydrolysis of 1,2-epoxyhexane and 1,2-epoxydecane8. However, very 
low enantioselectivities were observed and the formed diols were of low enantiomeric 
purity, even at very low conversions. Fungal epoxide hydrolase activities towards 
aliphatic 1,2-epoxides has been reported for the hydrolysis of C6 to C14 1,2-epoxyalkanes 
by crude cell extracts from Ulocladium atrum and Zopfiella karachiensis9. Activities 
were maximal for C8 and C10 epoxides but, enantioselectivities were not given. Bacterial 
epoxide hydrolase activities were tested in a study for the resolution of 1,2-epoxyoctane 
with cell suspensions of the genera Rhodococcus, Nocardia and Mycobacterium™. From 
this screening it was concluded that the enantioselectivities of all biocatalysts tested were 
very low for the hydrolysis of this substrate (E < 6). 
Recently, we have investigated the presence of enantioselective epoxide hydrolases in 
yeasts. Enantioselective hydrolysis of various aryl, alicyclic and aliphatic epoxides by a 
strain of the yeast Rhodotorula glutinis has been demonstrated11. We have now extended 
our study by investigating substrate specificities and enantioselectivities for a homolo-
gous range of C4 to C8 aliphatic 1,2-epoxides. 
Results and Discussion 
Substrate specificity and enantioselectivity of the yeast epoxide hydrolase towards 
aliphatic 1,2-epoxides was investigated by incubating epoxides (±)-l to (±)-5 with rest-
78 
Hydrolysis of aliphatic 1,2-epoxides 
ing cell suspensions of glucose-grown Rhodotorula glutinis (Scheme 1). The reactions 
were monitored by periodic sampling and followed by GLC analysis using enantioselec-
tive columns. The present study was initiated by optimizing the reaction conditions for 
epoxide 1. In comparison with experiments performed in our previous study", we have 
now raised the substrate concentration to a final concentration of 20 mM and lowered the 
biocatalyst concentration to maximal 0.5 grams dry weight per 10 ml reaction mixture. 
Under these conditions the reaction rate as well as the enantioselectivity for epoxide 1 
were improved (Table 1). The optimized reaction conditions were used in subsequent 
experiments for the hydrolysis of epoxides (±)-2 to (±)-5. 
4 5 
Scheme 1: Aliphatic 1,2-epoxides used as substrates for hydrolysis by Rhodotorula glutinis 
In the hydrolysis of racemic epoxides 1 to 5, the reaction was terminated when the resid-
ual epoxide reached an e.e. of more than 98%. The reaction time, yield of the epoxide 
and e.e. and yield of the formed diol were then determined. Initial hydrolysis rates, 
absolute configurations, e.e. values and yields of the residual epoxides and of the formed 
diols are summarized in Table 1. Absolute configurations of the epoxides and diols were 
determined by co-injection of commercially available reference compounds on chiral 
GLC and by comparison of the specific rotation values with data from the literature. 
From the results summarized in Table 1 it is evident that the epoxide hydrolase from 
Rhodotorula glutinis has a preference for substrates with a chain length of six carbon 
atoms and more. The reaction rates for epoxides 3, 4 and 5 are very much higher than 
those for epoxide 1 and 2. The high enantioselectivity observed for hydrolysis of epox-
ide (±)-4 and, in particular, for epoxide (±)-3 is remarkable. Resolution of unbranched 
aliphatic terminal epoxides with moderate or high selectivities has not been reported for 
epoxide hydrolases from other sources. 
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Table 1. Hydrolysis of linear-chain aliphatic 1,2-epoxides by Rhodotorula glutinis 
Epoxide (residual substrate) 
reaction 
ratea 
1 2.3 
2 7.2 
3 50.8 
4 106.1 
5 85.2 
e.e. 
>98% 
>98% 
>98% 
>98% 
>98% 
abs. 
conf. 
(S) 
(S) 
(S) 
(S) 
(S) 
yield 
21% 
40% 
48% 
44% 
38% 
reaction 
time (h) 
3.0 
0.7 
0.4 
0.3 
0.3 
Diol product 
la 
2a 
3a 
4a 
5a 
e.e. 
29% 
66% 
83% 
73% 
55% 
abs. 
conf. 
(R) 
(R) 
(R) 
(R) 
(R) 
yield 
78% 
54% 
47% 
52% 
60% 
a) Initial rate of epoxide hydrolysis in nmol/min, mg dw. 
Hydrolysis of 20 mM epoxide in 10 ml reaction mixture with glucose-grown cells of Rhodotorula glu-
tinis (dry weights ranging from 0.1 to 0.5 g). 
All tested epoxides were hydrolyzed to (R) diols with retention of configuration at the 
more hindered carbon atom. The enantiomeric purities of the diols, obtained after com-
plete resolution of the corresponding epoxides, were in all cases low. Enantiopure diols 
could only be obtained from the corresponding epoxides at low conversions. 
For determination of the enantiomeric ratio E, In [Ro]/[R] versus In [So]/[S] was plot-
ted. The slope of this curve represents the E value. The concentrations of the (R) enan-
tiomer at times 0 and t are represented by [Ro] and [R], while [So] and [S] are the con-
centrations of the (S) enantiomer at times 0 and t, respectively. Concentrations at times t 
were determined from samples taken at two minute intervals, during the course of the 
reaction. This method for determining E has previously been used in a study on the 
hydrolysis of p-nitrostyrene oxide by an epoxide hydrolase preparation from Aspergillus 
nigeri2. The effect of the substrate chain length on the enantiomeric ratio E and on the 
initial reaction rate in the resolution of epoxides (±)-l to (±)-5 is shown in Figure la and 
b, respectively. In other revelant studies on the hydrolysis of aliphatic terminal epoxides, 
it was found that enantioselectivities were only significantly higher when substrates with 
branched alkyl-chains were used8910. 
In order to investigate the effect of increased substrate concentration on the biocatalyst, 
we raised the concentration of epoxide (±)-3. In this experiment 500 mg epoxide (±)-3 
was added to 1200 mg (dry weight) cells of Rhodotorula glutinis in a total volume of 10 
ml. Such a substrate concentration, calculated to be theoretically 500 mM, exceeds the 
maximal solubility of epoxide-3. Under these conditions, substantial amounts of epoxide 
will be separated from the aqueous phase during the reaction. Chemical hydrolysis of the 
epoxide will be minimized and larger quantities of substrate can thus be resolved. This 
high epoxide concentration had no significant adverse effect on the biocatalyst since 
80 
Hydrolysis of aliphatic 1,2-epoxides 
there was only about 10% decrease in reaction rate (r = 45 nmol/min,mg dw), compared 
with the rate for 20 mM epoxide (±)-3. The use of high substrate concentrations will 
greatly facilitate the application of this method on a preparative scale. 
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Figure 1. Effect of the substrate chain length on the enantioselectivity E (a) and reaction rate (b) in the 
hydrolysis of unbranched aliphatic 1,2-epoxides by Rhodotorula glutinis. 
Conclusions 
Epoxide hydrolysis with moderate to high enantioselectivities has, for the first time, 
been demonstrated for the resolution of a homologous range of unbranched aliphatic 
1,2-epoxides by cells of the yeast Rhodotorula glutinis. (R) Epoxides were preferential-
ly hydrolyzed to (R) diols with retention of configuration at the more hindered carbon 
atom. Reaction rates as well as enantioselectivities were strongly influenced by the 
chain length of the epoxide used. High enantioselectivity (E = 84) in combination with 
relatively high activity was observed in the resolution of (±)-l,2-epoxyhexane. 
Experimental Section 
General 
Gas chromatography (GLC) was performed on Chrompack CP9000 and Hewlett-Packard 
6890 gaschromatographs equipped with FID detectors and using N2 as carrier gas. 
Determination of the enantiomeric excesses was performed by GLC using fused silica 
cyclodextrin capillary columns (30 m length, 0.25 mm ID and 0.25 jum film thickness). For 
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epoxides 1 and 2, a 6-DEX 225 column (Supelco Inc.) was used at oven temperatures of 
50°C and 55 °C, respectively. Enantiomer analysis of epoxides 3, 4 and 5 was done on a 
P-DEX 120 column (Supelco Inc.) at oven temperatures of 45°C, 45°C and 55°C respec-
tively. Chiral GLC analysis for diols la, 2a, 3a, 4a and 5a was performed on a (3-DEX 
120 column at oven temperatures of 90°C, 100°C, 125°C, 125°C and 130°C. 
Concentrations of epoxides and diols were derived from calibration curves using heat-
killed cells of Rhodotorula glutinis. Optical rotation values were measured on a Perkin-
Elmer 241 polarimeter at 589 nm. 'H-NMR spectra were recorded on a Brucker 300MHz 
spectrometer. 
Epoxides 1 to 5 
The commercially available racemic substrates (±)-l,2-epoxybutane 1, (±)-l,2-
epoxypentane 2, (±)-l,2-epoxyhexane 3, and (±)-l,2-epoxyoctane 5 were all obtained 
from Aldrich Chemie. Epoxide 5 was available from Fluka in enantiomeric pure (R) and 
(5) form as well. 
(±)-l,2-Epoxyheptane 4 was synthesized by direct epoxidation of the corresponding 1-
heptene using m-chloroperoxybenzoic acid (M-CPBA) in dichloromethane at 0°C. The 
structure of epoxide 4 was characterized by GC/MS analysis m/z 85(12, M+-CHO), 
71(100, CH3(CH2)4+), 55(43, CH3(CH2)2+). 'H-NMR of (±)-4 in CDC13: 5H 0.91 (3H, t, J=7 
Hz, CH3), 1.28-1.68 (8H, m, -(CH2)4-), 2.48 (1H, dd, J=5.1 and 2.8 Hz,CH2(0)CH-), 2.76 
(1H, dd, J=5.1 and 4Hz, CH2(0)CH), 2.90-2.95 (1H, m, CH2(0)CH-). 
Reference compounds la to 5a 
For identification and determination of the yields of the formed diols from epoxides 1 to 5, 
the corresponding racemic reference diol compounds la, 2a, 3a and 5a were purchased 
from Aldrich Chemie. Acid catalyzed hydrolysis was used to prepare (±)-l,2-heptanediol 
4a from the corresponding epoxide (±)-4. GC/MS analysis m/z 101(27, M+-CH2OH), 
83(77, M+-(CH2OH+H20)), 55(100, CH3(CH2)2+). 'H-NMR of (±)-4a in acetone-d6: dH 
0.89 (3H, t, J=7 Hz, CH3), 1.18-1.42 (6H, m, -(CH2)3-), 1.42-1.60 (2H, m, -CH2CH(OH)-), 
2.04-2.08 (1H, m, -CH(OH)-), 3.30-3.53 (2H, m, -CH2OH). 
Growth conditions for Rhodotorula glutinis 
The yeast Rhodotorula glutinis strain CIMW 147 was from our own laboratory culture 
collection. A mineral medium supplemented with 0.2% (w/v) yeast extract and 1% 
(w/v) glucose was used for cultivation. Rhodotorula glutinis was routinely grown in a 
chemostat culture under aerobic conditions in a 2-1 fermentor (with 1-1 working volume) 
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at 30°C, with a dilution rate of 0.15 h1. The pH of the culture was maintained at 6.0. 
The cells were harvested by centrifugation at 16,000 g, washed twice with 50 mM potas-
sium phosphate buffer pH 7.5, concentrated, and stored at -20°C. 
Epoxide hydrolysis by Rhodotorula glutinis 
Hydrolysis of epoxides was routinely performed in 100 ml screw-capped bottles sealed 
with rubber septa. The bottles contained 1 to 5 ml concentrated washed cell suspension 
of Rhodotorula glutinis (0.1 to 0.5 g dry weight) and 50 mM potassium phosphate buffer 
pH 7.5 to a total volume of 10 ml. The bottles were placed into a shaking waterbath at 
35°C and the reaction was started by addition of 0.20 mmol epoxide. The course of the 
epoxide hydrolysis was followed by periodic taking headspace sampling followed by 
analysis with chiral GLC. Initial reaction rates were determined from the epoxide dis-
appearance and correlated to the dry weight of the used yeast suspension. In general, 
reactions were terminated when the residual epoxides reached e.e.'s of more than 98%. 
Subsequently, diols were extracted with ethyl acetate from NaCl saturated supernatants, 
obtained after centrifugation of the reaction mixture. Analysis of the diols was by chi-
ral GLC. 
Absolute configuration of epoxides 1 to 5 
Absolute configurations were determined of the residual epoxides obtained after 
hydrolysis of 300 mg of the appropriate epoxide by 800 mg (dry weight) of 
Rhodotorula glutinis cells as described in this paper. The moment for terminating the 
reactions was determined by monitoring headspace samples with chiral GLC. The reac-
tions were stopped by removal of the yeast cells by centrifugation (20,000g, 10 minutes, 
4°C). Subsequently, the supernatants were extracted twice with an equal volume of cold 
pentane. The combined organic layers were dried over MgS04 and concentrated by 
evaporation at 40°C under atmospheric pressure. Because of the high volality of most 
epoxides, concentration was not further continued and measurement of the specific opti-
cal rotation values was performed in the concentrated pentane fraction. Chiral GLC was 
used for determination of e.e.'s and concentrations were derived from calibration curves. 
Data of chiral GLC analysis and specific optical rotation values of the residual epoxides are: 
epoxide (5)-l: [ocpD = - 15.5 (c = 0.20, pentane; e.e. = 95%) 
[Lit.«: (R)-l: [ot]% = + 12.4 (c = 5.98, dioxane; e.e. > 98%)] 
epoxide (S)-2: [oc]24D = - 16.8 (c = 0.28, pentane; e.e. > 98%) 
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epoxide (S)-3: [a]24D = -18.7 (c = 0.93, pentane; e.e. > 98%) 
[Lit.4: (R)-3: [<xpD = + 12.1 (neat; e.e. = 66%)] 
epoxide (5)-4: [a]24D = - 12.3 (c = 0.31, pentane; e.e. = 78%) 
[Lit.4: (/?)-4:[oc]25D = +15.1 (neat; e.e. = 94%)]. 
Determination of the absolute configurations was by comparison of our results with the 
data reported in the literature134. Absolute configuration of the resolved residual epoxide 
(S)-5 was determined by co-injection on chiral GLC with the enantiopure reference com-
pounds (R)-5 and (S)-5 from Fluka. 
Absolute configuration ofdiols la to 5a 
Absolute configurations were determined of the diols formed from duplicate hydrolysis 
of 300 mg of the appropriate epoxide by 800 mg (dry weight) of Rhodotorula glutinis 
cells as described. Experiments were carried out in duplicate as described in this paper 
for resolution of the epoxides. However, in case of the diols, the reactions were already 
terminated at low conversions in order to obtain diols with higher enantiomeric purities. 
The residual epoxides are removed from the reaction mixture by extraction with pentane 
as described. The remaining aqueous reaction mixtures were subsequently saturated with 
NaCl and extracted twice with an equal amount of ethyl acetate. The combined organic 
layers were dried over MgS04 and evaporated under reduced pressure to give an oily 
residu of diols l a to 4a, and a white solid in the case of diol 5a. For measurement of the 
specific optical rotation values and enantiomeric purities, the diols were redissolved in 
methanol. Chiral GLC analysis was performed for determination of the e.e. values. Data 
of chiral GLC analysis and specific optical rotation values of the formed diols are: 
diol (7?)-la: [a]24D = + 3.6 (c = 3.5, methanol; e.e. = 36%) 
[LitJ4: (5)-la: [ a p D = - 8.6 (c = 1.0, methanol; e.e. > 99%)] 
diol (R)-2a: [a]24D = + 9.9 (c = 5.4, methanol; e.e. = 67%) 
[Lit."*: (5)-2a: [ a p D = - 17.3 (c = 1.0, methanol; e.e. > 99%)] 
diol (/?)-3a: [oc]24D = + 13.5 (c = 5.8, methanol; e.e. = 91%) 
[Lit.'4: (5)-3a: [cc]2°D = - 16.4 (c = 1.0, methanol; e.e. > 99%)] 
diol (7?)-4a: [a]24D = + 14.4 (c = 2.4, methanol; e.e. = 93%) 
[Lit.'4: (S)-4a: [ocpD = - 15.4 (c = 1.0, methanol; e.e. > 99%)] 
diol (R)-5a: [oc]24D = + 12.8 (c = 0.95, methanol; e.e. = 80%) 
[Lit.14: (S)-5a: [ a p D = - 13.6 (c = 1.0, methanol; e.e. > 99%)] 
Determination of the absolute configurations was by comparison of our results with the 
data reported in the literature14. 
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Preparative-scale kinetic resolution of 1,2-epoxyhexane 
by Rhodotorula glutinis 
Abstract 
Preparative-scale kinetic resolution of epoxides was investigated with 1,2-epoxyhexane as a 
model substrate and cells of the yeast Rhodotorula glutinis as biocatalyst with epoxide hydrolase 
(EH) activity. Critical parameters observed in scaling-up this process were the limited water-sol-
ubility and high cytotoxicity of the epoxide substrate. Therefore, organic solvents were tested for 
application in a two-phase reaction medium. From the relationship between log P and EH activ-
ity, long-chain aliphatic alkanes were determined as suitable biocompatible organic solvents. 
Dodecane was eventually selected for further applications. Scale-up experiments showed that 
product inhibition by the formed diol additionally hampered prolongation of the kinetic resolu-
tion process. 
A two-phase hollow fiber membrane bioreactor in cascade configuration was successfully used 
to (\) minimize toxicity of the solvent and epoxide and (n) to remove inhibitory amounts of formed 
diol. By this method, preparative-scale resolution of 22 g 1,2-epoxyhexane resulted in 6.5 g enan-
tiopure (S)-epoxide, obtained as a concentrated 0.9 M solution in the organic solvent containing 
feed reservoir. 
A process for continuous extractive kinetic resolution was performed using a modified con-
figuration of the two-phase cascade membrane bioreactor. By this method, long-term operation 
was possible to produce 13.4 g enantiopure (S)-l,2-epoxyhexane in the effluent solvent phase. 
The process was operated for 12 days and allowed production of enantiopure epoxide without the 
need for complete resolution of the racemic substrate in the feed reservoir. 
The main part of this chapter has been published in: 
WJ. Choi, C.Y. Choi, J.A.M. de Bont, C.A.G.M. Weijers 
Applied Microbiology and Biotechnology 1999, 53, 7-11 
and 
W.J. Choi, C.Y. Choi, J.A.M. de Bont, C.A.G.M. Weijers 
Applied Microbiology and Biotechnology 2000, 54, 641-646 
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Introduction 
The biocatalytical potential of epoxide hydrolases (EHs) from microbial sources, either 
used as enzyme preparations or whole cells, has been regarded as to be superior to that 
of their counterparts from mammalian cells13. Microbial EHs have shown to be easily 
accessible tools for application in organic synthesis because large-scale production of 
these biocatalysts is relatively easy. However, despite of this, their use in industrial-scale 
production of enantiopure epoxides is still not widespread. Scaling-up has most probably 
been hampered by experimental limitations such as inhibition of catalytic activity at high 
substrate concentrations. This inhibition phenomenon has already been observed in one 
of the early studies on the hydrolysis of styrene oxide by fungal cells4. 
Single-phase systems 
Scaling-up EH-catalyzed resolution of epoxides in aqueous buffer media has been report-
ed for cells of Nocardia EH15, crude enzyme from Aspergillus niger6 and cells of 
Rhodosporidium toruloides1 and Rhodotorula glutinis strains83 which are summarized in 
Table 1. 
Table 1. Reported EH-catalyzed preparative-scale kinetic resolution in aqueous media 
Substrate substrate reaction EH source ref. 
cone. medium 
100 mM buffer yeast 3. 
270 mM buffer bacterial 5. 
330 mM buffer/DMSO fungal 6. 
500 mM buffer yeast 7. 
62 mM buffer yeast 8. 
Preparative-scale epoxide resolution 
The initial substrate concentrations as given in Table 1 in most cases will exceed the max-
imum solubility of the respective compounds in aqueous buffer. Under these conditions, 
substantial amounts of epoxide will not be dissolved in the aqueous phase but will be 
highly dispersed without forming a separate layer. In this way, relatively large amounts 
of epoxide can be resolved with high efficiency. However, when enzymes or cells are 
exposed to substrate concentrations from millimolar range up to 1 M or more, severe sub-
strate inhibition will certainly affect the action of the biocatalyst as a general rule9. 
Moreover, in case of whole-cell biocatalysis, acute cytotoxicity of the epoxide substrate 
will occur due to membrane damage and subsequent misfunctioning of membrane asso-
ciated enzymes10. In most of the studies referred to in Table 1, inhibition of epoxide 
hydrolysis at high substrate concentrations had been observed yet. In some cases, this 
inhibition could be effectively compensated by using higher amounts of biocatalyst, indi-
cating that only the ratio of substrate to cells/enzyme was of importance48. For other 
sources of EH, substrate inhibition was independent to the biocatalyst concentration, and 
was possibly due to the intrinsic toxicity of epoxides45. The high toxicity of epoxides will 
certainly limit scaling-up possibilities. 
For scaling-up in single-phase media, special attention has to be given to the decreased 
solubility in water when more complex epoxides are used as substrates. Hydrolysis of 
large amounts of these kinds of epoxides will be hampered by mass-transfer limitations. 
Addition of water-miscible cosolvents will then be necessary to reduce the problem with-
out causing a large decrease in volumetric productivity. It has been stated that the use of 
cosolvent containing single-phase systems is not desirable in biotransformations with 
toxic substrates. This is based on the assumptions that these systems will enhance the tox-
icity towards the biocatalyst by (/) the basic cytotoxicity of both the cosolvent and the 
substrate and (ii) the speed of action11. For water-miscible cosolvents in a single-phase 
system, direct access to the cell membrane or enzyme itself is easily possible so that any 
toxic effects will appear rapidly. Apart from direct physical damage to the membrane and 
associated enzymes, additional protein denaturation will occur by unfolding. Application 
of cosolvents has been investigated in the resolution of /?ara-nitrostyrene oxide by EH 
from Aspergillus niger6. In this study, the use of a cosolvent was essential because of the 
low solubility of the substrate in aqueous buffer. All cosolvents tested were inhibitory 
towards the activity and stability of the EH. Best results were obtained with dimethyl-
sulfoxide (DMSO) but, however, the activity of the EH was still inhibited for 84% by 
addition of this compound to a final low concentration of 0.2% (v/v). 
It can be concluded that single-phase systems are not suitable reaction media for 
kinetic resolution of epoxides on a preparative scale. 
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Two-phase systems 
Further increase of substrate concentrations in aqueous media will be of interest for 
scaling-up, because with many epoxides being organic liquids, a simple two-phase sys-
tem will be obtained with the concentrated epoxide serving as both organic phase and 
substrate reservoir. In these systems, the substrate transfer rate depends on the interfa-
cial area between the two phases, and the aqueous substrate levels are determined by the 
water-solubility only. 
Application of such a two-phase system has been reported for the preparative-scale 
resolution of para-bromo-oc-mefhyl styrene oxide by Aspergillus niger LCP 521 l2. The 
epoxide used in this study was poorly soluble in water and a concentration of 770 mM 
therefore formed a separate organic layer. The method has been successfully scaled-up 
for the complete resolution of 6 g epoxide substrate (380 mM) using crude fungal EH 
preparation. 
Nevertheless, such a simple two-phase system, with the epoxide itself serving as 
organic phase, will not be generally applicable for scaling-up kinetic resolutions of all 
kinds of epoxide substrates. In particular, epoxides which are relatively well soluble in 
water will cause severe inhibition of the biocatalyst due to exposure to high substrate 
concentrations. For these substrates a better-controlled dosage towards the biocatalyst 
can be obtained by the use of an epoxide containing organic solvent serving as second 
phase. And, in addition, for epoxides which are solids in concentrated form this would 
be the only possibility, apart from the less promising application of cosolvents as alter-
native. 
In the present study, we will focus on scaling-up epoxide hydrolysis in two-phase sys-
tems using cells of Rhodotorula glutinis. The EH present in this yeast was found to be 
a membrane associated protein and it was therefore assumed that the enzyme will per-
form best and be stabilized under the most optimal conditions in the intra-cellular envi-
ronment13. 
In this view, the effect of solvents on catalytic activity of yeast cells is of importance. 
Whole-cell yeast biotransformations in two-phase systems have not been described 
extensively. Studies that have been reported include (i) effects on cell structure14 (ii) tox-
icity of «-alkanes and their derivatives15 (Hi) effects of interphase mixing16 and (iiii) 
effects on catalytic activity and enantioselectivity1718. From these investigations it can be 
concluded that for optimization of novel biocatalytic two-phase systems an empirical 
screening of organic solvents will be necessary. In particular biocompatibility, based on 
low or acceptable toxicity towards the biocatalyst, is a restrictive criterion as it is an 
absolute condition, whereas other desirable solvent characteristics are more relative con-
ditions. 
Classification of solvents in terms of biocompatibility is generally based on parameters 
that are all related to the polarity of the solvent1920. The most widely used selection cri-
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terion for solvent biocompatibility has been studied first by Laane et al.2K They demon-
strated the correlation between biocatalytic activity and log P. The log P is the logarithm 
of the partition coefficient that is arbitrary determined in a standard 1 -octanol-water two-
phase system. The partition coefficient P is defined as 
P= [compound] octano, 
[compound]
 water 
Log P has conventionally been used in the pharmaceutical and medicinal chemistry 
fields as a part of drug activity studies22. As a general rule, biocatalytic activity is low 
in polar solvents with a log P < 2 and the activity will be retrieved in apolar solvents 
having a log P > 423. Cell activity as function of log P values for different homologous 
series of solvents has been studied by Vermue et al.24. The results of this study indi-
cates that biocompatibility of solvents can not be determined by their log P alone but 
is related to their concentration used and chemical structure as well. For membrane 
associated enzymes catalytic activity was found to be well correlated with the concen-
tration of solvent in the cell membranes25. Loss of activity was supposed to be mainly 
caused by alterations of membrane fluidity, and to some lower extend by lipid phase 
separation, direct protein-solvent interactions and membrane permeabilization. 
The use of organic solvents for biocatalytic resolution of epoxides has several poten-
tial advantages including (z) increased substrate concentrations for high volumetric 
productivity (//) protection of cells against inhibitory amounts of epoxide and (iii) pre-
vention of chemical hydrolysis of the epoxide substrate at longer reaction times. The 
main disadvantage that can be expected is a dramatic decrease in reaction rates due to 
additional solvent toxicity11. 
Membrane bioreactors 
Suitable organic solvents can be selected for scaling-up EH-catalyzed resolution of epox-
ides. However, for long-term operational stability of the biocatalyst, a more effective pro-
tection to the solvent and other reactants will be needed. This can be achieved by the use 
of a membrane bioreactor with a microporous membrane serving as a barrier between the 
used toxic compounds and the biocatalyst. Apart from enhanced activity and extended 
operational stability of the biocatalyst, this methodology has several other advantages, 
such as (i) prevention of the formation of emulsions and subsequent loss of solvent and 
substrate, (ii) possibility to easily remove reaction products for increased conversions and 
(Hi) modular design which allows simple scale-up. Operating principles, mathematics 
and applications of hollow-fiber membrane reactors have been reviewed recently26. 
Applications of two-phase membrane bioreactors in whole-cell biocatalysis have been 
reported for bioconversions in general2729 and for one example of kinetic resolution in 
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particular30. Enzymatic resolutions using membrane bioreactors have been described in a 
few cases more3133. Resolution of epoxides by use of membrane bioreactors has not been 
reported before in either case. 
Present study 
In the present study, scaling-up epoxide resolution was investigated with 1,2-epoxy-
hexane as a model substrate and cells of the yeast Rhodotorula glutinis were used as 
biocatalyst with yeast epoxide hydrolase activity (YEH)(Scheme 1). A membrane reac-
tor consisting of hollow-fibers with a large surface area was used as bioreactor for the 
kinetic resolution process. The membrane bioreactor was used in a batchwise operation 
mode and subsequently in a modified configuration for continuous extraction of the 
resolved enantiopure epoxide. 
Xj° + R. glutinis 
> 98 % e.e. (S) 83 % e.e. (/?) 
48 % yield 47 % yield 
Scheme 1. YEH-catalyzed kinetic resolution of (±)-1,2-epoxyhexane3 
Results and Discussion 
Solvent selection 
Solvent selection for aided resolution of 1,2-epoxyhexane was performed in a reaction 
medium consisting of aqueous buffer with cells of Rhodotorula glutinis and the appro-
priate organic solvent in a concentration of 30% (v/v). Water-miscible cosolvents like 
acetonitrile, methyl sulfoxide and 1,4-dioxane were initially tested but all of them 
showed almost complete inhibition of the YEH activity and were therefore excluded 
from further investigation. 
Water-immiscible solvents were found to be less inhibitory. But, nevertheless, mini-
mum inhibition still was about 75% when tested under the standard assay conditions. 
The disappointing result can be partly explained by low biocompatibility of the tested 
solvents but a greater part of inhibition was most probably caused by a limiting amount 
of epoxide available in the aqueous phase due to solvent extraction. In this context, 
kinetic constants for the expression of whole-cell epoxide hydrolysis are of importance. 
From data obtained by epoxide hydrolysis using similar experimental conditions, we 
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determined the maximum diol production rate V*max as 48 ± 4 nmol/min,mg dw and a 
K*M of 14 ± 2 mM for (7?)-l,2-epoxyhexane. Both extrinsic parameters were calculated 
from a "Eadie-Hofstee" plot. From the K*M value it can be understood that an epoxide 
concentration of 20 mM in the presence of extracting organic solvent can generate very 
low substrate concentrations in the aqueous phase which become rate limiting. We 
therefore raised the epoxide concentration up to 100 mM and screened a range of water-
immiscible solvents under the improved conditions. A concentration of 100 mM was 
obtained by addition of 2 mmol epoxide. This amount of epoxide could be resolved to 
completion within 180 minutes by 0.4 g cells of Rhodotorula glutinis. Partition coeffi-
cients for 1,2-epoxyhexane in the tested solvents were in the range of 64 to 34, resulting 
in epoxide concentrations from 5 to 9 mM in the aqueous phase by addition of 2 mmol 
substrate. 
Table 2. Epoxide hydrolase activity of Rhodotorula glutinis in aqueous/organic two-phase reaction 
media 
Solventa 
Aqueous buffer 
Glycerol 
Ethyl acetate 
Diethyl ether 
Dipropyl ether 
Pentane 
Hexane 
Octane 
Decane 
Dodecane 
Tetradecane 
Hexadecane 
1,2-Epoxyhexanea 
log/5 
. 
-
0.68 
0.85 
1.9 
3.0 
3.5 
4.5 
5.6 
6.6 
7.6 
8.8 
1.9 
reaction 
rateb 
43 
33 
0.1 
3.9 
14 
20 
20 
24 
28 
30 
31 
36 
38 
yield 
diolc 
47% 
43 % 
0.13 % 
12% 
26% 
33% 
38% 
38% 
41 % 
49% 
48% 
52% 
2.2% 
e.e. 
(fl)-diolc 
86% 
87% 
n.d. 
92% 
94% 
92% 
90% 
91 % 
91 % 
92% 
92% 
91 % 
95 % 
Hydrolysis of 100 mM 1,2-epoxyhexane in 20 ml reaction mixture with cells of Rhodotorula glutinis 
(dry weight 0.4 g). 
a> Reaction mixture containing 30 % (v/v) solvent or epoxide as an organic phase. 
b)
 Initial rate of diol production in nmol/min, mg dw at 35 °C, reaction started after 60 min preincu-
bation with the appropriate solvent. 
c> Concentration of 1,2-hexanediol and e.e. of (/?)-l,2-hexanediol after 3 h of incubation, 
n.d. Not determined 
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In order to minimize possible variations, caused by differences in time-dependent solvent 
sensitivity, a 60 min pre-incubation period was included in the experiment. During pre-
incubation, cells were exposed to the appropriate solvent without epoxide substrate. 
Under the present experimental conditions a more accurate determination of the EH 
activity was found by analysis of the formed diol rather than by analysis of the residual 
epoxide. The results are compiled in Table 2. 
Both reaction rate as well as degree of conversion was found to be dependent on the 
polarity of the solvent used. The effect of organic solvents on the initial reaction rates as 
shown in Table 2 is in accordance with the effect observed in the hydrolysis of 20 mM 
epoxide substrate. However, inhibition by the tested non-polar solvents is much less 
severe than in case of the experiment using the lower initial substrate concentration. 
Glycerol has been included in the experiment for observation of possible effects caused 
by decrease of the aqueous volume and subsequent increase of the cell concentration. In 
the control situation using glycerol, only a small inhibition of the reaction rate was 
observed due to the reduced amount of water. Glycerol itself was assumed not to show 
any intrinsic toxicity because this polyalcohol has been widely used for stabilization of 
the catalytic activity of enzymes34 and cells35. In fact, glycerol is able to maintain both 
the hydrophobic interactions essential for the native structure of the enzyme and the 
water shell around the protein molecule36. 
The relationships between retention of activity and log P and between enantiomeric ratio 
E and log P are shown in Figure 1. From these results, biocompatible solvents can be 
selected for the desirable activity and/or enantioselectivity. The relationship between 
activity retention and log P is somewhat divergent from the generally observed sigmoidal 
patterns. In the present case, there are only extreme log P values indicating the range of 
solvents being completely inhibitory or supporting complete retention of activity. The 
results show that an increase of Vmax for the substrate hydrolysis is correlated to increas-
ing log P values of the solvents used. This relationship is assumed to be equal for both 
the (/?)- and (S)-enantiomers individually. The overall small effect of enantioselectivity 
(Figure lb) can thus be explained by the ratio of Vm.MR / Vmms remaining almost constant. 
Corresponding effects of solvents have been reported for other kind of hydrolytic 
enzymes3738. 
Apart from biocompatibility, also other solvent characteristics are of importance. At 
first, limitations of substrate transfer must be avoided, so therefore, suitable solvents 
should have low or moderate partition coefficients for the substrate. And, secondly, suit-
able solvents should have a good selectivity in relation to partition of substrate and 
product. In case of selecting a solvent for the present study, a good selectivity would 
imply a moderate partition for the substrate and a very low one for the product. Such 
good selectivity greatly facilitates the separation of epoxide and diol as basically will be 
obtained by separation of the organic and aqueous phase. In view of these requirements, 
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and based on other more practical criteria22, dodecane was eventually selected from the 
biocompatible solvents. In dodecane, the partition coefficient for 1,2-epoxyhexane was 
determined to be 36. 1,2-Hexanediol showed no solubility in dodecane and hence the 
partition coefficient was accordingly determined as 0.02. From these data, the separa-
tion factor of dodecane for extraction of 1,2-epoxyhexane was calculated as 1800. 
c 
o 
> 
t3 
Figure 1. Relationship between activity retention (a) and log P and between enantiomeric ratio £(c,p) 
(b) and log P, in the hydrolysis of 1,2-epoxyhexane by cells of Rhodotorula glutinis when exposed to 
various organic solvents. The activity retention in case of addition of glycerol in the control experi-
ment is represented by the dotted line in figure (a). 
Diol inhibition 
Hydrolysis of 2 mmol 1,2-epoxyhexane proceeded to complete resolution of the racemic 
epoxide within the duration of the experiments. However, in case of epoxide hydrolysis 
in the two-phase reaction medium where 1,2-epoxyhexane (50 mmol) served for both 
substrate and organic phase, a very low conversion of only 2 % was obtained. The YEH 
activity was most probably inhibited by the high concentration of 30% (v/v) and intrin-
sic toxicity of the epoxide. But, however, loss of activity could also have been partly 
caused by product inhibition. The latter possibility was supported by the observation that 
in the course of this reaction, diol production leveled off when the formed diol reached 
concentrations of 50 mM or more. The effect of product inhibition was examined by 
comparison of YEH activity in the presence and absence of 50 mM 1,2-hexanediol. In 
this experiment, a similar amount of 50 mmol of 1,2-epoxyhexane was used but now dis-
solved in an equal volume of dodecane. Analysis of the aqueous phase resulted in an 
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epoxide concentration of about 55 mM under these conditions. The biocompatible sol-
vent was expected to be able to protect the yeast cells to the epoxide but not to the diol. 
The courses of these reactions are shown in Figure 2. 
120 160 200 240 
time (min) 
120 160 200 240 
time (min) 
Figure 2. Product inhibition in the hydrolysis of 50 mmol 1,2-epoxyhexane by cells of Rhodotorula 
glutinis (0.5 g dw) in a dodecane containing two-phase system. Course of production of (fl)-l,2-hexa-
nediol (•) and (S)-l,2-hexanediol (O) (a) and in the presence of 50 mM (+)-1,2-hexanediol (b). 
YEH activity could be prolonged by addition of dodecane, but, however, resolution of 
the epoxide nevertheless remained incomplete due to product inhibition. This phenom-
enon was observed more clearly in the presence of 50 mM 1,2-hexanediol. Inhibition of 
the initial reaction rate was determined to be 37% and, after terminating the experiment 
after 20 h of incubation, a decrease of 74% in the yield of formed diol was calculated. 
In a corresponding reference experiment, dodecane was replaced by glycerol. Inhibition 
of reaction rate and decrease in yield of formed diol were 36% and 72% respectively in 
this case. The inhibitory effect of increasing diol concentrations was tested in more 
detail. Inhibition of YEH activity was found to be directly correlated to the diol con-
centration. Diol concentrations from 100 to 200 mM resulted in inhibition of reaction 
rates of 60 to 90% respectively. 
Resolution of 1,2-epoxyhexane using a two-phase membrane bioreactor 
A cascade hollow-fiber membrane bioreactor was used for preparative-scale resolution 
of 1,2-epoxyhexane. The bioreactor is schematically depicted in Scheme 2 
(Experimental Section). 
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Dodecane was used as organic solvent in the substrate feed reservoir due to its charac-
teristics as discussed before. Especially the low substrate partition in dodecane was of 
interest for application in a membrane bioreactor as was indicated by theoretical data 
from literature31. Both hydrophilic as well as hydrophobic membranes were tested for 
the process. It was observed that hydrophobic membranes supported transfer of the non-
polar dodecane through the pores of the membrane surface where the solvent became in 
direct contact with the cells. We therefore selected a hollow-fiber membrane module 
consisting of hydrophilic cellulose membranes. In the present bioreactor, yeast cells are 
not able to pass the membrane pores and remain in the shell side without direct contact 
with the organic phase. Aqueous solutions however, are permitted to pass the membrane 
barrier towards the lumen side filled with the hydrophobic organic solvent. Cells of 
Rhodotorula glutinis were used as biocatalyst. 
The bioreactor was operated by recirculating racemic 1,2-epoxyhexane dissolved in 
dodecane through the fiber lumen side with transfer of epoxide to the yeast cells in 
aqueous buffer in the shell side. In the aqueous phase, 1,2-epoxyhexane was hydrolyzed 
by the biocatalyst. Subsequently, the aqueous phase was passed to the shell side of the 
second membrane unit where formed inhibitory high concentrations of diol were lowered 
by buffer recirculating through the lumen side. 
To strip off diol from the cell suspension, water-immiscible organic solvents with high 
extraction capacities for diols were tested. However, tested suitable solvents, like long-
chain aliphatic alcohols, in all cases extracted the partially resolved epoxide as well. In 
this way, complete resolution of epoxide was strongly hampered. We therefore applied 
phosphate buffer in the second membrane unit for dilution of the formed inhibitory diol 
in the cell suspensions. Since addition of buffer direct to the cell suspension would 
result in a substantial decrease of cell concentration, a second membrane unit was 
applied in a cascade configuration. 
In Table 3, epoxide and diol concentrations in dodecane, cell suspension and diol 
extracting buffer during the kinetic resolution process are shown. From the data pre-
sented, it can be concluded that the large amount of highly concentrated epoxide was 
successfully hydrolyzed and that the formed diol maintained below the previously 
observed inhibitory concentrations. A disadvantage of the cascade membrane configu-
ration is loss of epoxide by undesired extraction in the diol extraction buffer. 
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Table 3. Concentrations of 1,2-epoxyhexane and 1,2-hexanediol in solvent, yeast cell suspension and 
diol extracting buffer, during epoxide resolution in a cascade two-phase membrane bioreactor 
Time 
(h) 
- 3 a 
0a 
0.3 
1 
3 
7 
10 
14 
epoxide, 
dodecane 
(mM) 
3000 
2025 
1903 
1778 
1412 
1120 
913 
867 
epoxide, 
cells 
(mM) 
0 
28 
33 
31 
20 
17 
14 
13 
epoxide, 
extr. buffer 
(mM) 
0 
28 
28 
24 
17 
11 
11 
10 
diol, 
cells 
(mM) 
0 
0 
14 
18 
32 
41 
47 
52 
diol, 
extr. buffer 
(mM) 
0 
0 
2 
10 
28 
42 
50 
53 
a) Pre-run period 
In Figure 3, the course of epoxide conversion and diol production is shown. Kinetic res-
olution of 226 mmol 1,2-epoxyhexane by cells of Rhodotorula glutinis (7 g dw) was 
completed within 14 hours. Enantiopure epoxide was obtained as 65 mmol (6.5 g) (S)-
1,2-epoxyhexane (e.e. > 98%) in 30 % yield in the dodecane containing organic phase. 
No 1,2-hexanediol was detected in the dodecane phase. A decrease in yield of enan-
tiopure epoxide was mainly caused by the loss of, racemic as well as enantiopure, epox-
ide in the diol extraction buffer. Secondly, a small decrease in enantioselectivity during 
the final course of the reaction also influenced the yield of (^-epoxide and e.e. of 
formed (7?)-diol. 1,2-Hexanediol accumulated up to 126 mmol in the diol extraction 
buffer. The initial rate of YEH activity was 43 nmol/min mg dw. 
The results show that application of a two-phase cascade membrane bioreactor allows 
kinetic resolution of large amounts of epoxide in high concentrations without significant 
product inhibition. In addition, formed diols can be easily separated from the epoxides 
and, in specific cases, obtained in enantiopure form as well. The method can be opti-
mized for resolution of other epoxides and/or diol production. Results will even be better 
by using epoxides that are less soluble in water because then loss of substrate in the diol 
extraction buffer will decrease. In conclusion, the method is useful for large-scale reso-
lution of epoxides and particularly when chemically unstable and/or water-insoluble 
epoxides are used as substrates. 
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120 
120 160 200 240 
time (min) 
10 12 14 
time (h) 
Figure 3. Enantioselective hydrolysis of 226 mmol (22 g) 1,2-epoxyhexane by cells of Rhodotorula 
glutinis (7 g dw) in a cascade two-phase membrane bioreactor. Epoxide and diol during the pre-run are 
not shown. Course of epoxide hydrolysis (a) showing the total amounts of (R)- 1,2-epoxyhexane (O) 
and (S)- 1,2-epoxyhexane (•) in dodecane (75 ml). Course of diol production (b) showing the total 
amounts of (S)-l,2-hexanediol (O) and (#)-!,2-hexanediol (•) in diol extraction buffer (2.4 1). 
Continuous production of enantiopure 1,2-epoxyhexane in a two-phase membrane biore-
actor 
Application of a two-phase membrane bioreactor for batch-wise kinetic resolution of 
epoxides has shown to be a method with satisfactory results. In order to investigate the 
feasibility of using a membrane bioreactor for continuous production of enantiopure 
epoxides, we modified the previously used configuration of the equipment. The new 
process was designed for continuous extraction of the resolved epoxide during the 
course of kinetic resolution. Enantioselective hydrolysis of 1,2-epoxyhexane by cells of 
Rhodotorula glutinis was studied in a dodecane containing bioreactor consisting of 
microporous hydrophilic hollow-fiber membrane modules. The bioreactor for continu-
ous extractive kinetic resolution is schematically depicted in Scheme 3 (Experimental 
Section). 
A critical parameter in continuous biocatalytical processes is the long-term operational 
stability of the biocatalyst. Apart from the intrinsic stability characteristics of the YEH 
enzyme, inactivation in two-phase membrane bioreactors can additionally be attributed 
to cytotoxicity of the reactants and mechanical shear stress caused by pumping. We there-
fore evaluated the stability of YEH activity in the cell suspension while mimicking 
experimental conditions in the membrane reactor. Because it has been reported that EH 
stability could be enhanced by lowering the temperature39, we operated the bioreactor at 
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two different temperatures, 35°C and 25°C. Based on the inactivation patterns, half-
lives for the two different temperatures of 35°C and 25 °C were determined as 2 and 5 
days, respectively. The EH activity at 25°C was 85% of the maximum value obtained at 
35°C, while the half-life was 2.5 times longer at 25°C. Based on the improvement in 
enzyme stability, a reaction temperature of 25°C was chosen for the continuous process. 
The bioreactor was operated by circulating racemic 1,2-epoxyhexane dissolved in 
dodecane from the feed reservoir through the fiber lumen side of the first membrane 
module. Amounts of epoxide are transferred to the aqueous phase in the shell side for 
subsequent enantioselective hydrolysis of the (R) enantiomer by the yeast cells. The 
aqueous cell suspension with residual (S)-epoxide was passed to the shell side of the 
second membrane unit. Continuous extraction of the (^-epoxide was performed in this 
unit by a dodecane flow passing through the lumen side. Eventually, inhibitory formed 
1,2-hexanediol was stripped off continuously in the third membrane unit by effluent-
extracting aqueous buffer. The process for continuous extracting kinetic resolution was 
started with 3 mol (300 g) (±)-l,2-epoxyhexane as substrate. The time courses of extrac-
tion of (S)-epoxide and (7?)-diol are shown in Figure 4. 
10 12 
time (day) 
10 12 
time (day) 
Figure 4. Continuous extractive kinetic resolution of 3 mol 1,2-epoxyhexane by cells of Rhodotorula 
glutinis (9 g dw) in a two-phase membrane bioreactor. Time course of continuous extraction in efflu-
ent dodecane (a) showing concentration (•) and e.e. (A) of residual (S)-epoxide. Course of continu-
ous extraction in aqueous buffer (b) showing concentration (O) and e.e. (A) of the produced (fi)-diol. 
In Figure 4, the time course of extracted epoxide shows a low enantiopurity of the resi-
dual (S)-epoxide during the early stage of operation. This phenomenon indicates that the 
initial amounts of epoxide transported to the yeast cells exceeded the amount that could 
be hydrolyzed by the biocatalyst. Unreacted racemic epoxide thereby remained together 
with the resolved enantiopure (^-epoxide in the aqueous cell suspension. Partially 
resolved epoxide with low enantiopurity was subsequently extracted by dodecane in the 
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second membrane unit. After several recirculations, the aqueous cell suspension con-
tained residual (S)-epoxide in excess, due to the resolution process. The amount of (5)-
epoxide decreased the transfer of racemic epoxide from the substrate reservoir to the 
aqueous cell suspension. After 2 days of operation, the transfer of racemic substrate was 
in equilibrium with the amount of (7?)-epoxide that could be hydrolyzed completely by 
the yeast cells. Consequently, in the remaining resolution process, epoxide extracted from 
the aqueous phase in the second membrane unit consisted merely of the enantiopure 
residual (S)-epoxide. 
These observations indicate that optimization of the resolution process is highly 
dependent on the interfacial mass transfer of the epoxide and the amount of biocatalyst. 
In a given two-phase membrane bioreactor, the mass transfer is influenced by the sub-
strate concentration in the feed solution and by the recirculation flow rates of both phas-
es. However, optimization of the flow rates is strongly limited by the characteristics of 
the membrane. Careful consideration has to be taken to control the flow rates on both 
sides of the membrane in such a way that the generated transmembrane pressures do not 
exceed the 'breakthrough' pressure. The flow rates of the dodecane phases were therefore 
optimized to the minimum values that did not cause phase-mixing. 
The course of production of enantiopure (S)-epoxide, obtained in the extracting dode-
cane phase, is shown in Figure 5. The volumetric productivity gradually decreased dur-
ing the operation, due to loss of activity of the yeast cells. The initial specific activity, 
determined from the first 2 days interval, was 22 nmol/min, mg dw at 25 °C. After 12 
days of continuous operation an amount 134 mmol (13.4 g) enantiopure (S)-epoxide was 
obtained. An amount of 140 g of racemic epoxide was still present in the substrate reser-
voir indicating that an excess amount of epoxide was supplied at the beginning under 
these conditions. The overall yield of enantiopure (S)-1,2-epoxyhexane (e.e. >98%) was 
determined as 24% whereas the yield of epoxide in extracting dodecane was only 30% 
of this value. The low yield was caused by significant loss of epoxide by the continuous 
flow of extracting aqueous buffer in the third membrane unit. 
Enhancement of the productivity can be achieved by changing the epoxide extracting 
solvent used in the second membrane unit into a solvent with a much higher extracting 
capacity for the specific epoxide. The amount of epoxide transported to the third mem-
brane unit will then be substantially lowered. Consequently, a minimal loss of epoxide by 
the diol-extracting buffer will be achieved. However, use of higher extracting, more polar 
solvents may cause (/) inactivation of the biocatalyst due to higher cytotoxicity and (a) 
lower chemical purity of the resolved epoxide due to undesired co-extraction of amounts 
of diol. A higher yield of residual epoxide will also be obtained in case of resolution of 
less water-soluble epoxides due to similar reduced loss of epoxide in diol extraction 
buffer. Further optimization will be necessary for enhanced utilization of this new 
approach to kinetic resolutions. 
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Figure 5. Production of enantiopure epoxide by continuous extractive kinetic resolution in a two-
phase membrane bioreactor. Cumulative production of enantiopure (5)-l,2-epoxyhexane ( • ) in 
extracting effluent dodecane and course of the productivity (• ) for this epoxide during the process. 
In the present study we have developed a method to produce enantiopure epoxides in an 
effluent extracting solvent during the course of a kinetic resolution process. This method 
allows the continuous production of enantiopure epoxide without the need for complete 
resolution of the racemic epoxide in the substrate reservoir. In this way, the continuous 
process is potentially applicable to EH-catalyzed resolutions in which the biocatalyst 
shows a high activity but relatively low enantioselectivity towards a specific substrate. 
Conclusions 
Biocatalytic kinetic resolution of epoxides has been demonstrated in solvent containing 
two-phase reaction media. Long-chain aliphatic alkanes were found suitable biocompat-
ible organic solvents for epoxide hydrolase containing cells of Rhodotorula glutinis. 
Scaling-up of this reaction was hampered by inhibition due to substrate toxicity as well 
by product inhibition of formed diol. 
Preparative-scale resolution of highly concentrated epoxide was successfully per-
formed in a two-phase membrane bioreactor. A cascade configuration of two hollow-
fiber membrane modules was used to (/) minimize toxicity of the solvent and epoxide and 
(//) to remove inhibitory amounts of diol. After complete resolution, enantiopure epoxide 
was obtained in the organic solvent containing feed reservoir. 
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In a modified process design, the membrane bioreactor was used for continuous extrac-
tive kinetic resolution. Under these conditions, enantiopure epoxide was obtained in the 
effluent solvent phase during long-term operation. The process configuration allowed 
continuous production of enantiopure epoxide without the need for complete resolution 
of the racemic substrate in the feed reservoir. Further optimization of this process will be 
necessary for improvement of the volumetric productivity. 
Experimental Section 
General 
Gas chromatography (GLC) was performed on a Hewlett-Packard 6890 gaschromato-
graph equipped with a FID detector and using N2 as carrier gas. Determination of the 
enantiomeric excesses was performed by chiral GLC using a fused silica cyclodextrin 
capillary 6-DEX 120 column (30 m length, 0.25 mm ID and 0.25 mm film thickness, 
Supelco Inc.) as described previously40. Racemic 1,2-epoxyhexane, (7?)-l,2-epoxyhexa-
ne, 1,2-hexanediol, organic solvents and medium components were purchased from 
Sigma-Aldrich Chemie BV, The Netherlands. 
Concentrations of epoxide and diol were derived from calibration curves using heat-
killed cells of Rhodotorula glutinis. For determination of diol concentrations in two-
phase reaction media, individual calibration curves with the corresponding amounts of 
appropriate organic solvent and heat-killed cells were prepared. 
Biocatalyst 
The yeast Rhodotorula glutinis ATCC 201718 was originally obtained from our own lab-
oratory culture collection and previously referred to as strain CIMW 147. The yeast strain 
was cultivated for 48 h in a mineral medium supplemented with 2% (m/v) glucose and 
0.2% (m/v) yeast extract, at 30°C in a shaking incubator. Cells were harvested by cen-
trifugation at 16,000 g, washed with 100 mM potassium phosphate buffer pH 8.0, con-
centrated and stored - 20°C for future experiments. 
Solvent selection 
Hydrolysis of epoxide was performed in 100 ml screw-capped bottles sealed with rubber 
septa. The bottles contained 3 ml concentrated cell suspension of Rhodotorula glutinis 
(0.4 g dw), 6 ml appropriate organic solvent, and 50 mM potassium phosphate buffer pH 
8.0 to a total volume of 20 ml. The bottles were placed into a shaking waterbath at 35°C 
and the cells were pre-incubated with the organic solvent for 60 minutes. Under these 
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conditions, the solvent was dispersed in the reaction mixture but formed a separate layer 
when shaking was terminated. Epoxide hydrolysis was started by addition of 2.0 mmol 
1,2-epoxyhexane. The course of the reaction was followed for 3 h, by periodic taking 
samples from the cells containing aqueous buffer phase. Subsequently, formed 1,2-hexa-
nediol was extracted with ethyl acetate from NaCl saturated supernatants, obtained after 
centrifugation of samples from the aqueous cell suspension. Analysis of the diol was by 
chiral GLC. Initial reaction rates were determined from diol production and correlated to 
the dry weight of the used yeast suspension. Partition coefficients for 1,2-epoxyhexane 
were determined under similar experimental conditions. 
Diol inhibition 
Epoxide hydrolysis was performed in 100 ml screw-capped bottles sealed with rubber 
septa. The bottles contained 3 ml concentrated cell suspension of Rhodotorula glutinis 
(0.5 g dw), 6 ml dodecane and 5 ml potassium phosphate buffer pH 8.0. Duplicate re-
ference experiments were performed by replacing dodecane by glycerol. Product inhi-
bition was studied in bottles by addition of 1,2-hexanediol to a final concentration of 50 
mM. The bottles were placed into a shaking waterbath at 35°C for pre-incubation during 
60 minutes. Epoxide hydrolysis was started by addition of 50 mmol (6 ml) 1,2-epoxy-
hexane. The course of the reaction was followed for 4 h, by periodic sampling and sub-
sequent analysis of produced 1,2-hexanediol in the aqueous cell suspension. Total yield 
formed diol was determined after 20 h of incubation. Concentrations of diol were 
derived from calibration curves using heat-killed cells of Rhodotorula glutinis under 
similar experimental conditions. 
Effects of increasing concentrations of diol were studied under standard assay condi-
tions40 in the presence of 30 mM up to 400 mM 1,2-hexanediol. 
Membrane bioreactor for batchwise operation 
Two identical hollow-fiber membrane units were used in cascade for epoxide hydrolysis 
and subsequent diol extraction. The hollow-fiber module consisted of a microporous 
hydrophilic ultrafiltration membrane (diameter 200 mm, thickness 6.5 iim, 6500 mem-
branes/module). The ultrafiltration membrane was made of Hemophan, regenerated cel-
lulose, with a diffusive surface area of 1.05 m2 and housing material of acrylonitrile-buta-
diene-styrene copolymers. Bio Nephross Allegro membrane modules were purchased 
from COBE Nephross, The Netherlands. 
Epoxide hydrolysis was performed by cells of Rhodotorula glutinis (7 g dw) in 100 
mM potassium phosphate buffer pH 8.0 (Vy, 160 ml), placed in a waterbath at 35°C. The 
cell suspension was recirculated through the shell sides of the two membrane units by a 
peristaltic pump (<Dy, 60 ml/min). Substrate, (±)-1,2-epoxyhexane dissolved in dodecane 
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(Ve, 75 ml), was recirculated through the lumen side of the first membrane unit in a 
counter current direction (Oe, 30 ml/min). For diol extraction, 100 mM potassium phos-
phate buffer pH 8.0 (Vd, 2.4 1) was recirculated through the lumen side of the second 
membrane unit (Od, 60 ml/min). 
The membrane bioreactor was operated for 3 h without cells to obtain the partition 
equilibrium of the epoxide substrate between the organic and aqueous phases. 
Chemically inert Viton (Cole-Palmer, USA) was used for connecting tubing. The mem-
brane bioreactor could be reused several times without significant damage. 
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Scheme 2. Schematic diagram of a two-phase cascade membrane bioreactor for batch-wise epoxide 
resolution. 
Samples of the reaction mixture were withdrawn separately from the organic solvent 
phase, cell suspension and diol extraction buffer at periodic intervals. Samples (100 fi\) 
from the solvent phase were diluted ten times with ethyl acetate and analyzed directly by 
chiral GLC. Aqueous samples (300 fi\) were mixed with an equal volume of ethyl 
acetate, centrifuged at 16,000 g, and the remaining organic supernatants analyzed by chi-
ral GLC. The membrane bioreactor is schematically depicted in Scheme 2. 
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Membrane bioreactor for continuous operation 
Three identical hollow-fiber membrane units were used in cascade for epoxide hydrolyis 
and subsequent extracting of residual epoxide and formed diol. The hollow-fiber mod-
ules used were identical as the ones applied in the batch-wise operation of the bioreactor. 
ENANTIOPURE 
EPOXIDE 
IN SOLVENT 
<J>y 
YEAS' 
IN 
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vv 
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Scheme 3. Schematic diagram of a two-phase cascade membrane bioreactor for continuous extractive 
epoxide resolution. 
Epoxide hydrolyis was performed by cells of Rhodotorula glutinis (9 g dw) in 100 mM 
potassium phosphate buffer pH 8.0 (Vy, 400 ml), placed in a waterbath at 25°C. The cell 
suspension was recirculated through the shell sides of the three membrane modules by a 
peristaltic pump (Oy, 30 ml/min). Substrate, a solution of 1 M (±)-l,2-epoxyhexane dis-
solved in dodecane (Ve, 3 1), was recirculated through the lumen side of the first mem-
brane unit in a counter current direction (3>e, 2 ml/min). In the second membrane unit, 
epoxide was continuously extracted from the cell suspension in the shell side by dode-
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cane passing through the lumen side ((Os, 10 ml/h). For diol extraction, 100 mM potas-
sium phosphate buffer pH 8.0 was passed through the lumen side of the third membrane 
unit (Od, 100 ml/h). 
Sampling and subsequent analysis by GLC were in analogy as described for the batch-
wise operation of the bioreactor. The membrane bioreactor for continuous operation is 
schematically depicted in Scheme 3. 
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Enantiopure epoxides are versatile building blocks in fine chemistry. For their prepara-
tion, chemical and biotechnological production methods have been developed during 
the past decade. In the early start of the present study, no specific synthetic catalysts 
were yet available and enzymatic production of enantiopure epoxides had been 
described for mono-oxygenase reactions only. Mono-oxygenase-catalyzed epoxidations 
were, however, difficult to scale-up due to product inhibition by the toxic epoxides. A 
more promising alternative was expected from enzymatic kinetic resolution of racemic 
epoxides. Microorganisms, being easily accessible sources of enzymes, were therefore 
screened for the desired catalytic activity. 
Enantioselective epoxide conversion has been first observed in microbial strains that 
produce epoxides as intermediates: alkene-utilizing bacteria. Suitable enzymatic activi-
ties (with values of E > 20) were found in strains of Mycobacterium, Nocardia and 
Xanthobacter. Based on its catalytic activities and growth characteristics, Xanthobacter 
Py2 was selected for this study. 
Improved catalytic properties were subsequently found in epoxide hydrolase-contain-
ing yeasts and the epoxide hydrolase activity of Rhodotorula glutinis has been explored. 
Characteristics of both the cell structure and the yeast epoxide hydrolase allowed 
preparative-scale epoxide resolution by whole cells of this yeast in aqueous/organic 
two-phase media. 
Bacterial epoxide carboxylase 
Epoxide carboxylase activity was initially studied in cells of Xanthobacter Py2 for the 
kinetic resolution of 2,3-disubstituted aliphatic epoxides. (2^)-Enantiomers of short-
chain aliphatic epoxides were resolved from racemic mixtures with very high enantios-
electivities (E > 100). And, in addition, substrate concentrations of 100 mM or more 
were found not to be inhibiting the biocatalyst. Both these observations were interesting 
and epoxide conversion was studied in more detail in a subsequent study. 
Epoxide substrates were converted to ketones via a hydroxy intermediate. The enzy-
matic isomerization was dependent on NAD+ and a reducing cofactor, which could be 
replaced by dithiothreitol (DTT) or other synthetic dithiol compounds. The proposed 
putative enzyme mechanism suggested four steps for the epoxide isomerization reac-
tion. The multi-step conversion and particularly the dependence on both an oxidizing 
and reducing cofactor, was judged to be a major disadvantage for further development 
of the epoxide carboxylase reaction. Consequently, application of this reaction in a 
kinetic resolution process would be feasible only in case of using a whole-cell system 
and not by using the isolated enzyme(s). 
Follow-up studies by various other research groups concentrated on the metabolism of 
the physiological substrate 1,2-epoxypropane. In these studies, the enzymatic steps 
involved in 1,2-epoxypropane metabolism were eventually elucidated. The enzymes 
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involved in this mini-metabolic pathway are called the epoxide carboxylase system1. 
Also the physiological nucleophile and reducing cofactor were identified as 2-mercap-
toethanesulfonic acid (CoM) and NADPH, respectively. It will now be of interest to 
investigate if the enzymes of the epoxide carboxylase system are similarly involved in 
the isomerization of non-physiological 2,3-disubstituted epoxides. Subsequent charac-
terization of the enzyme responsible for the high enantioselectivity in this reaction can 
provide further insight into the structure requirements of chiral catalysts for epoxide 
resolution. 
Yeast epoxide hydrolase 
Initiated by the growing interest in enantiopure compounds, studies on the screening of 
alternative biocatalysts for kinetic resolution of epoxides were set up. For this, cofactor-
independent epoxide hydrolases from microbial origin were tested and their substrate 
scopes mapped out. Initially, the biocatalytical potential of fungal and bacterial epoxide 
hydrolases was investigated by several other research groups. The enzymes from fungal 
and bacterial origin share a common catalytic activity but nevertheless are divergent 
with respect to substrate scope and operational characteristics. Properties of both 
enzyme sources could be possibly found combined in yeasts, since (/) these eukaryotic 
organisms may contain enzymes with fungal and mammalian-resembling substrate 
specificities and (ii) their unicellular appearance would be advantageous in cultivation 
and in whole-cell biocatalysis. 
Yeast epoxide hydrolase (YEH) activity has been first demonstrated in our study on 
the hydrolysis of various epoxides by Rhodotorula glutinis ATCC 201718. The yeast 
enzyme showed a partially complementary substrate specificity in comparison with 
other microbial epoxide hydrolases (Scheme 1)2,°. Asymmetric hydrolysis of meso 
epoxides has been demonstrated as well and was interestingly restricted to the yeast 
enzyme. The substrate scopes, presented in Scheme 1, show that the structural require-
ments for YEH are less than for bacterial and fungal enzymes. Monosubstituted aliphat-
ic epoxides, 2,3-disubstituted aliphatic and aryl epoxides, and trisubstituted alicyclic 
epoxides were all hydrolyzed by YEH with significant enantioselectivities (E > 20). 
Interesting and typical substrates for YEH are the monosubstituted aliphatic epoxides. 
Enantiomeric discrimination was expected to be difficult for these highly flexible and 
rather 'slim' molecules. Therefore, kinetic resolution of a homologous range of aliphat-
ic 1,2-epoxides by Rhodotorula glutinis was studied in more detail. Activities as well as 
enantioselectivities were found to be strongly influenced by the chain length of the sub-
strate used. Similar patterns were observed in a subsequent study using these substrates 
and their unsaturated corresponding epoxyalkenes for YEH-catalyzed hydrolysis by 
Rhodotorula glutinis and related basidiomycetes yeast strains8. Best results, in case of 
Rhodotorula glutinis ATCC 201718, were obtained in the resolution of 1,2-epoxyhexa-
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ne and its unsaturated structure analog 1,2-epoxyhexene. To date, no other epoxide 
hydrolases have been found suitable for the kinetic resolution of monosubstituted 
aliphatic epoxides. An alternative method for kinetic resolution of corresponding sub-
strates is by using the synthetic Jacobsen's salen(Co)III(OAc) catalysts11. 
yeast EH 
bacterial EH fungal EH 
Scheme 1. Complementary and overlapping substrate specificities of microbial epoxide hydrolases. 
Substrates are selected when hydrolyzed with significant enantioselectivities (values of E > 20). Meso 
substrates are not included. Bacterial EH comprises epoxide hydrolases from the genera of 
Rhodococcus, Nocardia, Streptomyces and Agrobacterium, fungal EH those from Aspergillus and 
Beauveria and yeast EH those from Rhodotorula and Rhodosporidium. 
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The present study shows that YEH can accept structurally diverse molecules as sub-
strates, which is a common feature of detoxifying enzymes in general. In this view it 
will be of interest to identify the physiological substrate(s) of YEH in order to (i) deter-
mine whether its biological function is involved in detoxification and («'/) to exploit its 
substrate scope even more effectively. 
Preparative-scale YEH-catalyzed resolution 
Scaling-up kinetic resolution of epoxides was studied by using cells of Rhodotorula glu-
tinis for the resolution of 1,2-epoxyhexane, which was used as a model substrate. 
Substrate concentrations up to 100 mM could be effectively hydrolyzed in aqueous 
media. Under these conditions, substantial amounts of epoxide will however not be dis-
solved in the aqueous phase but will be highly dispersed without forming a separate 
layer. Scaling-up by further increase of substrate amounts seemed very attractive, 
because a simple two-phase system would be obtained with the excess epoxide serving 
as both organic phase and substrate reservoir. However, under these conditions the 
YEH-catalyzed reaction was severely inhibited due to (0 substrate toxicity and iii) prod-
uct inhibition by the formed diol. 
In order to reduce substrate toxicity, biocompatible organic solvents were tested for 
application in an aqueous/organic two-phase reaction medium. Dodecane was selected 
to serve as substrate reservoir, showing no significant loss of catalytic productivity of 
the yeast cells (Figure 1, B,). However, dodecane (and other biocompatible solvents) 
gave no protection to the formed diol and consequently further scaling-up was ham-
pered. In this respect, a distinction can be made between the actual amount of epoxide 
recovered in the process by extraction {effective catalytic productivity) and the amount 
of epoxide resolved by the biocatalyst {overall catalytic productivity). Catalytic pro-
ductivities of kinetic resolution of 1,2-epoxyhexane under various reaction conditions 
are shown in Figure 1. 
An aqueous/organic two-phase membrane bioreactor in cascade configuration was 
applied for separate recirculation of the yeast cells, the organic solvent with concentrat-
ed epoxide, and formed diol in aqueous buffer. In this way, the diol concentration was 
kept below the critical concentration of 50 mM. Enantiopure (S)-epoxide was thus 
obtained as a concentrated 0.9 M solution in dodecane. The overall catalytic productivi-
ty was significantly enhanced in this process (Figure 1, B3). The effective catalytic pro-
ductivity was, however, slightly lower by some undesired loss of epoxide in the recircu-
lating diol extracting buffer. 
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Figure 1. Overall ( • ) and effective ( • ) catalytic productivities in YEH-catalyzed kinetic resolutions 
of 1,2-epoxyhexane. Methods used are: kinetic resolution in aqueous buffer (A,, A2), in aqueous/dode-
cane two-phase medium (B,), and by using a two-phase cascade membrane bioreactor in a batchwise 
operation mode (B3) and in continuous extraction mode (B2). Catalytic productivities are expressed as 
mmol (S^-l^-epoxyhexane (e.e. > 98%) resolved from racemic substrate, per g dry weight of biocat-
alyst used. The overall catalytic productivity is based on the total amount of epoxide resolved by the 
biocatalyst; the effective catalytic productivity on the amount eventually recovered in the process. 
Amounts of biocatalyst were 0.18 g (Ax), 0.4 g (A2), 0.4 g (B,), 9 g (B2) and 7 g (B3) cells of 
Rhodotorula glutinis. 
Almost similar strategies for scaling-up kinetic resolution of epoxides have been fol-
lowed by other research groups in subsequent studies: either by using an aqueous/organ-
ic two-phase system without membrane12, or a membrane bioreactor without organic sol-
vent13. 
Further enhancement of the catalytic productivity was achieved by using the mem-
brane bioreactor in a modified configuration for continuous extractive kinetic resolu-
tion. The modified configuration allowed continuous production of enantiopure epoxide 
without the need for complete resolution of the racemic substrate in the feed reservoir. 
After 12 days of operation, an amount of 134 mmol (13.4 g) enantiopure (S)-epoxide 
(e.e. > 98%) was obtained by incomplete resolution of 3 mol substrate. A low yield of 
only 35% of the total resolved enantiopure (S)-epoxide (379 mmol), very much reduced 
the increase in overall catalytic productivity (Figure 1, B2). The result was mainly 
caused by incomplete extraction of the enantiopure (S)-epoxide in the second membrane 
unit, followed by subsequent loss of the epoxide in the diol extraction buffer. 
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Optimization can possibly be achieved by using a solvent with a higher extracting capa-
city for the epoxide passing through the second membrane unit. However, significant 
amounts of diol may than be extracted as well, resulting in more complicated product iso-
lation. In order to completely utilize the overall high catalytic productivity, a refined 
screening of solvents for selective epoxide extraction will then be necessary. 
Alternatively, better results will also be obtained in case of resolution of less water-solu-
ble epoxides due to similar improved extraction characteristics. 
YEH enzyme vs. whole cells 
Crude enzyme preparations of YEH can be obtained from cells of Rhodotorula glutinis 
in a yield of 90% of the total activity. Further purification will however result in a low 
yield of only 3% of this membrane-associated enzyme14. In organic solvent-containing 
reaction media, it can be advantageous to use enzymes in stead of whole cells because 
enzymes require smaller amounts of water to maintain their catalytic activity. The activ-
ity of crude YEH enzyme was tested in a dodecane-containing reaction mixture. From 
this, the minimal amount of water to maintain activity was determined as 1% (v/v) of 
the total reaction volume (10% moisture content related to the amount of protein). The 
use of the YEH enzyme on a large-scale has however been hampered by the limited 
amounts of enzyme that can be isolated from Rhodotorula glutinis. 
YEH-containing cells of Rhodotorula glutinis, on the other hand, are easily available 
in large quantities and have attractive intrinsic biocatalyst characteristics like (i) an uni-
cellular appearance and a relatively low sensitivity towards (ii) mechanical shear dam-
age and (Hi) toxicity of organic solvents. These characteristics, the good availability, and 
the absence of undesired side-reactions or product degradation, make the use of whole 
cells more advantageous to study preparative-scale reactions. By using cells of 
Rhodotorula glutinis, the feasibility of preparative-scale YEH-catalyzed epoxide reso-
lution has been demonstrated and the critical parameters for scaling-up determined. 
Further application of YEH 
In the course of the present study, related studies were set up in our laboratory to char-
acterize the YEH enzyme and its encoding gene. As a result from these studies, the YEH 
enzyme of Rhodotorula glutinis has been purified14 and its encoding gene cloned and 
characterized15. Subsequently, the YEH has been overexpressed in Escherichia coli16. 
The productivities shown in Table 1 indicate, that both the YEH and the synthetic 
Jacobsen's catalyst intrinsically can be equally effective. The use of the synthetic cata-
lyst has already been demonstrated in a preparative-scale resolution. But the YEH, 
either as isolated enzyme or overexpresed in E. coli, has been tested only on a smaller 
scale. 
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Table 1. Overall catalytic productivities in batch-wise kinetic resolutions of 1,2-epoxyhexane 
Catalyst 
YEH / cells of 
Rhodotorula glutinis 
YEH / cells of 
recombinant E. coli BL21(DE3) 
YEH / enzyme of 
Rhodotorula glutinis 
Jacobsen's catalyst / 
(5,5)-salen(Co)III(OAc) 
amount of resolved 
(S)-1,2-epoxyhexane 
90 mmol 
4.103 mmol 
4.103 mmol 
460 mmol 
yield 
40% 
40% 
40% 
46% 
productivity 
(mmol/g) 
12 
133 
333 
164 
ref. 
present 
study 
16 
14 
11 
A major challenge for application of the improved catalytic productivity of YEH will be 
the scaling-up from bench-scale reactions to a large-scale production process. For this, 
application of either (z) the isolated YEH enzyme or (//) cells from a host, containing 
overexpressed YEH, should be further investigated. In the case of whole-cell applica-
tion, expression of YEH in a more suitable host will probably be necessary. Cells of 
recombinant E. coli don't have the favorable biocatalyst characteristics like the wild-
type Rhodotorula glutinis, and are thus much less applicable for whole-cell epoxide res-
olutions on a large-scale. However, the price to be paid for replacement of E. coli by 
another host, might be a lower expression of YEH. Alternatively, E. coli can be effec-
tively used for the production of high amounts of YEH enzyme, for further development 
of a process with isolated enzyme. 
In conclusion, the catalytic properties of YEH make this biocatalyst the ultimate can-
didate for application in a large-scale process for the preparation of a number of enan-
tiopure epoxides. 
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Summary 
Molecular chirality is of great importance for many processes in biological systems. 
Examples are interactions with enzymes and receptor systems for hormones, sensory 
recognition and drug metabolism. Activation of biological activity when initiated by 
interaction with bioactive compounds is highly based on complementary stereochem-
istry. Synthetic bioactive compounds, like agrochemicals and pharmaceuticals, are 
therefore now preferably produced as single enantiomers. 
Various bioactive compounds can be effectively prepared from enantiopure epoxides. 
These chiral building blocks can be used to introduce one or two adjacent chirality cen-
ters in a target molecule. In the present study, enzymatic kinetic resolution via direct 
epoxide ring-opening has been studied for the preparation of enantiopure epoxides. For 
this method, the biocatalytic activities of a bacterial epoxide carboxylase and a yeast 
epoxide hydrolase have been explored (Scheme 1). 
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Scheme 1. Kinetic resolution of CM- (R)= H, R2= alkyl) and trans- (R[= alkyl, R2= H) 2,3-disubsti-
tuted epoxides by enzymatic nucleophilic ring-opening. XH2 represents NADPH or a reducing dithi-
ol compound. (Ketone: R= alkyl). 
Bacterial epoxide carboxylase 
In alkene-utilizing bacteria, epoxides are generated by mono-oxygenases and subse-
quently further degraded. The epoxide-degrading enzyme system has been recently iden-
tified as an epoxide carboxylase. However, in the absence of C02, the reaction catalyzed 
is actually an isomerization of the epoxide. The enzyme can therefore also be regarded 
as an epoxide isomerase. 
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Epoxide carboxylase/isomerase from Xanthobacter Py2 was found enantioselective in 
the conversion of 2,3-disubstituted aliphatic epoxides (Scheme 1). Only (2S)-enan-
tiomers were converted by propene-grown cells of Xanthobacter Py2 and (2/?)-enan-
tiomers were thus resolved from a racemic mixture with almost maximal feasible yield 
(Chapter 2). Aliphatic 1,2-epoxides, being intermediates in 1-alkene metabolism, were 
converted without remarkable enantioselectivity. 
In the subsequent study, epoxide bioconversion was studied in more detail (Chapter 3). 
Epoxide substrates were found to be converted to ketones via a hydroxy intermediate. 
The enzymatic reaction was dependent on NAD+ and a reducing cofactor, which could 
be replaced by synthetic dithiol compounds. Based on these findings, a four-step reaction 
mechanism was proposed starting from nucleophilic ring-opening of the epoxide. 
Follow-up studies by various other research groups concentrated on the metabolism of 
the physiological substrate 1,2-epoxypropane. By these studies, the enzymatic steps 
involved in 1,2-epoxypropane metabolism were further elucidated. 
Yeast epoxide hydrolase 
Cofactor-independent microbial epoxide hydrolases are generally regarded as attractive 
biocatalytical tools. Epoxide hydrolase catalyzed ring-opening of epoxides can be 
exploited for the production of enantiopure epoxides and vicinal diols (Scheme 1). The 
biocatalytical potential of microbial epoxide hydrolases has been first recognized in 
studies using enzymes from fungal and bacterial origin. Epoxide hydrolase activities in 
yeasts have been subsequently explored. 
Yeast epoxide hydrolase (YEH) activity has been demonstrated for the hydrolysis of 
various structurally divergent epoxides by Rhodotorula glutinis ATCC 201718 
(Chapter 4). Very high enantioselectivities were determined in the hydrolysis of 2,3-dis-
ubstituted aryl and aliphatic epoxides (Scheme 1). Asymmetric hydrolysis of meso 
epoxides has been demonstrated and interestingly this property has been restricted to 
yeasts in particular. 
Typical other substrates for the yeast enzyme are monosubstituted aliphatic epoxides. 
Enantiomeric discrimination was expected to be difficult for these highly flexible and 
rather 'slim' molecules. Therefore, kinetic resolution of a homologous range of alipha-
tic 1,2-epoxides by Rhodotorula glutinis was studied in more detail (Chapter 5). 
Activities as well as enantioselectivities were found to be strongly influenced by the 
chain length of the substrate used. Best results were obtained in the resolution of 1,2-
epoxyhexane. 
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Preparative-scale YEH-catalyzed resolution 
Preparative-scale kinetic resolutions were investigated with 1,2-epoxyhexane as a 
model substrate and cells of Rhodotorula glutinis as biocatalyst {Chapter 6). Scaling-up 
was hampered by inhibition due to substrate toxicity, and to an even higher extend, by 
product inhibition of the formed diol. A critical inhibitory diol concentration was deter-
mined as 50 raM for 1,2-hexanediol. For protection against high epoxide concentrations, 
aqueous/organic two-phase reaction media were tested. Long-chain aliphatic alkanes 
were suitable biocompatible solvents and dodecane was selected for further applica-
tions. However, dodecane and other biocompatible solvents gave no protection towards 
the diol. 
Preparative-scale resolution of 1,2-epoxyhexane (22 g) was performed successfully in 
an aqueous/organic two-phase membrane bioreactor. A cascade configuration of two hol-
low-fiber membrane modules was used (z) to separate the biocatalyst from the organic 
solvent containing feed solution with concentrated epoxide (2 M) and (ii) to remove 
inhibitory amounts of diol. 
In a modified process design, the membrane bioreactor was used for continuous 
extractive kinetic resolution of 1,2-epoxyhexane (1 M in dodecane). Under these condi-
tions, enantiopure (S)-epoxide (13 g) was obtained in the effluent solvent phase. The 
process allowed long-term continuous production of enantiopure epoxide without the 
need for complete resolution of the racemic substrate in the feed reservoir. Optimization 
of this process will however be necessary for improvement of the productivity. 
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Epoxiden zijn verbindingen die door hun cyclische structuur een hoge chemische reac-
tiviteit bezitten. De meest bekende reactie van epoxiden is de nucleofiele substitutie, 
waarbij na ringopening een 1,2-additie product gevormd wordt. Op deze manier kunnen 
diverse substituenten als nucleofiel in het reactieproduct gebracht worden. In enan-
tiomeer zuivere vorm kunnen epoxiden gebruikt worden voor de synthese van speci-
fieke biologisch actieve stoffen. Bij interacties tussen receptoren en biologisch actieve 
stoffen speelt de enantiomere zuiverheid van biologisch actieve stoffen vaak een grote 
rol voor het genereren van de gewenste activiteit. 
Een methode om enantiomeren in zuivere vorm te verkrijgen is de kinetische resolutie 
van racemische mengsels. In het geval van enantiomeer zuivere epoxiden, is nucleofiele 
ringopening met een selectieve chemische- of enzymatische katalysator, hiervoor een 
geschikte reactie. Enzymatische opening van epoxiden kan op eenvoudige wijze uit-
gevoerd worden onder de milde omstandigheden zoals die plaatsvinden in biologische 
systemen. 
Het onderzoek, zoals beschreven in dit proefschrift, was gericht op de bestudering van 
de kinetische resolutie van epoxiden via ringopening met behulp van microbiele enzy-
men. De methode werd bestudeerd met een bacterieel epoxidecarboxylase en een gist 
epoxidehydrolase. 
Bacterieel epoxidecarboxylase 
Biologisch gevormde epoxiden ontstaan in de meeste gevallen door mono-oxygenase 
gekatalyseerde epoxidaties van alkenen of aromaten. Gezien de hoge toxiciteit van 
epoxiden hebben epoxide producerende organismen eveneens systemen om de epoxiden 
via ringopening onschadelijk te maken. In alkeen gebruikende bacterien worden epoxi-
den evenwel gevormd als intermediairen in het alkeen metabolisme. Het bacterieel 
alkeen metabolisme is uitgebreid bestudeerd aan Xanthobacter Py2. Groeisubstraten 
voor Xanthobacter Py2 waren bekend als (C2 tot C6) 1-alkenen en overeenkomstige 1,2-
epoxiden werden dan ook volledig omgezet. 
Conversie van methylgesubstitueerde 2,3-epoxiden door Xanthobacter Py2 ging 
daarentegen gepaard met een hoge enantioselectiviteit (E > 100). Van racemische sub-
straten werden enkel de (25)-enantiomeren omgezet zodat (2#)-enantiomeren in zuivere 
vorm verkregen werden (Hoofdstuk 2). 
Epoxide conversie werd vervolgens bestudeerd in celextracten van Xanthobacter Py2 
(Hoofdstuk 3). De reactie bleek afhankelijk te zijn van zowel NAD+ als een reducerende 
cofactor, welke vervangen kon worden door dithiol verbindingen. Ketonen werden ge-
identificeerd als producten van de reactie met 1,2- en (25)-epoxiden, Aan de hand van 
de resultaten werd een reactiemechanisme opgesteld. Ringopening van het epoxide en 
NAD+-afhankelijke oxidatie van een 8-hydroxythioether intermediair, vormden de cen-
trale readies in dit mechanisme. Het fysiologische mechanisme voor de omzetting van 
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1,2-epoxypropaan is vervolgens door andere onderzoeksgroepen verder in detail 
bestudeerd (zie Hoofdstuk 1, 1.1.3.). De laatste stap van dit mechanisme geeft aan dat in 
aan- of afwezigheid van C02, respectievelijk een 8-ketocarbonzuur of een keton als reac-
tieproduct kan ontstaan. Het betrokken enzymsysteem is overeenkomstig omschreven als 
een epoxidecarboxylase. 
Gist epoxidehydrolase 
Het huidige onderzoek werd voortgezet met de bestudering van een epoxidehydrolase 
uit gist. Epoxidehydrolasen katalyseren de additie van water aan epoxiden en maken op 
deze wijze deel uit van het detoxificerende enzymsysteem van vele organismen. 
Epoxidehydrolase activiteit in gist werd beschreven voor Rhodotorula glutinis ATCC 
201718 {Hoofdstuk 4). Een opvallende eigenschap van dit epoxidehydrolase was de 
grote variatie in molecuulstructuren die als substraat geaccepteerd werden. Daarnaast 
was asymmetrische hydrolyse van meso substraten nog niet waargenomen bij andere, 
reeds bekende bacteriele en schimmel epoxidehydrolasen. Hoge enantioselectiviteiten 
(E > 100) werden gevonden in de hydrolyse van methylgesubstitueerde aryl- en ali-
fatische 2,3-epoxiden. 
Hydrolyse van een reeks alifatische 1,2-epoxiden werd vervolgens in detail bestudeerd 
(Hoofdstuk 5). Enzymatische kinetische resolutie met voldoende enantioselectiviteit 
was voor deze substraten nog niet mogelijk gebleken. Het ontbreken van specifieke sub-
stituenten en de grote bewegingsmogelijkheid van deze groep van substraten zou een 
selectieve binding van de enantiomeren bemoeilijken. Deze verwachting werd bij epox-
ide hydrolyse door Rhodotorula glutinis echter maar ten dele waargenomen. De resul-
taten waren afhankelijk van het gebruikte substraat: de ketenlengte van het epoxide 
bleek een grote invloed te hebben op de activiteit en enantioselectiviteit van het enzym. 
Goede resultaten werden verkregen bij de resolutie van 1,2-epoxyhexaan. 
Opschaling van de epoxidehydrolase reactie 
Opschaling van de kinetische resolutie werd bestudeerd met 1,2-epoxyhexaan als model-
substraat en Rhodotorula glutinis als biokatalysator (Hoofdstuk 6). Kritische parameters 
in de opschaling bleken remming van de reactie door toxiciteit van het epoxide en daar-
naast door hoge concentraties diol. Remming door 1,2-hexaandiol werd waargenomen 
bij concentraties van 50 mM of hoger. 
Scheiding tussen gistcellen en hoge concentraties epoxide is mogelijk door toepassing 
van een reactiemedium met een gescheiden tweede fase, bestaande uit een organisch 
oplosmiddel met daarin opgelost substraat. Oplosmiddelen die zelf weinig remming van 
de epoxidehydrolase reactie vertoonden, werden gevonden in de groep van apolaire ali-
fatische alkanen. Hiervan is dodecaan geselecteerd voor verdere toepassingen. 
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Gebruik van hollevezel membranen bleken effectief voor een proces met gescheiden cir-
culatie van gistcellen en buffer met diol. Op deze manier werd de concentratie van het 
gevormde diol voldoende laag gehouden. Minimaal contact tussen gistcellen en epoxide 
was mogelijk door gescheiden circulatie van celsuspensie en geconcentreerd 1,2-epoxy-
hexaan in dodecaan. Epoxide resolutie werd daarom uitgevoerd door recirculatie van 
gistcellen door twee membraan modulen: de eerste module voor hydrolyse van het 
epoxide en de tweede module voor verwijdering van het gevormde diol. Met de meth-
ode werd 6,5 g (S)-l,2-epoxyhexaan verkregen, als een 0,9 M oplossing in dodecaan, na 
volledige resolutie van 22 g substraat. 
Kinetische resolutie met continue extractie werd uitgevoerd door toepassing van drie 
membraan modules en modificatie van het proces. Hierbij werd (S)-l,2-epoxyhexaan, 
verkregen na resolutie van het substraat, direct geextraheerd in dodecaan en kwam daar-
door continu en apart beschikbaar. Op deze manier kon 13 g enantiomeer zuiver epoxide 
worden verkregen zonder volledige kinetische resolutie van het substraat in het voorraad 
reservoir. Optimalisering van de continue extractie zal nodig zijn om de epoxidehydro-
lase activiteit meer efficient te kunnen benutten. 
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Een proefschrift is als bekroning van een onderzoek gewoonlijk als een van de doel-
stellingen in een onderzoeksproject opgenomen. Bij het huidige onderzoek was er aan-
vankelijk nog geen doel om een proefschrift te schrijven. Het hier beschreven onderwerp 
leverde dan ook louter het plezier om in grote vrijheid met het onderzoek bezig te zijn en 
aan de hieraan verbonden 'randactiviteiten' te kunnen deelnemen. 
Bij de afsluiting van het onderzoek werd door mijn promotor Jan de Bont het voorstel 
gedaan om de resultaten in een proefschrift samen te vatten. Jan, voor deze mogelijkheid 
om te kunnen promoveren ben ik je dan ook zeer dankbaar. Ook wil ik je bedanken voor 
de nimmer aflatende belangstelling en waardering voor het epoxide-onderzoek tijdens de 
gehele periode. Het was vooral daardoor aangenaam om te werken in de bijzondere 
werkomgeving van Industriele Microbiologic Naast de aanpak van mijn eigen onder-
werp heb ik ook veel van je geleerd over de organisatie van onderzoek en onderwijs in 
het algemeen. Ondanks de veranderde situatie was het overleg tijdens het schrijven van 
het boekje gelukkig nog steeds als vanouds. 
Lof ook voor de mensen van Organische Chemie en Proceskunde. Jullie steun in het 
afgelopen jaar maakte het mede mogelijk dat ik het onderzoek op positieve wijze heb 
kunnen afronden. Met name Maurice Franssen en Ernst Sudholter wil ik bedanken voor 
hun inzet om bij Organische Chemie te kunnen komen en mij de ruimte te geven om het 
proefschrift af te ronden. Zonder hun steun zou ik niet aan het boekje zijn begonnen. 
Maurice, daarnaast wil ik je bedanken voor je hulp bij 'mechanistische chemie' en voor 
de bijdrage die je samen met Hugo Jongejan hebt geleverd aan het onderzoek zoals 
beschreven in hoofdstuk 3. 
Het grootste deel van het werk is van dichtbij meegemaakt door mijn ex-kamergenoot 
Martin de Wit. Martin, jouw steun en manier van relativeren heeft mij vaak geholpen 
om de zaken op het goede spoor te houden. Ook de directe hulp bij het gebruik van 
apparatuur en PC's is voor mij altijd belangrijk geweest om het onderzoek te kunnen 
uitvoeren. Bedankt voor je collegialiteit. 
Een woord van dank eveneens aan Jan Verdoes. Jan, in de periode dat ik aan dit boek-
je werkte was jij degene die nog direct in de buurt was om mijn vragen en twijfels aan te 
horen. Jouw vermogen om onder alle omstandigheden gewoon door te werken was voor 
mij (en vele andere IM-ers) een sterke stimulans om zelf ook door te gaan. Bedankt voor 
je steun en voor het overnemen van diverse taken in die periode. 
Een stapeltje onderzoeksresultaten is nog geen proefschrift. Om van de tekst en plaat-
jes uiteindelijk een proefschrift te maken is het werk van Karin Scheele essentieel 
geweest. Karin, dankzij jouw ervaring en inzet is er nu een boekje met een uniforme lay-
out. Ook voor de vele adviezen en begeleiding tijdens het eindtraject ben ik je heel 
dankbaar. 
Door een aantal studenten is tijdens hun afstudeervak een bijdrage aan het onderzoek 
geleverd. Met betrekking tot het eerste onderwerp wil ik daarvoor bedanken: Jan Dirk 
Jansma, Nicolette Klijn, Imke Leenen, Bart Fraaye, Maureen Cox, Marco Fraaye en in 
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het bijzonder Andre de Haan die voor een belangrijk deel aan de start van het onderzoek 
heeft bijgedragen. Het epoxidehydrolase onderzoek heeft vorm gekregen dankzij de bij-
drage van Eyke van den Ban, Bert Beekman, Anneke van der Zwet, Use van Nijhuis, 
Herman van Herk en Jeroen Rouwkema. 
Een sterke impuls voor het onderzoek was ook de samenwerking met binnenlandse en 
buitenlandse collega's. Hierbij is de hulp van Henk Swarts vooral terug te vinden in de 
hoofdstukken 4 en 5. Henk, bedankt dat je altijd wel tijd wist vrij te maken om me te 
helpen bij de synthese en analyse van nieuwe verbindingen. Op een heel ander terrein 
was de samenwerking met Hans Visser. Hans, bedankt dat je me wilde inwijden (of 
althans geprobeerd hebt) in de moleculaire biologie van het gist epoxidehydrolase. Ik ben 
blij dat jouw onderzoek uiteindelijk de goede kant op is gegaan en nu ook met een boek-
je afgerond kan worden. 
I am grateful to Christoph Syldatk, David Leak and Manuela da Fonseca for their con-
tribution to the study on the epoxide isomerization. Dear David, I enjoyed and learned a 
lot from the discussions with you during participation in the EC-project. 
Very successful was the collaboration with Martie van Dyk and Adri Botes from the 
University of the Orange Free State in South Africa. Dear Martie and Adri, I very much 
enjoyed the time I spent in Bloemfontein. Our work has initiated the use of aliphatic 1,2-
epoxides as substrates for the yeast epoxide hydrolase and our first joint paper is includ-
ed as chapter 5 in this thesis. 
Chapter 6 is based on the work done together with Won Jae Choi from the Republic of 
South Korea. Dear Won Jae, from the day of your arrival it was a pleasure to work with 
you during your stay here. It was remarkable how you rapidly adapted to our life and 
actually felt like a Dutchman. From all the work you have done we were able to publish 
only a small part of it. The results are however of great importance for the application of 
the yeast epoxide hydrolase. 
Lieve Elly, Julia en Paul, een deel van het boekje is geschreven in de tijd die jullie 
hebben ingeleverd ten koste van andere activiteiten. Bedankt dat jullie me een jaartje 
'vrijaf hebben gegeven om aan het proefschrift te kunnen werken. 
Carel 
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